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A B S T R A C T
Background
Work disability such as sickness absence is common in people with depression.
Objectives
To evaluate the effectiveness of interventions aimed at reducing work disability in employees with depressive disorders.
Search methods
We searched CENTRAL (The Cochrane Library), MEDLINE, EMBASE, CINAHL, and PsycINFO until January 2014.
Selection criteria
We included randomised controlled trials (RCTs) and cluster RCTs of work-directed and clinical interventions for depressed people
that included sickness absence as an outcome.
Data collection and analysis
Two authors independently extracted the data and assessed trial quality. We used standardised mean differences (SMDs) with 95%
confidence intervals (CIs) to pool study results in the studies we judged to be sufficiently similar. We used GRADE to rate the quality
of the evidence.
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Main results
We included 23 studies with 26 study arms, involving 5996 participants with either a major depressive disorder or a high level of
depressive symptoms. We judged 14 studies to have a high risk of bias and nine to have a low risk of bias.
Work-directed interventions
We identified five work-directed interventions. There was moderate quality evidence that a work-directed intervention added to a
clinical intervention reduced sickness absence (SMD -0.40; 95%CI -0.66 to -0.14; 3 studies) compared to a clinical intervention alone.
There was moderate quality evidence based on a single study that enhancing the clinical care in addition to regular work-directed care
was not more effective than work-directed care alone (SMD -0.14; 95% CI -0.49 to 0.21).
There was very low quality evidence based on one study that regular care by occupational physicians that was enhanced with an
exposure-based return to work program did not reduce sickness absence compared to regular care by occupational physicians (non-
significant finding: SMD 0.45; 95% CI -0.00 to 0.91).
Clinical interventions, antidepressant medication
Three studies compared the effectiveness of selective serotonin reuptake inhibitor (SSRI) to selective norepinephrine reuptake inhibitor
(SNRI) medication on reducing sickness absence and yielded highly inconsistent results.
Clinical interventions, psychological
We found moderate quality evidence based on three studies that telephone or online cognitive behavioural therapy was more effective
in reducing sick leave than usual primary or occupational care (SMD -0.23; 95% CI -0.45 to -0.01).
Clinical interventions, psychological combined with antidepressant medication
We found low quality evidence based on two studies that enhanced primary care did not substantially decrease sickness absence in the
medium term (4 to 12 months) (SMD -0.02; 95% CI -0.15 to 0.12). A third study found no substantial effect on sickness absence in
favour of this intervention in the long term (24 months).
We found high quality evidence, based on one study, that a structured telephone outreach and care management program was more
effective in reducing sickness absence than usual care (SMD - 0.21; 95% CI -0.37 to -0.05).
Clinical interventions, exercise
We found low quality evidence based on one study that supervised strength exercise reduced sickness absence compared to relaxation
(SMD -1.11; 95% CI -1.68 to -0.54). We found moderate quality evidence based on two studies that aerobic exercise was no more
effective in reducing sickness absence than relaxation or stretching (SMD -0.06; 95% CI -0.36 to 0.24).
Authors’ conclusions
We found moderate quality evidence that adding a work-directed intervention to a clinical intervention reduced the number of days on
sick leave compared to a clinical intervention alone. We also found moderate quality evidence that enhancing primary or occupational
care with cognitive behavioural therapy reduced sick leave compared to the usual care. A structured telephone outreach and care
management program that included medication reduced sickness absence compared to usual care. However, enhancing primary care
with a quality improvement programdid not have a considerable effect on sickness absence. There was no evidence of a difference in effect
on sickness absence of one antidepressant medication compared to another. More studies are needed on work-directed interventions.
Clinical intervention studies should also include work outcomes to increase our knowledge on reducing sickness absence in depressed
workers.
P L A I N L A N G U A G E S U M M A R Y
Interventions to help depressed people resume work
Depression is a major problem that affects about 300 million people globally. Symptoms of depression include the core symptoms
of low mood or loss of interest coupled with other symptoms such as feelings of inadequacy and hopelessness or sleep problems.
These symptoms usually impair functioning and therefore sickness absence is common in people with depression. We evaluated the
effectiveness of interventions that can help depressed workers to resume work activities.
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Studies we found
We found 23 studies, involving 5996 participants, that looked at the effects on sick leave of changes at work that were in addition to
regular treatment, better psychological treatment, improving primary care, antidepressant pills and exercise.
Effects of changes at work in addition to regular care
In three studies with 251 participants, researchers looked at changes at work such as work modification or coaching in addition to
regular care and found that these reduced sickness absence to a moderate extent.
In two studies, researchers tried to improve care that was already directed at changes at work but did not find any effects of these
improvements on sick leave.
Effects of psychological treatment
In three studies with 326 participants, researchers found that cognitive behavioural therapy that was provided online or by telephone
reduced sickness absence to a moderate extent compared to regular care.
In one high quality study, a special care programme carried out via the workplace also reduced sick leave when compared to regular
care.
Effects of antidepressant pills
Three studies compared antidepressant pills with each other but there were no consistent effects on sickness absence.
Improving primary care
Improving primary care through quality improvement programs for general practitioners did not reduce sickness absence in three
studies.
Exercise
One study found that participants had a reduction in sick leave after doing stretching exercises. Two other studies did not find an effect
on sick leave after physical exercises such as running or using the gymnasium.
More studies should look at the effects of changes at work. Regular clinical studies should also measure the effects on sick leave because
this is an important consequence of depression.
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
Work-directed intervention plus clinical intervention compared to clinical intervention alone for depressive disorder
Patient or population: Persons with depressive disorder
Settings: Two studies were conducted in outpat ient and one in a workplace or Employee Assistance Program
Intervention: Work-directed intervent ion plus clinical intervent ion
Comparison: Clinical intervent ion alone




Quality of the evidence
(GRADE)
Comments
Assumed risk Corresponding risk
Clinical intervention Work-directed inter-
vention plus clinical in-
tervention
Days of sickness ab-
sence
Follow up: 4 -12 months
The mean days of sick-
ness absence in the in-
tervent ion groups was
0.4 standard devia-
tions lower
(0.66 to 0.14 lower)






A standard deviat ion of
0.5 represents a moder-
ate dif f erence between
groups
* The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% conf idence interval) is
based on the assumed risk in the comparison group and the relative effect of the intervent ion (and its 95%CI).
CI: Conf idence interval; SMD: Standardised Mean Dif ference
Intervention description:
In two studies, an occupat ional therapy program focusing on work reintegrat ion, combining modif ied work and support ive intervent ions was added to clinical care. In one
study a regular Employee Assistance program was expanded and incorporated work coaching and modif icat ion
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our conf idence in the est imate of ef fect.
Moderate quality: Further research is likely to have an important impact on our conf idence in the est imate of ef fect and may change the est imate.
Low quality: Further research is very likely to have an important impact on our conf idence in the est imate of ef fect and is likely to change the est imate.





























































































































































































B A C K G R O U N D
Description of the condition
Depression is a major public health problem, with 298 million
cases of major depressive disorders at any time point in 2010
(Ferrari 2013). The worldwide point prevalences of depressive dis-
order were 4.4% in both 2005 and 2010 (Ferrari 2013). Symp-
toms of depressive disorder include the presence of one or two core
symptoms of low mood and loss of interest, coupled with other
symptoms such as feelings of inadequacy and hopelessness, sleep
disturbance, weight change, fatigue, impaired concentration, ag-
itation or slowing down of movement and thought, and suicidal
ideation (APA 2013). Depressive disorders can be classified along
a continuum by the levels of symptom severity, number of mental
or physical symptoms, and duration. Corresponding diagnostic
categories range from persistent depression (dysthymia) and sub-
clinical states (minor depressive disorder) to major depressive dis-
order (APA 1994; APA 2013).
Besides the serious consequences in terms of individual suffering,
depression has a large impact on social functioning and the ability
of patients to work (Hirschfeld 2000; Lerner 2008). In a popula-
tion of US workers, the 12-month prevalence of major depressive
disorder was found to be 6% and was associated with 27.2 lost
workdays per ill worker per year (Kessler 2006). In terms of an-
nualised human capital loss to employers in the US labour force,
this amounted to about USD 36 billion (Kessler 2009). The high
prevalence of depressive disorders, combined with the impact on
work disability, has extensive societal consequences. In 1990, ma-
jor depressive disorders were the 15th leading contributor to the
global burden of disease in terms of ’Disability Adjusted Life Years’
(DALYs), which is the sum of years of productive life lost due to
premature mortality and the years of productive life lost due to
disability. Data from the global burden of disease study in 2010
showed that depressive disorders are now ranked 11th (Murray
2012).
While working is important from a societal point of view, work
is also an important aspect of the quality of life of individuals
(Bowling 1995). Work provides income, structure, and social in-
teractions. One salient consequence of depression is absenteeism,
but depression can also affect the at-work productivity for work-
ers (Lerner 2008). Depressed workers experience specific limita-
tions in their ability to function at work. These limitations include
performing mental and interpersonal tasks (Adler 2006; Burton
2004). The quality of work performance can also be affected, as
was shown in studies focusing on errors and safety issues (Haslam
2005; Suzuki 2004). Depressed workers may need to make an ex-
tra effort to be productive during their work (Dewa 2000), which
may lead to spillover effects of fatigue after work.
Description of the intervention
Work ability of depressedworkers canbe targeted by interventions.
First of all, work-directed interventions aim to ameliorate the con-
sequences of the depressive disorder on the ability to work. These
types of interventions either target the work itself, by modifying
the job task, or (temporarily) reduce the working hours. Work-
directed interventions can also support the worker in dealing with
the consequences of their depression at the workplace.
Second, clinical interventions aimed at reducing depression symp-
toms may improve work ability (Hees 2013b). Current clinical
practice guidelines for the treatment of major depressive disor-
der recommend pharmacotherapy, psychotherapy, or a combi-
nation of both (APA 2010; NICE 2010). Pharmacologic treat-
ment for major depressive disorder includes antidepressant med-
ication such as tricyclic antidepressants (TCAs), selective sero-
tonin reuptake inhibitors (SSRIs), monoamine oxidase inhibitors
(MAO inhibitors), and selective norepinephrine reuptake in-
hibitors (SNRIs). With regard to psychotherapy, cognitive be-
havioural therapy (CBT) and interpersonal therapy are considered
effective treatment options (NICE 2010). Exercise has been in-
creasingly used as an alternative to pharmacological or psychother-
apeutic interventions (Cooney 2013).
How the intervention might work
Work-directed interventions are deemed to reduce work disabil-
ity by creating a work environment better suited for a depressed
worker, such as modifying work tasks or working hours.Moreover,
the worker can be supported in dealingwith the depression at work
by a gradual return to work program or by enhancing skills to cope
with work situations (Lagerveld 2012). Clinical interventions may
reduce work disability by reducing depressive symptoms, thereby
eliminating the obstacles to working.
Why it is important to do this review
Considering the impact of depressive disorders on the occupational
health of many affected workers, it is vital to know what types of
interventions are effective in improving occupational health. In
the first version of this review, in 2008, we concluded that there
was an urgent need to evaluate interventions that address work
issues in future research. Since then, several such studies have been
published underpinning the need for an update of the review.
O B J E C T I V E S
The goal of this review was to evaluate the effectiveness of inter-
ventions aimed at reducing work disability in employees with de-
pressive disorders.
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We considered the effectiveness of two types of interventions:
1. work-directed interventions, i.e. addressing the work or the
work-worker interface as part of the clinical treatment or as a
stand-alone intervention; and
2. clinical interventions, i.e. treatment of depressive disorder
without a focus on work.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We included all randomised controlled trials (RCTs), including
cluster RCTs, in this review. We did not use any language restric-
tions.
Types of participants
Patient characteristics and setting
The population was limited to adult (that is over 17 years old)
workers (employees or self-employed). We included participants
from occupational health settings, primary care, or outpatient care
settings. We based the selection of the studies on the primary
outcome only.
Diagnosis
We defined depressive disorder as a main diagnosis fulfilling
the criteria of the Diagnostic and Statistical Manual (DSM-IV)
(APA 1994; APA 2013), the Research Diagnostic Criteria (RDC)
(Spitzer 1979), or the InternationalClassificationofDisease (ICD-
10) (WHO 1992) for one of the following disorders: dysthymic
disorder, minor depressive disorder, or major depressive disor-
der. We also included studies that defined depressive disorder as
a level of depressive symptoms assessed by validated self-report
instruments published in peer-reviewed journals. An examples is
the Beck Depression Inventory (BDI) (Beck 1987); or clinician-
rated instruments such as the Hamilton Depression Rating Scale
(HDRS) (Hamilton 1967) or the Montgomery-Åsberg Depres-
sion Rating Scale (MADRS) (Montgomery 1979).
Exclusion criteria
We excluded studies involving workers with a primary diagnosis
of a common mental disorder other than a depressive disorder.We
did not exclude workers with a co-morbidity from other common
mental disorders (such as anxiety disorders), but we did exclude
workers with bipolar disorders or depressive disorders with psy-
chotic features.
Types of interventions
We included all interventions aimed at reducing work disability,
thereby differentiating work-directed interventions from clinical
interventions. Examples of work-directed interventions are light
duty, graded work exposure, or supportive interventions enhanc-
ing the coping of the worker with depression in the workplace.
We categorised work-directed interventions as:
1. modified work, modified working hours or job tasks;
2. supportive, supporting the worker in coping with
depression at the workplace; and
3. a combination of modified work and supportive
interventions.
We divided clinical interventions into:
1. antidepressant medication, interventions that use any type
of antidepressant medication at any dose;
2. psychological, where psychological interventions are
restricted to cognitive behavioural interventions (CBT),
interpersonal therapy (IPT), problem solving therapy (PST),
psychodynamic therapy, counselling, and occupational therapy,
undertaken by qualified trained therapists; and
3. physical, where physical interventions are restricted to those
using exercise, i.e. strength or aerobic training.
Main comparisons
We conducted, where data were available, the following treatment
comparisons in order to address the review’s objectives.
1. Work-directed interventions
• Work-directed intervention plus clinical intervention versus
clinical intervention alone
• Work-directed intervention plus clinical intervention versus
work-directed alone
• Any work-directed intervention versus no intervention or
care as usual
• Any work-directed intervention versus an alternative work-
directed intervention
2. Clinical interventions, antidepressant medication
• Any antidepressant medication versus any other
antidepressant medication
• Any antidepressant medication versus placebo
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• Any antidepressant medication versus any psychological
intervention
3. Clinical interventions, psychological
• Any psychological intervention versus other psychological
intervention
• Any psychological intervention versus no intervention or
care as usual
4. Clinical interventions, psychological plus antidepressant
medication
• Psychological intervention combined with antidepressant
medication versus antidepressant medication alone
• Psychological intervention combined with antidepressant
medication versus no intervention or care as usual
5. Clinical interventions, exercise
• Exercise intervention versus any other exercise intervention
• Exercise intervention versus no intervention or care as usual
Types of outcome measures
In this review, we operationalised reduction in work disability
as a reduction in sickness absence and as enhancement in work
functioning.
Primary outcomes
The main outcome measure in this review was days of sickness
absence during the follow-up period. Sickness absence data could
be extracted from the employee attendance records or the files of
a compensation board, or could be self-reported.
Secondary outcomes
When available, we included the following secondary outcomes
from the included studies.
1. Depression (either dichotomously or continuously
measured).
2. Work functioning (Nieuwenhuijsen 2010). Examples of
work functioning measures are the Endicott Work Productivity
Scale (EWPS) (Endicott 1997) and the Sheehan Disability Scale
(SDS) (Sheehan 1996). We only included instruments that
separately measured work functioning (instead of work and other
activities combined).
3. Employment status after a period of time (categories being:
’not working’, ’working less hours than the contract hours or
having modified duties’, or ’working all contract hours without
modified duties’.
We did not include other outcomes such as employee satisfaction,
general social functioning (not work specific), or quality of life
scales.
We considered the effects measured with all the above instruments
on the following timescales:
• short term, up to one month;
• medium term, from one month to a year; and
• long term, over a year.
Search methods for identification of studies
Electronic searches
The updated search included all publications from January 2006
up until January 2014 (Appendix 1). For this update, we searched
the following electronic databases: CENTRAL (The Cochrane
Library), MEDLINE, PsycINFO, EMBASE, and CINAHL. We
used three types of terms: depression-related words combined
with work-related words and database-specific methodological fil-
ter terms. We adapted search terms for PsycINFO, EMBASE,
and CINAHL from the MEDLINE search to fit the specific re-
quirements of those databases. For CENTRAL, we replaced the
methodological filter by a filter to identify trials.
We based the selected work-related search terms on previous stud-
ies. Work* and occupation* are sensitive single terms used to lo-
cate occupational health studies, as advocated byVerbeek (Verbeek
2005). Furthermore, we selected database-specific terms relevant
to our objective from a study testing which work-related search
terms are best suited for literature searching on chronic disease
(rheumatoid arthritis, diabetes mellitus, hearing problems, and
depression) and work (Haafkens 2006).
We conducted the original search strategy for the first version of
this review in 2006, using no limits on publication date (Appendix
2).
Searching other resources
We checked the reference lists of all articles that we retrieved as
full papers and of all retrieved systematic and narrative reviews in
order to identify further potentially eligible studies.
Data collection and analysis
Selection of studies
Pairs of authors (KN, BF, CF, UB, AV) independently reviewed
all studies retrieved from the searches for eligibility. If the title and
abstract provided sufficient information to decide that the study
did not fulfil the criteria for selection, we excluded the study at that
point. We excluded studies in this phase only if the study did not
include participants with depressive disorders or it was not a con-
trolled intervention study. When it was not clear whether sickness
absence was measured, we retrieved the full article before deciding
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upon exclusion. We then examined the full text publications of
the remaining studies in order to decide which studies fulfilled
all inclusion criteria. We documented the reasons for exclusion at
that stage. The two authors discussed any disagreement about the
inclusion of studies until they reached consensus. If they could not
resolve their difference of opinion, they consulted a third author
(JV).We had all articles published in languages other than English
translated or assessed for inclusion by a native speaker.
Data extraction and management
We constructed a data extraction form that enabled the authors
to extract the data from the included studies. For each study, one
author filled out the forms and this form was checked by a second
author (AN, AV, BF, CF, HH, KN, and UB participated in data
extraction) and they solved differences of opinion by discussion.
When only a proportion of the study population was workers, we
extracted the data for that subgroup from the article. In the case
where these data were not reported, we asked the original authors
to provide the data for this subgroup. We used the same procedure
for studies where only a proportion of the study population was
depressed.
Assessment of risk of bias in included studies
Pairs of authors (AN, AV, CH, HH, or UB with either KN or
BF) independently assessed the risk of bias of the included studies.
We used the following items to assess risk of bias in the included
studies: random sequence generation (selection bias), allocation
concealment (selection bias), blinding of participants and person-
nel (performance bias), blinding of outcome assessment (detec-
tion bias), incomplete outcome data (attrition bias), and selective
reporting (reporting bias). We evaluated risk associated with in-
complete outcome data or with blinding of outcome assessments
separately for depressive symptoms and the sickness absence data.
We assessed the risk of bias in RCTs and cluster RCTs by using
the Cochrane Collaboration’s risk of bias tool (Higgins 2011).
With regard to the risk of attrition bias, we calculated the per-
centage lost to follow up taking the number randomised as the
starting point and the number analysed at the latest follow-up
measurement as the endpoint. We assigned a high risk of attrition
bias to studies with a percentage of participants lost to follow up
of more than 20%, and a low risk for studies with less than 10%
lost to follow. The risk of attrition bias for studies with 10% to
20% lost to follow up depended on whether the analyses of results
accounted for attrition sufficiently.
We rated each potential source of bias as ‘high risk’ of bias, ‘low
risk’ of bias, or ‘unclear risk’ of bias in the ‘Risk of bias’ table.
Next, we constructed a ‘Risk of bias’ summary figure together
with an overview ‘risk of bias’ graph as described in the Cochrane
Handbook for Systematic Reviews of Interventions (Higgins 2011).
Where information on risk of bias related to unpublished data or
correspondence with a researcher, we noted this in the risk of bias
table.
Measures of treatment effect
We plotted the results of each trial as means and standard devi-
ations (SD) for continuous outcomes. For each timescale (short
term, medium term, and long term), we selected the last avail-
able observation within this period for the meta-analysis. For the
primary outcome measure, that is days of sickness absence, we
transformed the number of days or hours worked during the fol-
low up into days of sickness absence. To do so, we extracted the
hours or days worked from the maximum of hours an employee
would work in that specific country. When transforming the data
from days worked to days not worked, the SDs did not need to be
transformed. When transforming the data from hours to days, we
divided both the means and SDs by eight. Studies used different
time spans during which they measured the number of days of
sickness absence. Therefore, for days of sickness absence we used
the standardised mean difference (SMD) with a 95% confidence
interval (CI)) between the intervention and control groups as the
summary effect measure.
For the secondary outcome measures, we also used SMDs because
it is likely that these outcomes were measured with different in-
struments.We chose to treat ordinal variables using a scale of more
than five categories as continuous variables (it should be noted
that this choice was based on arbitrary criteria). We dichotomised
scales with less than five categories. For dichotomous data, we cal-
culated the risk ratios (RRs) and 95% CIs.
For depression data, where studies presented both dichotomous
and continuous data, we preferred the continuous outcome mea-
sures since the majority of the studies presented these.
Unit of analysis issues
For studies that employed a cluster randomised design and did not
consider the design effect in the analyses, we planned to calculate
the design effect by following the methods stated in the Cochrane
Handbook for Systematic Reviews of Interventions (Donner 2002)
based on a fairly large assumed intra-cluster correlation of 0.10.
However, the cluster RCTs included in the review reported neg-
ligible intra-cluster correlations. Therefore, we did not adjust the
measures of effect presented by the authors.
Dealing with missing data
If the SDs (continuous data) or numbers of outcomes for each
group (dichotomous data) were not presented in the publication,
we contacted the authors with a request to provide these data.
Whenever authors were unable or unwilling to provide this infor-
mation, we calculated SDs from P values and CIs following the
instructions of the Cochrane Handbook for Systematic Reviews of
Interventions (Higgins 2011).
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We sought additional information regarding study details or sta-
tistical data, or both, from the authors of 20 studies and received
information from 15 authors. Ten of the authors provided sta-
tistical data that had not been published in their articles, which
enabled us to include nine of these studies in the meta-analyses. In
the case of two studies the correspondence led to the exclusion of
the study because essential information on the primary outcome
measure could not be provided (Simon 2000; Stant 2009).When-
ever essential information concerning the risk of bias could not be
obtained within four weeks of contacting the authors, we listed
the corresponding details as ’unclear’.
Assessment of heterogeneity
We assessed statistical heterogeneity in the meta-analyses with the
I² statistic. If we observed considerable heterogeneity (I² > 75%),
we refrained from statistical pooling of the studieswithin that com-
parison. Substantial inconsistency (I² statistic) also led to down-
grading of the quality of the evidence (see Data synthesis for de-
tails).
Assessment of reporting biases
We planned to produce funnel plots for visual inspection of possi-
ble publication bias. However, due to the small number of studies
in each comparison we did not perform these.
Data synthesis
For each predefined comparison, we analysed data for each out-
comemeasure separately.Whenever interventions belonged to the
same category in the comparison but two authors (KN and JV,
or KN and BF) judged them to be dissimilar, we defined subcat-
egories for these types of intervention. We conducted meta-anal-
ysis if two authors (KN and BF) judged a group of trials suffi-
ciently homogeneous in terms of participants, interventions, and
outcomes to provide a meaningful summary. In such cases we cal-
culated pooled SMDs for the predefined outcome measures using
the Review Manager software (RevMan 2012) with a random-ef-
fects model. For three-armed trials contributing evidence to two
different comparisons, we divided the number of participants of
the arm used in both comparisons by two.
We used the GRADE approach to assess the quality of a body
of evidence regarding the primary outcome category of the com-
parisons addressed in the review. At the start of the GRADE as-
sessment process we assumed high quality for all studies and we
downgraded the quality of the evidence for each comparison by
one to three levels depending on the seriousness of the violations
in each domain.
To assess the risk of bias for a comparison, we considered the risk
of bias tables for each study in that comparison. We saw Items
related to selection bias, detection bias, and attrition bias as pre-
requisites for high quality. We only considered studies with low
risks on these items to have a low risk of bias. For each compari-
son we considered the risk of bias serious (-1) if a majority of the
evidence in the studies included in the meta-analysis (in terms of
weights) were of low quality. We applied a -2 downgrade in cases
where the majority of the studies did not have adequate random
sequence generation and allocation concealment. For consistency,
we considered an I2 value of 50% to 75% to indicate substantial
inconsistency, which lead us to downgrade (-1). If the I² value
exceeded 75%, we refrained from pooling the results and we anal-
ysed the results for each study separately. Indirectness of the evi-
dence was not an issue in our review as all comparisons in the in-
cluded studies directly addressed the comparison. For imprecision
of results, we judged serious imprecision leading to downgrading
(-1) if a comparison either included a number of fewer than 400
participants or a wide CI around the effect estimate. For a non-
significant effect, we considered a CI to be wide if it included an
SMD of both 0 and a moderate effect size (SMD > 0.5 or < -0.5).
For a significant effect, we considered a CI to be wide if it included
both a small and large effect size (SMD small = -0.2 or 0.2; SMD
large = 0.8 or -0.8). We could not detect publication bias in our
review due to the low number of studies per comparison.
The resulting interpretation of the quality of the level of evidence
per comparison was as follows.
High: further research is very unlikely to change our confidence
in the estimate of effect.
Moderate: further research is likely to have an important impact
on our confidence in the estimate of effect and may change the
estimate.
Low: further research is very likely to have an important impact
on our confidence in the estimate of effect and is likely to change
the estimate.
Very low: any estimate of effect is very uncertain.
We created a ‘Summary of findings’ table with GRADEpro soft-
ware (GRADEpro 2008) for the main comparisons using the pri-
mary outcome categories.
Sensitivity analysis
We planned to conduct sensitivity analyses by excluding:
1. low quality studies,
2. studies with skewed data,
3. cluster randomised trials, and
4. studies in which workers were a small subgroup of the study
population.
However, the small numbers of studies in each comparison did
not allow for this.
R E S U L T S
10Interventions to improve return to work in depressed people (Review)
Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Description of studies
Results of the search
Figure 1 displays a PRISMA study flow chart of the inclusion
process. The original and updated electronic searches resulted in
6392 plus 4917 hits. We assessed the titles and abstracts of these
combined searches (n = 11,776) for eligibility. This resulted in the
full text assessment of 73 (30 plus 43) publications. We excluded
fifty (19 plus 31) studies after further scrutiny (see Characteristics
of excluded studies). In addition, we identified five ongoing studies
(see Characteristics of ongoing studies).
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Figure 1. PRISMA Study flow diagram of the study selection process.
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Included studies
We included 23 studies in the review (see Characteristics of
included studies). Three of these studies included three study arms
(Kendrick 2005; Knekt 2013; Krogh 2009). Therefore, we in-
cluded a total of 26 intervention groups in this review.
Designs
Of the included studies, 20 were RCTs and three were cluster
RCTs (Noordik 2013; Rost 2004; Schoenbaum 2001). Intra-class
correlations for these studies were reported to be negligible and
therefore we did not adjust the data.
Sample sizes
The total number of participants in the included studies was 6278.
The number of participants included in the analysis was lower
(5996) as we reported on the subgroup of ’employed and depressed
participants only’ in cases where studies included other subgroups
as well. The number of participants in the smallest intervention
(sub)group was lower than 20 in one study, between 20 and 100
in 13 studies, between 100 and 200 in six studies, and more than
200 in three.
Time period, setting and participants
Three studies were published before 2000, seven between 2000
and 2005, and 13 after 2005. Five studies were conducted in the
US, while 18 were conducted in Europe. Participants were re-
cruited in primary care settings (seven studies), outpatient settings
(10 studies), workplace settings (two studies), occupational health
care (two studies), a managed care setting (one study), and one
study was conducted in a community mental health centre. In 18
studies, all participants had a major depressive disorder. In five
studies (Bee 2010; Kendrick 2005; Knekt 2013; McCrone 2004;




We identified five work-directed interventions (Hees 2013; Lerner
2012;Noordik 2013; Schene 2006; Vlasveld 2013). The first three
compared the addition of a work-directed intervention to clinical
care with clinical care alone, whereas one study (Vlasveld 2013)
compared work-directed and clinical care with work-directed care
alone, and another study (Noordik 2013) compared two alter-
native work-directed interventions. The Hees 2013 and Schene
2006 studies compared fairly similar interventions, an occupa-
tional therapy program focusing on work reintegration and com-
bining modified work and supportive interventions. The inter-
vention in both studies included contact with the occupational
physician and the employer, exploration and solving of work prob-
lems, and preparation and start of work reintegration. The Lerner
2012 study compared an extension of Employee Assistance Coun-
selling (EAP) to regular EAP. This program incorporated both
work modification and support and consisted of: 1) work coach-
ing and modification, 2) care co-ordination, and 3) cognitive be-
havioural strategies. The Vlasveld 2013 study compared the addi-
tion of enhanced clinical care to regular support by the occupa-
tional physicianwhohadbeen trained andhad access to the psychi-
atric consultation. The program contained the following elements:
6 to 12 sessions of Problem Solving Therapy, manual-guided self-
help, a workplace intervention and, depending on patient pref-
erence, prescription of antidepressant medication according to a
treatment algorithm. The Noordik 2013 study compared an ex-
posure-based return to work intervention (RTW-E) conducted by
occupational physicians (OPs), gradually exposing the participants
to more demanding work situations, to regular support by the OP.
The RTW-E program provided workers with several homework
assignments aimed at preparing, executing, and evaluating an ex-
posure-based RTW plan. The work-directed ’care as usual’ by OPs
in the Vlasveld 2013 and Noordik 2013 studies was based on a




Six studies examined the effectiveness of antidepressant medi-
cation. Three studies compared a SSRI with SNRI medication
(Fernandez 2005; Romeo 2004;Wade 2008), one study compared
a SSRI with TCA (Miller 1998), one study compared two differ-
ent SSRIs (Fantino 2007), and a fourth study compared TCA or
MAO inhibitors with placebo (Agosti 1991).
Psychological interventions
One study (Knekt 2013) with three study arms compared two
psychological interventions (short-term and long-term psychody-
namic psychotherapy) with an alternative psychological interven-
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tion, solution-focused therapy. Four studies looked at the effects of
a specific psychological intervention as compared to care as usual
(Bee 2010; Hollinghurst 2010; Kendrick 2005; McCrone 2004).
The Kendrick 2005 study had three intervention arms and com-
pared two types of psychological interventions performed by
community mental health nurses (Problem Solving Therapy and
generic counselling) with general practitioner care as usual. Two
studies (Hollinghurst 2010; McCrone 2004) compared a com-
puterised form of CBT with general practitioner care as usual. In
the Hollinghurst 2010 study, participants receiving online CBT
were offered up to 10 sessions each having a duration of 55 min-
utes. Each participant was assigned their own therapist for the
duration of the study. Participants and therapists typed free text
into the computer, with messages sent instantaneously, and only
used this means of communication. Online CBT in the McCrone
2004 study included a 15-minute introductory video, eight 50-
minute sessions of CBT, and homework projects between sessions.
The program was interactive and feedback was provided to both
the patient and general practitioner after each session. One study
(Bee 2010) compared telephone CBT to usual primary and oc-
cupational health services. Telephone CBT was delivered over 12
weeks by registered graduate mental health workers. Participants
worked with therapists through regular phone calls to identify and
challenge negative thoughts, develop self-care skills, and complete
workbook exercises emphasizing behavioural activation.
Psychological interventions plus antidepressant medication
Five studies included interventions with a combination of psycho-
logical interventions and antidepressant medication. One study
(Burnand 2002) compared the effect of psychodynamic therapy
combinedwithTCAmedicationwithTCAmedication alone.The
intervention included individual sessions by a nurse combined
with clomipramine for a duration of 10 weeks. The frequency of
the psychotherapy sessions was not fixed. This was compared to a
group receiving the same medication and who received supportive
care (an individual session with empathic listening, guidance, and
support).
Three studies (Rost 2004; Schoenbaum 2001; Simon 1998) com-
pared enhanced primary care with primary care as usual. In these
types of interventions general practitioners were enrolled in a qual-
ity improvement program and were expected to provide enhanced
care including antidepressant medication and psychological inter-
ventions, according to primary care guidelines.
One study (Wang 2007) compared a structured telephone out-
reach and care management program to usual managed care. The
telephone outreach systematically assessed needs for treatment, fa-
cilitated entry into in-person treatment (both psychotherapy and
antidepressant medication), monitored and supported treatment
adherence, and (for those declining in-person treatment) provided
a structured psychotherapy intervention by telephone. Interven-
tion participants declining in-person treatment and experiencing
significant depressive symptoms after two months were offered a
structured eight-session cognitive behavioural psychotherapy pro-
gram.
Exercise
Two studies (Krogh 2009; Krogh 2012), of which the first one
included three study arms, looked at the effect of exercise inter-
ventions. Krogh 2009 compared supervised strength training or
aerobic training to relaxation training. The strength training was
designed to increase muscular strength. The training was a circuit
training program with six exercises involving large muscle groups
onmachines. The aerobic training was designed to increase fitness,
as measured by maximal oxygen uptake. The program involved
10 different aerobic exercises using large muscle groups. Machines
were used for cycling, running, stepping, abdominal exercises, and
rowing. In both exercise interventions, all patients were scheduled
to meet twice per week during a four-month period for a total of
32 sessions. The relaxation training was designed to avoid mus-
cular contractions or stimulation of the cardiovascular system and
included exercises onmattresses followed by light balance exercises
and by relaxation exercises with alternating muscle contraction
and relaxation in different muscle groups while lying down.
In the Krogh 2012 study, aerobic training was compared to an
attention control group (stretching exercises at low intensity). The
aerobic training was designed to increase fitness as measured by
maximal oxygen uptake. After an initial 10 minutes of general
low-intensity warm-up, the participants did 30 minutes of aerobic
exercise on a stationary cycle ergometer followed by a five-minute
low-intensity cool down period. Both groups were scheduled to
meet three times per week for three months, for a total of 36
sessions.
Outcomes
Studies were only selected if they reported on sickness absence. Of
the 23 included studies, six studies (Agosti 1991; Bee 2010; Krogh
2012; Miller 1998; Schene 2006; Wang 2007) reported days or
hours worked instead of days of sickness absence. These measures
were transformed into days of sickness absence as described in the
’Methods’ section (see Measures of treatment effect).
We were able to collect data on depression for all but one of the
included studies (Agosti 1991). Of all studies reporting on depres-
sion, one study (Schoenbaum 2001) presented only dichotomous
depression data while all others presented continuous data.
Eight studies (Agosti 1991; Burnand 2002; Hees 2013; Lerner
2012; Miller 1998; Rost 2004; Wade 2008; Wang 2007) reported
on work functioning using a (sub)scale that separately measured
work instead of work and other activities combined.
None of the included studies reported on employment status after
a period of time with the predefined categories: ’not working’,
’working fewer hours than the contract hours or having modified
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duties’ or ’working all contract hours without modified duties’.
However, three studies (Krogh 2012; Schoenbaum 2001; Wade




None of the included studies had the last outcome measurement
within one month.
(b) Medium term
In 19 studies the last follow-up measurement was between one
month and a year after inclusion. Four studies had the last follow-
up measurement later than one year but provided data on earlier
time points as well (Hees 2013; Knekt 2013; Rost 2004; Schene
2006). We included these outcomes in the medium-term analysis.
We used the last available observation within the first year for this
purpose.
(c) Long term
In five studies, the last follow-up measurement was later than
one year after inclusion. One study reported on a follow-up pe-
riod of 18 months (Hees 2013), two on 24 months (Rost 2004;
Schoenbaum 2001), one on 42 months (Schene 2006), and one
on five years (Knekt 2013). However, only depression data and
not the days of sickness absence were reported at two years in the
Schoenbaum study. We therefore refrained from using the depres-
sion data at this time point, leaving four studies with long-term
outcome data.
Excluded studies
We excluded a total of 50 studies from the review. Reasons for
excluding studies were:
• sickness absence not measured as an outcome (Ahola 2012;
Amore 2001; Barbui 2009; Boyer 1998; Brandes 2011; Carlin
2010; Castillo-Pérez 2010; Dunlop 2011; Erkkilä 2011; Finley
2003; Hirani 2010; Kojima 2010; Kroenke 2001; Kuhs 1996;
Lam 2012; Martinez 2011; Meyer 2009; Mundt 2001; Oakes
2012; Salminen 2008; Sandahl 2011; Simon 2000; Sir 2005;
Stant 2009);
• participants had a mild depressive disorder or were not
diagnosed with a depressive disorder at all (Aelfers 2013; Bakker
2007; Blonk 2007; Brouwers 2007; Furukawa 2012; Hackett
1987; Lagerveld 2012; Lexis 2011; Mino 2006; Morgan 2011;
Zeeuw 2010);
• not a RCT design (Bech 2000; Eklund 2012; Knekt 2011;
Schmitt 2008; Zambori 2002);
• no worker population (Alexopoulos; Folke 2012; Forman
2012);
• study took place in an inpatient care setting (Dick 1985;
Hordern 1964);
• participants had a severe mental disorder such as
schizophrenia (Becker 1998);
• not able to define a subgroup of depressed patients
(Gournay 1995); and
• a double publication (Schoenbaum 2002; Wells 2000).
Studies awaiting assessment
There were five ongoing studies awaiting further assessment
(Beurden 2013; Geraedts 2013; Heer 2013; Hellstrom 2013;
Warmerdam 2007).
Risk of bias in included studies
We judged studies to have an overall high risk of bias when the
items for random sequence generation, allocation concealment,
and incomplete outcome data for our primary outcome measure
all scored a rating of high risk of bias. We considered the overall
risk of bias to be high in 14 studies (Agosti 1991; Burnand 2002;
Hollinghurst 2010; Kendrick 2005; Knekt 2013; Krogh 2009;
Miller 1998; Noordik 2013; Romeo 2004; Rost 2004; Schene
2006; Schoenbaum 2001; Simon 1998; Wade 2008), Of these
14 studies, six studies (Agosti 1991; Burnand 2002; Miller 1998;
Noordik 2013; Rost 2004; Schoenbaum 2001) had either unclear
or inadequate random sequence generation or allocation conceal-
ment, causing us to classify these studies as having a very high
risk of bias. We considered nine studies to have an overall low risk
of bias (Bee 2010; Fantino 2007; Fernandez 2005; Hees 2013;
Krogh 2012; Lerner 2012; McCrone 2004; Vlasveld 2013; Wang
2007). See Figure 2 and Figure 3 for an overview of the risk of
bias per study and the ’Risk of bias’ tables that form part of the
Characteristics of included studies for details.
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Figure 2. Risk of bias graph: review authors’ judgements about each risk of bias item presented as
percentages across all included studies.
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Figure 3. Risk of bias summary: review authors’ judgements about each risk of bias item for each included
study.
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Allocation
The method for generating random numbers was not adequately
described in eight studies. However, personal communications
with the authors revealed that in four studies the chosen method
was adequate. In the other four studies this information could not
be retrieved, which led us to rate the studies as having an unclear
risk of bias for this item.
In the three cluster RCTs (Noordik 2013; Rost 2004; Schoenbaum
2001) allocation concealment was not adequate, which was prob-
ably indicative of the non-feasibility of allocation concealment in
this type of design. In three further studies (Agosti 1991; Burnand
2002; Miller 1998) information on allocation concealment could
not be retrieved, leading to a judgment of unclear risk of bias.
Blinding
Risk of performance bias was low in studies using a double-blind
design (blinding of participant and care provider). This design
was feasible in studies comparing the occupational health effects
of antidepressant medications. This type of study has a low risk of
performance bias (Agosti 1991; Fantino 2007; Fernandez 2005;
Miller 1998; Romeo 2004; Wade 2008). In work-directed, psy-
chological, or exercise interventions blinding of the participant
or care provider is not feasible. However, we considered the risk
of performance bias high only in those studies where the control
intervention could be considered less desirable by participants or
care provider. One study (Burnand 2002) managed to compose
two evenly desirable psychological interventions, leading to an as-
sessment of low risk of performance bias.
Our primary outcome measure (days of sickness absence) could be
measured either by self-report or retrieval from attendance records.
In the case of self-report, the outcome could be biased by un-
blinded participants’ knowledge of the intervention. In 15 studies
we considered the risk of detection bias to be high, and in one case
this risk was unclear.
Incomplete outcome data
We found nine of the 23 studies to have a low risk of attrition
bias, with some studies (Knekt 2013; McCrone 2004; Vlasveld
2013) showing different levels of risk of bias for sickness absence
and depressive symptoms. Studies with attrition between 10%
and 20% could still be classified as having low risk of attrition
bias if adequate analyses were conducted to take selective attrition
into account. Examples of such analyses are multiple imputation
methods or sensitivity analyses.
Selective reporting
For the majority of the studies (19), no design paper or trial reg-
istration could be identified in order to assess the risk of selec-
tive reporting. In three studies we considered the risk to be low
(Hees 2013; Kendrick 2005; Vlasveld 2013) and in one study an
outcome measure that was presented in the study design was not
reported as an outcome (Noordik 2013).
Other potential sources of bias
We did not identify other potential sources of bias.
Effects of interventions
See: Summary of findings for the main comparison Work-
directed intervention plus clinical intervention compared to
clinical intervention alone for depressive disorder; Summary of
findings 2 Any psychological intervention versus no intervention
or care as usual for depressive disorder; Summary of findings
3 Psychological intervention combined with antidepressant
medication versus no intervention or usual care for depressive
disorder
The 23 studies included in the review examined work-directed
and clinical interventions. The clinical interventions studied were
antidepressant medication, psychological or exercise intervention,
or a combination of two. We present summary of findings tables
for the comparisons with more than two included studies. Table
1 presents the GRADE assessment of the quality of the evidence
per comparison.
We did not identify any studies for the comparisons: ’any work-
directed intervention versus no intervention or care as usual’, ’any
antidepressant medication versus any psychological intervention’,
’exercise intervention versus any other exercise intervention’. We
refrained from conducting sensitivity analyses due to the small
number of studies in each comparison.
Below we present the results for our primary outcome, sickness
absence, for each of the comparisons. We present our secondary
outcomes, depressive symptoms and work functioning, for each of
the work-directed interventions as well. For the clinical interven-
tions we chose to only present the effect on depressive symptoms
if the intervention reduced sickness absence.
1. Work-directed interventions
1.1 Work-directed intervention combined with a clinical
intervention versus clinical intervention alone (medium
term)
Three studies looked at the effectiveness of a work-directed in-
tervention combined with a clinical intervention in comparison
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to a clinical intervention alone (Hees 2013; Lerner 2012; Schene
2006). The summarised sickness absence results showed moder-
ate quality evidence of a positive effect of adding a work-directed
intervention to a clinical intervention (SMD -0.40; 95% CI -
0.66 to - 0.14). The two studies adding occupational therapy to
clinical depression care (Hees 2013; Schene 2006) alone did not
find a statistically significant effect on sickness absence (SMD -
0.30; 95% CI -0.61 to 0.01), while the single study evaluating
a multicomponent work-focused intervention (Lerner 2012) did
find a reduction of sickness absence days (SMD -0.66; 95% CI -
1.15 to -0.16; Analysis 1.1). See Summary of findings for themain
comparison and Figure 4.
Figure 4. Forest plot of comparison: 1 Work-directed plus clinical versus clinical alone (medium term),
outcome: 1.1 Days of sickness absence.
The combined results of these three studies showed no difference
between the interventions when evaluating depressive symptoms
(SMD -0.32; 95% CI -0.88 to 0.25) or work functioning (SMD
-0.31; 95% CI -0.79 to 0.16; Analysis 1.2; Analysis 1.3).
1.2 Work-directed intervention combined with clinical
intervention versus clinical intervention alone (long term)
Two studies also reported long-term effects. We combined these
in a separate comparison (Hees 2013; Schene 2006). These two
studies provided moderate quality evidence that adding a work-
directed intervention to a clinical intervention did not reduce sick-
ness absence in the long term (SMD -0.19; 95%CI: -0.49 to 0.12;
Analysis 2.1). However, one of the two studies (Hees 2013) found
that the work-directed intervention reduced depressive symptoms
in the long term (SMD -0.63; 95% CI -1.02 to -0.24; Analysis
2.2).
1.3 Work-directed intervention combined with clinical
intervention versus work-directed alone (medium term)
We included one study in this comparison (Vlasveld 2013). The
study compared the addition of enhanced clinical care (collabora-
tive care model) to regular support by the occupational physician
only. This single study provided moderate quality evidence that
the intervention was not more effective in reducing sickness ab-
sence (SMD -0.14; 95%CI -0.49 to 0.21) or depressive symptoms
(SMD 0.26; 95% CI -0.20 to 0.72) than the control intervention
(Analysis 3.1; Analysis 3.2).
1.4 Any work-directed intervention versus alternative work-
directed intervention
We included one study (Noordik 2013) in this comparison; an
exposure-based return to work program was compared to regu-
lar occupational physician support. The study provided very low
quality evidence that sickness absence could have been reduced
more in the control group but this effect was not statistically sig-
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nificant (SMD 0.45; 95% CI -0.00 to 0.91; Analysis 4.1). The
exposure-based return to work program also did not reduce de-
pressive symptoms (SMD -0.18; 95% CI -0.84 to 0.49; Analysis
4.2).
2. Clinical interventions, antidepressant medication
2.1 Any antidepressant medication versus any other
antidepressant medication (medium term)
2.1.1 SSRI versus SNRI
Three studies compared a SSRI to SNRI in depressed workers
(Fernandez 2005;Romeo 2004;Wade 2008). In themeta-analysis,
the inconsistency of results between these three studies (I²) was
83% and so we did not pool them (Figure 5). The results of the
single studies were highly inconsistent. We found no difference
in sickness absence between a SSRI and SNRI in the Fernandez
2005 study (SMD -0.03; 95% CI -0.37 to 0.31) as well as in
the Romeo 2004 study (SMD 0.28; 95% CI -0.13 to 0.69). The
Wade 2008 study revealed evidence of an effect on sickness absence
favouring a SSRI (SMD -0.57; 95% CI -0.88 to -0.26; Analysis
5.1). Measured with the Sheehan disability scale, this study also
reported a favourable effect on work functioning (difference of
2.4; 95% CI 0.4 to 4.1) but the reported data did not allow for
inclusion in the meta-analysis.
Figure 5. Forest plot of comparison: 5 Any antidepressant medication versus any other antidepressant
medication, outcome: 5.1 Days of sickness absence.
2.1.2 SSRI versus TCA
Miller 1998 was the only study comparing a SSRI to TCAmedica-
tion in depressed workers. This study found no difference between
a SSRI and TCA in reducing sickness absence (SMD 0.08; 95%
CI -0.08 to 0.25; Analysis 5.1). The Miller 1998 study measured
work functioning using the SAS work composite (Wells 1989). A
higher score on this measure reflects a higher level of impairment.
The study reported no significant difference on work functioning
between the groups (difference of -0.08; 95% CI -0.24 to 0.09;
Analysis 5.3).
2.1.3 SSRI versus SSRI
One study (Fantino 2007) compared one SSRI to another SSRI.
This study found evidence of a greater reduction in sickness ab-
sence with escitalopram compared to citalopram (SMD -0.31;
95% CI -0.54 to -0.07; Analysis 5.1).
2.2 Any antidepressant medication versus placebo
One study compared a TCA or MAO to placebo (Agosti 1991).
We found very low quality evidence, based on one study, that
antidepressant medication did not reduce sickness absence. The
effect may even have been in favour of the placebo condition
(SMD 0.48; 95% CI -0.05 to 1.00) but this was not statistically
significant (Analysis 6.1). Measured with the Work functioning
subscale of the LIFE interview, Agosti 1991 did find a statistically
significant positive effect in favour of antidepressant medication
(SMD -0.58; 95% CI -1.11 to -0.05; Analysis 6.2).
20Interventions to improve return to work in depressed people (Review)
Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
3. Clinical interventions, psychological
3.1 Any psychological intervention versus other
psychological intervention (medium term)
One study (Knekt 2013) with three treatment arms evaluated the
effect of alternative psychological interventions. Two study arms
assessed psychodynamic therapy, where one study arm examined
short-term and the other long-term therapy. Both were compared
to solution focused therapy. The inconsistency (I²) in this meta-
analysis was 97%, therefore we refrained from pooling the results
of the two psychodynamic therapy conditions.
We found lowquality evidence of short-termpsychodynamic ther-
apy not being more effective than solution focused therapy in re-
ducing sick leave (SMD 0.25; 95% CI -0.39 to 0.89) and of so-
lution focused therapy being more effective in reducing sick leave
than long-term psychodynamic therapy (SMD1.16; 95%CI 0.49
to 1.83; Analysis 7.1).
The depressive symptoms and work functioning outcomes were
better for the short-term psychodynamic therapy than for solution
focused therapy (SMD -0.66; 95% CI -1.03 to -0.30), but solu-
tion focused therapy showed better results than the long-term psy-
chodynamic therapy (SMD 1.00; 95% CI 0.63 to 1.36; Analysis
7.1; Analysis 7.2).
3.1 Any psychological intervention versus other
psychological intervention (long term)
The Knekt 2013 study also had long-term results (five-year follow
up). We refrained from statistically pooling the results due to high
inconsistency (I² = 99%). The separate analyses yielded lowquality
evidence of long-term (SMD -0.91; 95% CI -1.62 to -0.19) and
short-term psychodynamic psychotherapy (SMD -4.61; 95% CI
-5.84 to -3.39) reducing sickness absence more effectively than
solution focused therapy in the long term (Analysis 8.1).
3.1 Any psychological intervention versus no intervention or
care as usual (medium term)
3.1.1 Online or telephone CBT versus care as usual
Three studies compared online or telephone CBT with care as
usual (Bee 2010;Hollinghurst 2010;McCrone 2004). The pooled
results showed that there was moderate quality evidence (SMD -
0.23; 95% CI -0.45 to -0.01) that online or telephone CBT re-
duced sickness absence more than usual primary or occupational
care. See Summary of findings 2 and Analysis 9.1. Online or tele-
phone CBT also reduced depressive symptoms (SMD -0.56; 95%
CI -0.76 to -0.36; Analysis 9.2).
3.1.2 Problem solving or counselling by community mental
health nurse versus general practitioner
One study (Kendrick 2005) looked at two types of psychologi-
cal interventions performed by community mental health nurses
(ProblemSolving Therapy and generic counselling) and compared
these interventions with general practitioner care as usual. The
pooled results from the two psychological interventions yielded
low quality evidence (SMD0.22; 95%CI -0.36 to 0.79) that these
interventions were no better in reducing sickness absence than care
by general practitioners (Analysis 9.1).
See Figure 6 for the forest plot of this comparison.
Figure 6. Forest plot of comparison: 9 Any psychological versus no intervention or care as usual, outcome:
9.1 Days of sickness absence.
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4. Clinical interventions, psychological plus antidepressant
medication
4.1 Psychological intervention combined with antidepressant
medication versus antidepressant medication alone (medium
term)
One study (Burnand 2002) evaluated the effectiveness of psycho-
dynamic therapy combined with TCA medication versus TCA
medication alone. This study provided very low quality evidence
of psychodynamic therapy combined with TCA medication re-
ducing sickness absence more than TCA medication alone (SMD
-0.71; 95% CI -1.25 to -0.17; Analysis 10.1).
The effects of the intervention on work functioning (SMD -0.11;
95% CI -0.57 to 0.35) and depressive symptoms (SMD -0.49;
95% CI -1.02 to 0.04) were both not significant (Analysis 10.2;
Analysis 10.3).
4.2 Psychological intervention combined with antidepressant
medication versus no intervention or care as usual (medium
term)
The findings for this comparison are displayed in Summary of
findings 3.
Three studies tested enhanced primary care interventions, which
were deemed similar enough for statistical pooling (Rost 2004;
Schoenbaum 2001; Simon 1998). However, for the study by Rost
2004 we could not obtain from the author the SDs around the
mean estimates, nor could we calculate them. Therefore, we could
not include this study in themeta-analysis. Because the publication
itself only presented data over two years, we qualitatively described
the results of this study for the long-term outcome only.
Both trials with usable data (Schoenbaum 2001; Simon 1998)
failed to show a significant difference in days of sickness absence
between the intervention and comparison groups. The pooled
results of these two trials provided low quality evidence of no effect
of enhanced primary care on sickness absence (SMD -0.02; 95%
CI -0.15 to 0.12; Analysis 11.1). In addition, Schoenbaum 2001
did not find a significant difference in employment status between
the intervention and the control groups in the medium term (RR
1.08; 95% CI 0.99 to 1.18; Analysis 11.2).
One study (Wang 2007) looked at a different type of intervention,
a structured telephone outreach and care management program,
in comparison to usual care. We found high quality evidence of
an effect on sickness absence in favour of the intervention (SMD
-0.21; 95% CI -0.37 to -0.05; Analysis 11.1) based on this study.
The effect on depressive symptoms was similar (SMD -0.23; 95%
CI -0.39 to -0.07; Analysis 11.3). However, the effect on work
functioning favoured the control condition (SMD 0.50; 95% CI
0.34 to 0.66; Analysis 11.5).
4.3 Psychological intervention combined with antidepressant
medication versus no intervention or care as usual (long
term)
Only one study (Rost 2004) reported long-term outcomes. Data
were insufficient for us to calculate a SMD in days of sickness
absence. The authors reported no statistically significant effect on
sickness absence and depression but did report that work func-
tioning was significantly improved using a subjective rating on a
0 to 10 scale at work.
5 Clinical interventions, exercise
5.1 Exercise intervention versus no intervention or care as
usual
We included two studies in this comparison (Krogh 2009; Krogh
2012), of which one (Krogh 2009) had two study arms.
5.1.1 Strength exercise versus relaxation
We found lowquality evidence, based onone study, that supervised
strength exercise was more effective than relaxation in reducing
sickness absence (SMD -1.11; 95% CI -1.68 to -0.54; Analysis
12.1).
5.1.2. Aerobic exercise versus relaxation or stretching
The pooled effect of two studies yieldedmoderate quality evidence
that aerobic exercise was not more effective than relaxation or
stretching in reducing sickness absence (SMD -0.06; 95% CI -
0.36 to 0.24; Analysis 12.1).
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A D D I T I O N A L S U M M A R Y O F F I N D I N G S [Explanation]
Any psychological intervention versus no intervention or care as usual for depressive disorder
Patient or population: Persons with depressive disorder
Settings: One study was conducted in a workplace sett ing and two in primary care
Intervention: Any psychological intervent ion versus no intervent ion or care as usual (medium term)




Quality of the evidence
(GRADE)
Comments
Assumed risk Corresponding risk
Care As Usual (CAU) Any psychological in-
tervention
Days of sickness ab-
sence
Follow up: 3 - 8 months
The mean days of sick-
ness absence in the in-
tervent ion groups was
0.23 standard devia-
tions lower
(0.45 to 0.01 lower)






A standard deviat ion
of 0.2 represents a
small dif f erence be-
tween groups
* The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% conf idence interval) is
based on the assumed risk in the comparison group and the relative effect of the intervent ion (and its 95%CI).
CBT : Cognit ive-Behavioral Therapy; CAU: Care As Usual; CI: Conf idence interval; SMD: Standardised Mean Dif ference
Intervention description
All three intervent ions were cognit ive-behavioral therapy, one by telephone and two online. Each of the intervent ions were interact ive, with therapists or specialised nurses
providing feedback
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our conf idence in the est imate of ef fect.
Moderate quality: Further research is likely to have an important impact on our conf idence in the est imate of ef fect and may change the est imate.
Low quality: Further research is very likely to have an important impact on our conf idence in the est imate of ef fect and is likely to change the est imate.
Very low quality: We are very uncertain about the est imate.































































































Psychological intervention combined with antidepressant medication versus no intervention or usual care for depressive disorder
Patient or population: Persons with depressive disorders
Settings: Two studies were conducted in a primary care and one in a managed care sett ing
Intervention: Psychological intervent ion combined with ant idepressant medicat ion versus no intervent ion or usual care (medium term)




Quality of the evidence
(GRADE)
Comments
Assumed risk Corresponding risk




Days of sickness ab-
sence - Enhanced pri-
mary care versus CAU
Follow up: 7 -12 months
The mean days of sick-
ness absence in the in-
tervent ion groups was
0.02 standard devia-
tions lower
(0.15 lower to 0.12
higher)






A standard deviat ion
of 0.2 represents a
small dif f erence be-
tween groups
Days of sickness ab-
sence - Telephone out-
reach and care man-
agement program ver-
sus CAU
Follow up: mean 12
months
The mean days of sick-
ness absence in the in-
tervent ion groups was
0.21 standard devia-
tions lower
(0.37 to 0.05 lower)






A standard deviat ion
of 0.2 represents a
small dif f erence be-
tween groups
* The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% conf idence interval) is
based on the assumed risk in the comparison group and the relative effect of the intervent ion (and its 95%CI).

































































































General pract it ioners were enrolled in a quality improvement program and were expected to provide enhanced care including ant idepressant medicat ion and psychological
intervent ions, according to primary care guidelines
Telephone outreach and care management
This program systematically assessed needs for treatment, facilitated entry into in-person treatment (both psychotherapy and ant idepressant medicat ion), monitored and
supported treatment adherence, and (for those declining in-person treatment) provided a structured psychotherapy intervent ion by telephone
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our conf idence in the est imate of ef fect.
Moderate quality: Further research is likely to have an important impact on our conf idence in the est imate of ef fect and may change the est imate.
Low quality: Further research is very likely to have an important impact on our conf idence in the est imate of ef fect and is likely to change the est imate.
Very low quality: We are very uncertain about the est imate.
1 Downgraded with one level because all studies were of low quality































































































D I S C U S S I O N
Summary of main results
We included 20 RCTs and three cluster RCTs in the review, with
five studies evaluating work-directed interventions and 18 evaluat-
ing clinical interventions. Within these broad categories, the type
of intervention varied widely from one study to another, which
limited the number of studies in each predefined comparison. This
review showed that there is moderate quality evidence that adding
a work-directed intervention to a clinical intervention reduces the
number of days on sick leave in themedium term (4 to 12 months;
SMD -0.40). Similar effects on depressive symptoms and work
functioning could not be demonstrated. The absolute difference
in days absent from work differed in each of the studies. The Hees
2013 study found the smallest absolute difference, 1.7 versus 2.1
days over a 12-month period. Schene 2006 found a difference of
66 versus 83 days absence over a period of six months; and Lerner
2012 found an absolute difference of one versus 2.2 days over a pe-
riod of two weeks. Moderate quality evidence, from a comparison
including a single study, showed that enhancing the clinical care
in addition to regular work-directed care did not reduce sickness
absence more than work-directed care alone (with regular access
to clinical care). There was very low quality evidence, based on
one study, that regular care by occupational physicians that is en-
hanced with an exposure-based return to work program does not
reduce sickness absence compared to regular care by occupational
physicians.
With regard to antidepressant medication, this review found
highly inconsistent results regarding the effect of SSRIs compared
to other medications on days of sickness absence (four studies).
Compared to SNRI medication (three studies), one single study
found that SSRI reduced sickness absence (Wade 2008), no differ-
ence in effect on sickness absence was found in another (Fernandez
2005), and a non-significant difference in effect on sickness ab-
sence was found in the last (Romeo 2004). One single study found
that a SSRI did not reduce sickness absence more than TCA med-
ication (Miller 1998). One study (Fantino 2007) compared one
SSRI to another SSRI. This study found that escitalopram reduced
sickness absence more than citalopram (SMD -0.31). One study
compared a TCA or MAO to placebo (Agosti 1991). This study
found that the antidepressant medication did not reduce sickness
absence more than placebo.
This review found moderate quality evidence based on three stud-
ies that telephone or online CBT reduced sick leave more than
usual primary or occupational care in the medium term (three
to eight months; SMD -0.23). These interventions also reduced
depressive symptoms compared to usual primary or occupational
care (SMD -0.56). The absolute differences in days of sickness
absence were 3.9 versus 4.3 over four weeks (Bee 2010); 3.8 versus
11.2 over eightmonths (McCrone 2004); and 7.6 versus 12.7 over
eight months (Hollinghurst 2010).
This review found low quality evidence of no effect of enhanced
primary care on sickness absence in the medium term (four to 12
months), based on the pooled results of two studies (SMD -0.02).
A third study found no statistically significant effect on sickness
absence of this intervention in the long term (24 months).
This review found high quality evidence from one study that a
structured telephone outreach and care management program re-
duced sickness absencewhen compared tousual care (SMD-0.21).
The absolute difference on the original scale was 42.3 (interven-
tion) versus 39.5 (control) hours worked per week over the last
four weeks.
Overall completeness and applicability of
evidence
The studies included in this reviewhave been conducted in Europe
and the United States of America only. Therefore, the generalis-
ability of our findings to other parts of the world remains unclear.
In line with our inclusion criteria, the included studies cover a
range of clinical states. In 13 studies a major depressive disorder
according to theDSM-IV or III was used as an inclusion criterion,
while others included patients based on their symptom severity as
measured by a questionnaire.Moreover, study setting is likely to be
a source of clinical heterogeneity. Most studies were conducted in
primary care settings (seven studies) and in outpatient settings (10
studies). In only two studies patients were recruited in a workplace
setting, and in another two in occupational health care. In many
instances the occupation of the participants was not reported even
though it is conceivable that the effect of interventions partly de-
pends on the specific work situation. A lack of studies on work-
related factors which may be predictors for work outcomes in de-
pressed workers has already been pointed out (Lagerveld 2010).
Therefore, we cannot assess the potential impact of work situa-
tions on the effectiveness of the included interventions.
In this updated review, we were able to include studies on work-
directed interventions as well as clinical interventions. While it is
important to assess the effects of clinical interventions on occu-
pational health, we are aware that the primary reason to choose
between one or another clinical intervention is clinical effective-
ness. However, in line with the emerging paradigm of value-based
medicine, it is central to care to offer interventions to patients
providing the greatest patient value (Brown 2013). As being able
to work may be one of the factors on which patient preference
is based, assessing occupational health outcomes for clinical in-
terventions is key. Moreover, from the point of view of patient
preference, work functioning may be as important as sickness ab-
sence. However, in most included studies this outcome was not
measured. Evaluating the effect of interventions on work func-
tioning would further enable us to assess the patient value of these
interventions.
In contrast to the first version of this review, we were able to in-
clude studies in most of the predefined comparisons. However, the
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number of studies within each comparison was small, and even
within some of the comparisons the interventions were too dis-
similar to pool the results. One example is the comparison ’psy-
chological intervention combined with antidepressant medication
versus no intervention or usual care’. Two studies were on inter-
ventions indirectly targeting the worker by enhancing the care of
the care provider (Schoenbaum 2001; Simon 1998). One other
study (Wang 2007) evaluated an intervention in which the work-
ers were directly targeted as they received psychotherapy by tele-
phone. Only the latter intervention reduced the days of sickness
absence more than care as usual. Another consequence of the low
number of studies per comparison is that we were unable to per-
form subgroup analyses for participant and intervention charac-
teristics, which impedes generalisation of the results.
The clinical relevance of the observed effects can best be evaluated
by looking at the absolute differences in days of sickness absence.
It should, however, be noted that these differences vary from one
study to another. Part of the explanation is that the outcome mea-
sure ’days of sickness absence’ is by definition partly determined
by the length of follow up. Nonetheless, variations in the absolute
difference between studies are not always explained by differences
in length of follow up (see Hees 2013; Schene 2006). The rele-
vance of reductions in days of sick leave depends on the perspec-
tive of the stakeholder. A reduction in sick leave of one day may
not be relevant from the worker’s point of view but can be relevant
for stakeholders who bear the costs of the lost productivity, such
as employers or insurance companies.
Quality of the evidence
Of the included studies, 20 were RCTs and three were cluster
RCTs. The number of participants per study was fairly small, less
than 100 in 14 studies, between 100 and 200 in six, andmore than
200 in three. In some cases the low number of participants was due
to our need to focus only on a subgroup of the study population,
either disregarding participants with other mental disorders or
participants who did not work.
We considered the overall risk of bias to be low in nine studies. In
14 studies we considered it to be high as either random sequence
generation, allocation concealment, or incomplete sickness ab-
sence data were inadequate. In six of these the random sequence
generation or allocation concealment was unclear or inadequate.
In the three cluster RCTs allocation concealment was not ade-
quate, probably indicative of the non-feasibility of allocation con-
cealment in this type of design due to all participants in one clus-
ter (for example in a practice or with a healthcare provider) be-
ing automatically assigned to the same study arm. In three further
studies information on random sequence generation or allocation
concealment could not be retrieved, leading to a judgment of un-
clear risk of bias.
We found a high risk of performance bias in 14 of the included
studies. In work-directed, psychological, or exercise interventions,
blinding of the participant or care provider is not feasible. How-
ever, the risk of performance bias also depends on how desirable
the intervention is compared to the control group, according to ei-
ther care providers or participants. One study evaluating a psycho-
logical intervention in addition to medication managed to com-
pose two evenly desirable psychological interventions by ensuring
an equal number of supportive instead of therapeutic sessions.
In this review, we chose to assess detection and attrition bias sepa-
rately for sickness absence and depressive symptoms. We felt that
not being blind to allocation may bias a self-report assessment of
depressive symptoms more than the reporting of a more factual
outcome such as the days absent from work in a given period.
Also, sickness absence may be retrieved from employee attendance
records while depression is measured with a self-report question-
naire. In those instances the lack of blinding of outcome assess-
ment cannot influence the sickness absence but may well bias the
depressive outcome.
Potential biases in the review process
This review included studieswith a study population of bothwork-
ers and non-workers. This means that subgroups of the original
sample were used for measuring the effect on sickness absence.
These studies did not usually present all data for workers sepa-
rately, but their sickness absence reports were by definition based
on the workers in the study population. Some studies included
participants with mental disorders other than depression. We in-
cluded the studies in this review if the authors were willing to
provide data for the depressed subgroup.
Subgroup analyses in individual studies may lead to biased results
for the following three reasons (Freemantle 2001). First, in the
event that no effect is found for the primary outcome it is common
that researchers look for a more positive outcome among possible
subgroups. Thus the chance for a positive subgroup result would
be spuriously increased. Next, in the event of a positive main effect
the power for finding an effect in a subgroupwould be substantially
reduced, and finding no effect for a subgroup could just be amatter
of lack of power. Further, testing many subgroups would increase
the likelihood of finding a statistically significant result by chance
alone. In 19 of the included studies the primary outcome was not
work-related and we had to base our conclusions on subgroups
of the original sample for which data on work-related outcomes
were collected. However, none of the authors specifically looked
for a work-related outcome because of the absence of an effect
for the primary outcome, and neither did we. Therefore, we are
not concerned that this would have influenced our results. This
similarly holds for the other argument against the use of subgroups,
the testing of multiple groups. We predefined the subgroups; we
did not test multiple potential subgroups in the hope of finding
a statistically significant group. However, we do agree that a lack
of power leading to statistically non-significant findings may have
occurred in our review. We were, therefore, careful to not describe
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non-significant findings with wide confidence intervals as evidence
of no effect.
This review evaluates the effectiveness of a range of interventions
aiming to reduce sickness absence in depressed workers rather than
one specific intervention. While we believe this is appropriate for a
complex and multifactorial outcome such as sickness absence, the
categorisation of interventions under the comparisons has been
challenging. This categorisation is likely to influence the results as
it determines, for each intervention, with which other interven-
tions the results will be pooled and to which other interventions
it will be compared. The way interventions are categorised entails
a potential bias in the review process.
Another methodological issue concerns the handling of sickness
absence data. We accepted both self-report and administrative
databases as sources of data on sickness absence. Administrative
databases are sometimes considered the gold standard. Agreement
between the two sources has been reported to be good (Ferrie 2005;
Severens 2000) but also limited (Pole 2006; van Poppel 2002).
Furthermore, for the purpose of calculating standardised mean
differences (SMDs) we considered sickness absence a construct for
which different instruments could be used, as long as they pro-
vided information on absenteeism. This meant that as long as we
reported SMDs we could incorporate studies with different time
spans (and therefore with a differentmaximum of sickness absence
days during follow up) and scales that differed in the maximum
score. Also, this enabled us to compare studies from various coun-
tries as we know that days of sickness absence tend to be calculated
differently in different countries (for instance due to differences
in whether calendar days or only work days are included as absen-
teeism days). Moreover, we transformed reports of days worked
into days of sickness absence by extracting the days worked from
the days that should have been worked (’the scale maximum’).
This is analogous to transforming the scores of a scale in which
a high score indicates a good outcome into a scale where a high
score indicates a bad outcome. However, for this transformation
we had to make inferences about the mean number of hours and
the number of hours a day an employee would work in a specific
country. In summary, caution is recommended when interpreting
sickness absence data in meta-analyses as this is a relatively new
field and the methodological issues have not been thoroughly in-
vestigated.
Agreements and disagreements with other
studies or reviews
A review of the effects of interventions for major depressive dis-
order on occupational health outcomes was published some years
ago (Timbie 2006). Compared to the previous review we were
able to identify seven additional studies. Furthermore, Timbie
and colleagues chose to combine all studies in their meta-analy-
sis, while we judged the interventions to be too dissimilar for this
purpose. Finally, they did not distinguish between time missed
from work and workforce participation (both were called labour
output). Therefore, we find their conclusion that interventions
for depressive disorder have a small but positive effect on labour
output too general and believe that we have been able to make
better inferences. A more recently published review (Furlan 2012)
searched the literature until 2010 and concluded that the evidence
was of insufficient quality to determine which interventions are
effective and are of value for the management of depression in
the workplace. This conclusion was similar to the first published
version of this review (Nieuwenhuijsen 2008). This updated ver-
sion of our review has markedly different conclusions due to the
inclusion of a substantially greater number of studies.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
We found moderate quality evidence based on three studies that
adding a work-directed intervention to a clinical intervention re-
duces the number of days on sick leave in the medium term when
compared to a clinical intervention alone.
There is currently no evidence of a difference in effect on sickness
absence of one antidepressant medication compared to another.
We found moderate quality evidence that enhancing primary or
occupational care by providing workers with a structured tele-
phone or online cognitive behavioural therapy reduces sickness
absence compared to regular care.
We found low quality evidence of no considerable effect for en-
hancedprimary care targeting general practitioners through a qual-
ity improvement program.
Based on a single study yielding high quality evidence, we found
that a structured telephone outreach and care management pro-
gram may also lead to reductions in sickness absence of depressed
workers.
Implications for research
More research is needed on the addition of work-directed inter-
ventions to the clinical care provided. This review shows that such
interventions have the potential to reduce sickness absence but the
number of studies evaluating these types of interventions is still
limited.
More often including occupational outcomes such as sickness ab-
sence and work functioning in clinical intervention studies will re-
veal which clinical interventions can be effective in reducing sick-
ness absence.
To facilitate the synthesis of evidence from various intervention
studies, the occupational health field should work towards stan-
dardising and validating measures of sickness absence. For future
28Interventions to improve return to work in depressed people (Review)
Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
reviews including absenteeism as an outcome measure, it is advis-
able to report standardised mean differences instead of means as
this takes into account the differences in measurement methods.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Agosti 1991
Methods Double-blind randomised trial with four arms (3 treatment and one placebo). Recruit-
ment: unclear. Follow up: 6 weeks. Lost to follow up: 29.5%
Participants 61 were randomised (T1: 38, C: 23). Setting: Outpatients in New York, USA
Inclusion:
- DSM-III diagnosis of depressive disorder
- mood reactivity (i.e. significant lifting of mood in response to positive environmental
events)
- onset prior to age 21 yrs
- rated by experienced clinician to be depressed for most or virtually all of the time
through adulthood




Divorced or separated: 19.6%
Working: 70%
Interventions T1: Treatment with increasing dose of either TCA or MAO
- 60 to 90 mg/day of phenelzine (T1a)
- 200 to 3000 mg/day of imipramine (T1b)
- 40 mg/day of L-deprenyl (T1c)
Duration: 6 weeks.
C: 4 to 6 placebo pills/day. Duration: 6 weeks
Outcomes Absenteeism:
1) hours worked in past week (baseline and at 6 weeks)
Clinical:
1) CGI (measured but not reported!)
2) HAM-D (measured but not reported!)
Productivity:




Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Random sequence generation not reported
“Following baseline evaluation, patients
were treated with single-blind placebo for
1-2 weeks, those who were still depressed
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Agosti 1991 (Continued)
were randomly assigned to 6 weeks of treat-
ment with increasing doses of one of four
agents in a double blind design.”
Allocation concealment (selection bias) Unclear risk Allocation concealment not reported
“Following baseline evaluation, patients
were treated with single-blind placebo for
1-2 weeks, those who were still depressed
were randomly assigned to 6 weeks of treat-
ment with increasing doses of one of four
agents in a double blind design.”
Blinding of participants and personnel
(performance bias)
Sick Leave
Low risk A double blind design was used
“Following baseline evaluation, patients
were treated with single-blind placebo for
1-2 weeks, those who were still depressed
were randomly assigned to 6 weeks of treat-
ment with increasing doses of one of four
agents in a double blind design.”
Blinding of outcome assessment (detection
bias)
Sick Leave
Low risk Patients reported sick leave in an interview,
but were blinded to treatment allocation
“Sick leave was assessed by the LIFE. The
LIFE is a semi-structured interview which
tracks episodes of psychiatric illness. The
portion of the LIFE which we used as-
sessed the psychosocial functioning during
the week in five areas; employment..etc.
The LIFE was administered to the patient
by the treating physician.”
Blinding of outcome assessment (detection
bias)
Depressive symptoms
Low risk Depressive symptoms were determined by
personnel, were blinded to treatment allo-
cation
“Clinical outcome was determined by the
treating psychiatrist on the basis of Clinical
Global Improvement.”
Incomplete outcome data (attrition bias)
Depressive symptoms
Unclear risk Outcome not reported
Incomplete outcome data (attrition bias)
Sick Leave
High risk Loss to follow up is considered to be high:
T1: 28.9%; T2: 30.4%, even though the
proportion of incomplete data was compa-
rable in both groups
Selective reporting (reporting bias) Unclear risk No design paper or trial registration could
be identified to assess this risk
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Agosti 1991 (Continued)
Other bias Unclear risk None Identified
Bee 2010
Methods RCT. Recruitment: over 10 months, human resources mailed all potential participants a
study information pack. Follow up: 3 months. Lost to follow up: overall 40%, subgroup
depressed workers: 0%
Participants 53 were randomised (T1: 26; T2: 27). Subgroup of depressed workers: 12. Setting: large
communications company. Inclusion: employees of a large communications company
absent fromwork withmild tomoderate mental health difficulties for 8 to 90 days autho-
rised by general practitioner certificate Exclusion: severe or complex disorders (psychosis,
comorbid personality disorder), degenerative cognitive disorders, substance misuse or
active self-harm
For the subgroup of depressed workers:
mean age: 50.9 (SD 10.04)
male: 58%
Interventions T1: Telephone CBT, delivered over 12 weeks by one of two registered graduate men-
tal health workers. Participants worked with therapists through regular phone calls to
identify and challenge negative thoughts, develop self-care skills and complete work-
book exercises emphasizing behavioural activation. Therapists received 12 h of didactic
instruction and role play and weekly supervision from a senior CBT therapist
T2: Usual care, primary and occupational health services.
Outcomes Absenteeism:
1) self-reported actual working hours (HPQ) in last four weeks
Clinical:
1) depression, assessed by the HADS
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Personal communication: “Yes there was a
random component in the sequence gen-
eration - and the sequence was held by an
independent trial units.”
Allocation concealment (selection bias) Low risk “Randomization was conducted centrally
by an independent service, with minimiza-
tion on age, gender and illness severity”. “[.
..] internal validity was heightened trough
allocation concealment via central random-
ization [ .. ]”
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Bee 2010 (Continued)
Blinding of participants and personnel
(performance bias)
Sick Leave
High risk Due to the nature of the intervention, the
participants could not be blinded
Blinding of outcome assessment (detection
bias)
Sick Leave
High risk The actual working hours were assessed by
the participants themselves. As they were
aware of the allocation status, risk of detec-
tion bias is considered to be high
Blinding of outcome assessment (detection
bias)
Depressive symptoms
High risk Depression is assessed by theHADS, which
is a self-reported instrument. As the partic-
ipants were aware of their allocation status,
risk of detection bias is considered to be
high
Incomplete outcome data (attrition bias)
Depressive symptoms
Low risk Personal communication: “For the sub-
group of depressed workers, there is no loss
to follow up.”
Incomplete outcome data (attrition bias)
Sick Leave
Low risk Personal communication: “For the sub-
group of depressed workers, there is no loss
to follow up.”
Selective reporting (reporting bias) Unclear risk No design paper or trial registration could
be identified to assess this risk
Other bias Unclear risk None identified
Burnand 2002
Methods RCT, random assignment stratified by presence of personality disorder, past major de-
pressive syndrome and gender; two conditions. Recruitment: screening by nurse and
psychiatrist of consecutive patients referred for acute outpatient treatment. Follow up:
10 weeks. Lost to follow up: 22%
Participants 95 were randomised (T1: 35; C: 39); Setting: outpatient community mental health
centre in Switzerland; Inclusion: age 20 to 65 years, new episode of care, MDD DSM-
IV (SCID) + HDRS at least 20; Exclusion: bipolar disorder, psychotic symptoms, severe
substance dependence, organic disorder, mental retardation, history of severe intolerance
to clomipramine, poor command of French language
Age: T1: 36 (SD 9.5); C: 36.7 (SD 10.4)
Female: T1: 66%; C: 56%
Stable employment: T1: 71%; C: 82%
Interventions T1: Psychodynamic psychotherapy: individual sessions by nurse + clomipramine: 25 mg
first day, gradually increasing to 125mgonfifth day (dosage adjustment allowed). Refusal
or severe side effects: 20 to 40 mg citalopram per day. Duration: 10-week program,
frequency psychotherapy sessions not fixed, duration of clomipramine 10 weeks
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Burnand 2002 (Continued)
C: Supportive care: individual sessions: empathic listening, guidance and support. +
clomipramine: 25 mg first day, gradually increasing to 125 mg by fifth day (dosage
adjustment allowed). Refusal or severe side effects: 20 to 40 mg citalopram per day.
Duration supportive care: not fixed, duration clomipramine 10 weeks
Outcomes Absenteeism:
1) number of days of sick leave in 10 weeks
Clinical:
1) full remission (at most 7 HDRS) (at 10 weeks)
2) severity of depression (HDRS score; GAS) (at 10 weeks)
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Randomisation procedure not reported
Allocation concealment (selection bias) Unclear risk Randomisation procedure not reported
Blinding of participants and personnel
(performance bias)
Sick Leave
Low risk No blinding but risk of performance bias
low as both treatments can be considered
equally desirable for patients
“Both treatments involved the same
clomipramine protocol and intensive nurs-
ing in a specialized milieu. In addition,
the amount of structured psychodynamic
psychotherapy provided during combined
treatment was comparable to the amount
of supportive care provided during treat-
ment with clomipramine alone.”
Blinding of outcome assessment (detection
bias)
Sick Leave
High risk Outcome assessor for sick leave was
blinded, but (non-blinded) patients had to
report the number of sick leave days to
them
“The psychologists who made the assess-
ments of hospitalizations, number of days
of sick leave, and GAS scores were blinded
to each patient’s treatment assignment.”
Blinding of outcome assessment (detection
bias)
Depressive symptoms
High risk “The individuals who rated the presence
and severity of major depression andHSRS
scores at ten weeks were not blinded to
treatment assignment.”
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Burnand 2002 (Continued)
Incomplete outcome data (attrition bias)
Depressive symptoms
High risk Loss to follow up is high: 22%. Risk of at-
trition bias due to follow up losses is there-
fore considered to be high, although multi-
ple analyses were used to study the effect on
the findings and the authors conclude oth-
erwise: “Twenty-one patients (12 in the ex-
perimental and nine in the control group,
or 22 percent) were excluded from the anal-
ysis--four who did not return for treatment
(three in the experimental group and one in
the control group), three who dropped out
against medical advice (two in the experi-
mental group and one in the control group)
, and 14 who were discharged because they
had exclusion characteristics that were not
detected at entry, including severe alcohol
or drug dependence (five in each group)
and adverse effects (two in each group).
These patients were not significantly dif-
ferent from the other patients in terms of
the main outcome variables at intake. The
74 patients who completed the study were
not significantly different from the 21 who
were withdrawn or from the group of 95 as
a whole. To control for intent to treat, the
analyses were repeated with all 95 patients
who had been randomly assigned to treat-
ment.”
“This finding was unchanged when we re-
peated the analyses and controlled for age,
gender, initial severity of depression, GAS
score at intake, compliance and intent to
treat”
Incomplete outcome data (attrition bias)
Sick Leave
High risk Loss to follow up is high: 22%. Risk of at-
trition bias due to follow up losses is there-
fore considered to be high, although multi-
ple analyses were used to study the effect on
the findings and the authors conclude oth-
erwise: “Twenty-one patients (12 in the ex-
perimental and nine in the control group,
or 22 percent) were excluded from the anal-
ysis--four who did not return for treatment
(three in the experimental group and one in
the control group), three who dropped out
against medical advice (two in the experi-
mental group and one in the control group)
, and 14 who were discharged because they
had exclusion characteristics that were not
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Burnand 2002 (Continued)
detected at entry, including severe alcohol
or drug dependence (five in each group)
and adverse effects (two in each group).
These patients were not significantly dif-
ferent from the other patients in terms of
the main outcome variables at intake. The
74 patients who completed the study were
not significantly different from the 21 who
were withdrawn or from the group of 95 as
a whole. To control for intent to treat, the
analyses were repeated with all 95 patients
who had been randomly assigned to treat-
ment.”
“This finding was unchanged when we re-
peated the analyses and controlled for age,
gender, initial severity of depression, GAS
score at intake, compliance and intent to
treat”
Selective reporting (reporting bias) Unclear risk No design paper or trial registration could
be identified to assess this risk
Other bias Unclear risk None Identified
Fantino 2007
Methods RCT. Recruitment: patients were recruited by psychiatrists or by general practitioners.
Follow up: 8 weeks. Lost to follow up: 8.1%
Participants 280 were randomised (T1: 138; T2: 142). Setting: outpatient; general or psychiatric
practices in France. Inclusion: all patients fulfilling the DSM-IV criteria for MDD and
having a baseline MADRS total score of at least 30 were eligible for the study. Exclusion:
patients meetingDSM-IV for primary diagnoses for any axis I disorder other thanMDD
or those with a history of mania, bipolar disorder, schizophrenia or other psychotic
disorder, obsessive-compulsive disorder, cognitive disorder including mental retardation
or personality disorder, patients who met the DMS-IV criteria for substance abuse or
dependence within the past 12 months, or used a depot antipsychotic within 6 months
before study inclusion or any antipsychotic or anticonvulsantmedicationswithin 2weeks
before the first administration of study medication
Male: T1: 28.3%; T2: 38.0%
Age: T1: 44.1 (SD 10.9); T2: 46.2 (SD 11.1)
Family situation:
T1: 23.9% single; T2: 16.2% single
T1: 49.3% married, living with partner; T2: 50.7% married living with partner
T1: 26.8% separated, divorced, widowed; T2: 33.1% separated, divorced, widowed
Occupational status:
T1: 35.5% unemployed; T2: 29.6% unemployed
T1: 64.5% employed; T2: 70.4%
T1: 4.5% craftsman, tradesman; T2: 7.0% craftsman, tradesman
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Fantino 2007 (Continued)
T1: 9.0% manager; T2: 12.0% manager
T1: 21.3% technician; T2: 30.0% technician
T1: 9.0% workman; T2: 4.0% workman
Interventions T1: Escitalopram (SSRI) 10 mg daily during the first week, 20 mg per day for the
remaining 7 weeks
T2: Citalopram (SSRI) 20 mg/day daily during the first week, 40 mg per day for the
remaining 7 weeks
All study medications were provided in identical blister packs of identical capsules ad-
ministered as one capsule per day, regardless of dose or
treatment group. No adjustment of dosage was allowed
Outcomes Absenteeism:
1) says of sick leave for the 2-month pre-study period and for the 8-week study period
(percentage of patients and mean consumption of those patients)
Clinical:
1) sepression severity, assessed by the Montgomery-Asberg Depression Scale (MADRS)
2) remission, defined as the total score MADRS of ≤ 12
3) MADRS-S, the self-reported version of MADRS
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Personal communication: “Allocation was
random. This includes random allocation
using equal block sizes.”
Allocation concealment (selection bias) Low risk Personal communication: “Allocation was
concealed. Investigators allotted patients to
a treatment defined by the patient inclu-
sion number. All treatments were prepared
and identical, the only difference being the
treatment number, corresponding to the al-
location table, which was kept by the per-
son who prepared the treatments. The in-
vestigators were not aware of the nature of
the treatments.”
Blinding of participants and personnel
(performance bias)
Sick Leave
Low risk Trial is double-blind: “Those meeting the
eligibility criteria were randomly assigned
to receive double-blind, fixed doses of ei-
ther escitalopram 20 mg daily or citalo-
pram 40 mg daily during 8 weeks, with
equal block randomization at baseline.”
“All study medications were provided in
identical blister packs of identical capsules
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Fantino 2007 (Continued)
administered as one capsule per day, re-
gardless of dose or treatment group.” Per-
sonal communication: “The psychiatrist or
GP both included the patient, dispensed
the study medication, and did the assess-
ments. Patient and investigator were both
blind to the treatment, which were identi-
cal in aspect. Since this was not placebo-
controlled, both comparators were active
and quite similar, differing only be the pres-
ence of 20 mg R-citalopram in the 40 mg
citalopram.This actually reduces the risk of
unblinding by recognizable drug effects or
side-effects.”
Blinding of outcome assessment (detection
bias)
Sick Leave
Low risk “A standardized form was used by trained
investigators to record healthcare services
and days of sick leave for the 2-month pre-
study period and for the 8-week study pe-
riod.” Since the investigators were blinded,
the risk of bias is considered to be low
Blinding of outcome assessment (detection
bias)
Depressive symptoms
Low risk The MADSR was done by investigators
who are trained or confirmed in the proper
use of the MADSR scores and who were
blinded for the allocation status. The
MADSR-S is a self-reported version, but
patients were also blinded for treatment al-
location
Incomplete outcome data (attrition bias)
Depressive symptoms
Low risk Loss to follow up is considered to be low.
T1: 4.3%; T2: 10.6%
Incomplete outcome data (attrition bias)
Sick Leave
Low risk No missing sick leave data: “Valid resource
utilization information corresponding to
the pre study and study periods was thus
available for 280 patients.”
Selective reporting (reporting bias) Unclear risk No design paper or trial registration could
be identified to assess this risk
Other bias Unclear risk None identified
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Fernandez 2005
Methods Randomised, double-blind, flexible-dose, multinational, clinical trial with a one-week
run-in period with no treatment. After randomisation: two treatment arms Recruitment:
patient were asked to participate by GP. Follow up: 8 weeks. Lost to follow up: 16%
Participants 293 were randomised (T1: 148; T2: 145). Setting: primary care at 44 sites in 8 European
countries. Inclusion: patients in primary care
Age 18 to 85 yrs, DSM-IV diagnosis of MDD (current or first), Minimal MADRS score
of 18. Exclusion: History of mania or any bipolar disorder, schizophrenia or any psy-
chotic disorder, Currently suffering from obsessive-compulsive disorder, eating disorder,
mental retardation, any pervasive development disorder, or cognitive disorder (DSM-IV
criteria), MADRS of at least 5 on item 10 (suicidal thoughts), Alcohol or drug abuse
problems within the previous 12 months, Having had treatment with: antipsychotics,
antidepressants, psychotropics (except zolpidem or stable low doses of benzodiazepines
for insomnia), serotonin receptor antagonists, lithium, carbamazepine, valproate, or val-
promide, ECT, treatment with CBT or psychotherapy, Being pregnant or breastfeeding,
Medications likely to interfere with the study
Mean age T1: 48.4; T2: 46.5
Sex: T1: 75.4% female; T2: 71.2% female
Married or cohabiting: T1: 61.9%; T2: 56%
Employed: T1: 51.5%; T2: 60%
Long-term sickness absence: T1: 11.1%; T2: 11.2%
Higher education: T1: 9.5%. T2: 11.2%
Interventions T1: Escitalopram (SSRI): initial 10 mg/day. At week 2 or 4 dose could be increased to
20 mg/day at the investigator’s discretion if patient’s response was unsatisfactory. After 8
weeks of treatment, 1 week run-out period. Patients on 20 mg/day were down-tapered
to 10 mg for the first 4 days and placebo the last 3. Patients on lower dose received 7
days of placebo
T2: Venlafaxine XR (SNRI), initially 75 mg/day. At week 2 or 4 dose could be increased
to 150 mg/day at the investigator’s discretion if patient’s response was unsatisfactorily.
After 8 weeks of treatment, 1-week run-out period. Patients on 150 mg/day were down-
tapered to 75 mg for the first 4 days and placebo the last 3. Patients on lower dose
received 7 days of placebo
Outcomes Absenteeism:
1) % of patients on sick leave and average length of sick leave per week (3 months prior
baseline and during 8 weeks of study)
2) personal communication; days of sick leave during 8 weeks of study, for workers only
Clinical:
1) MADRS (at 8 weeks)
2) HAM-D (at 8 weeks)
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
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Fernandez 2005 (Continued)
Random sequence generation (selection
bias)
Low risk Personal communication with first author:
”Patients who met the selection criteria at
the baseline visit were assigned to 8 weeks
of double-blind treatment according to a
computer-generated randomisation list.“
Allocation concealment (selection bias) Low risk Personal communication with first author:
”The details of the randomisation series
were unknown to any of the investigators
andwere contained in a set of sealed opaque
envelopes.“
Blinding of participants and personnel
(performance bias)
Sick Leave
Low risk An economic evaluation was conducted
alongside a double-blind,multinational,
randomised clinical trial. Personal commu-
nicationwith first author: ”Thismeans that
both investigator and patient were blinded
regarding allocation to treatment.“
Blinding of outcome assessment (detection
bias)
Sick Leave
Low risk ”Data at baseline consisted of self-reported
patient questionnaires recording use of
healthcare services and days of sick leave ..
..“
Personal communication with first author:
”Patients were blinded regarding allocation
to treatment.“
Blinding of outcome assessment (detection
bias)
Depressive symptoms
Low risk ”Depressive symptoms were assessed by
trained raters.“ Personal communication
with first author: ”Outcome assessors were
blinded for the allocation of patients.“
Incomplete outcome data (attrition bias)
Depressive symptoms
High risk Loss to follow-up depression data is 15%,
which we consider high and no appropri-
ate method has been used to account for
attrition
”Efficacy analyses were conducted on
the intention-to-treat (ITT) population,
which included all randomised patients
who took at least
1 dose of double-blind study medication
and who had at least 1 valid post-baseline
assessment of the MADRS total score. The
ITT
population thus comprised 146 patients in
the escitalopram group and 142 patients
in the venlafaxine group. A total of 249
patients (of 293) completed the study.“
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Fernandez 2005 (Continued)
Incomplete outcome data (attrition bias)
Sick Leave
High risk Lost to follow-up sick leave data is 16%,
which we consider high and no appropri-
ate method has been used to account for
attrition
”Data at baseline consisted of self-reported
patient questionnaires recording use of
healthcare services and days of sick leave
Of the 293 patients in the trial, valid cost
information in the 3-month pre-study pe-
riod was available for 251 patients; for 22
patients in the escitalopram arm and 20
patients in the venlafaxine arm, either the
physician or patient did not fill in the re-
source use questionnaire. Of the 251 evalu-
able patients, 126 received escitalopram
and 125 received venlafaxine.Of these, 245
patients reported valid cost information for
the 8-week duration of the trial (four esci-
talopram and two venlafaxine patients were
lost relative to the pre-study period)
“Given the very low rate of attrition in the
sample during the trial, patients with miss-
ing data were unlikely to represent serious
bias to the results of the present analysis.
As a result, no attempt was made to impute
missing data.”
Selective reporting (reporting bias) Unclear risk No design paper or trial registration could
be identified to assess this risk
Other bias Unclear risk None Identified
Hees 2013
Methods TwoarmedRCT.Recruitment: BetweenDecember 2007 andOctober 2009, participants
were referred by occupational physicians from several occupational health services. Follow
up: 18 months. Lost to follow up: 13.7%
Participants 117 were randomised (T1: 39; T2: 78); Setting: Outpatient; Department of Psychiatry,
Academic Medical Center, Amsterdam; Inclusion: Age 18 to 65, DSM-IV diagnosis of
MDD, Absent from work at least 25% of their contract hours due to their depression.
In addition, the duration of the depression had to be at least 3 months or the duration of
their sickness absence had to be at least 8 weeks. Finally, there had to be a relation between
the depressive disorder en the work situation, that is, work was one of the determinants of
depressive disorder and contributed substantially (> 25%), or the depressive symptoms
reduced productivity or hindered RTW
Exclusion: severe alcohol or drug dependence, bipolar disorder, psychotic disorder, de-
pression with psychotic characteristics, indication of inpatient treatment
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Age: T1: 41.5 (SD 9.6); T2: 43.8 (SD 9.0)
Male: T1: 41%; T2: 53%
Education (years): T1: 13.9 (SD 3.7); T2: 13.5 (SD 3.1)
Martital status: T1: 59%married or living together; T2: 58%married or living together;
T1: 23% single; T2: 28% single; T1: 18% divorced or widowed; T2: 14% divorced or
widowed
Contract (number of hours): T1: 32.7 (SD 5.8); T2: 35.0 (SD 5.0)
Absenteeism (number of hours): T1: 27.1 (SD 8.8); T2: 27.6 (SD 10.0)
Duration of absenteeism (months): T1: 3.8 (IQR 2.0 - 6.5); T2: 5.0 (IQR 2.8 - 5.0)
Occupational sector: financial or insurance: T1: 54%; T2: 58%; Health care: T1: 18%;
T2: 9%; Other: T1: 28%; T2: 33%
Work experience (years): T1: 14.1 (SD 9.6); T2: 15.9 (SD 11.0)
Interventions T1: Treatment as usual: treatment by psychiatric residents in an outpatient university
clinic according to a treatment protocol consistent with the APA guidelines. 19 visits
consisted of clinical management, including psycho education, supportive therapy and
cognitive behavioural interventions. Therapies were supervised on a weekly basis by an
experienced senior psychiatrist specialised in depression. If needed, participants received
pharmacotherapy according to a protocolised algorithm. If the participant’s condition
deteriorated and outpatient treatment was no longer deemed adequate, he or she was
referred to day treatment or inpatient treatment
T2: Adjuvant occupational therapy: consisted of 18 sessions (nine individual sessions,
eight group sessions and a meeting with the employer), and was conducted by two expe-
rienced occupational therapists who had received extensive training in the intervention
protocol. During the intervention, the occupational therapist frequently communicated
with the occupational physician and the resident treating psychiatric. Employees were
recruited to work at least 2 hours per week when starting OT, so that employees were
able to directly practise the things learned (e.g. new coping strategies) during therapy
Outcomes Absenteeism:
1) work participation, defined in: a) average number of hours of absenteeism over each
6-month period and b) duration of sick leave due to depression in calender days from
the start of treatment until partial (or full) RTW. Time until partial or full RTW was
operationalised as the duration of sick leave due to depression in calendar days from
the start of treatment until partial (or full) RTW. Partial RTW was defined as working
an increment of at least 5 hours (compared with hours worked at baseline), for at least
4 weeks without partial or full recurrence. Full RTW was defined as working the full
number of contract hours in own or other work for at least 4 weeks, without partial or
full recurrence
Clinical:
1) severity of depression, assessed by the Hamilton Rating Scale for depression (HRSD)
2) depression remission, defined as having HRSD ≤ 7
3) severity of depression, assessed by the Questionnaire Inventory of Depressive Symp-
toms Self-Report (StIDS-SR)
Functioning:
1) at work functioning: weekly self-report records of work efficiency on a scale 1-0 and
3 sub scales of WLQ: Output, time, mental-interpersonal
2) health-related functioning, 3 subscales of MOS-SF 36: role limitations due to emo-
tional problems, mental health, role limitations due to physical problems
48Interventions to improve return to work in depressed people (Review)




Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “Randomization was conducted by an in-
dependent research assistant, using soft-
ware based on a minimization randomiza-
tion procedure.”
Allocation concealment (selection bias) Low risk “Randomization was conducted by an in-
dependent research assistant, using soft-
ware based on a minimization randomiza-
tion procedure.”
Blinding of participants and personnel
(performance bias)
Sick Leave
High risk “Due to the nature of the intervention,
neither patients nor therapists could be
blinded to the patient’s allocation status.
” Both treatments cannot be considered
equally desirable for patients, so risk of per-
formance bias high
Blinding of outcome assessment (detection
bias)
Sick Leave
High risk Sickness absence data are measured by
the use of self-report. As patients are not
blinded for the allocation status, risk of bias
is high
Blinding of outcome assessment (detection
bias)
Depressive symptoms
Low risk “Study assessment were conducted by a
psychiatrist and a researcher who where
blind to group allocation.” As the HRSD is
a clinician-rated instrument, there is a low
risk of bias for the HRSD outcome
Incomplete outcome data (attrition bias)
Depressive symptoms
Low risk Lost to follow up: T1: 15.4%; T2: 12.8%
but appropriate imputation methods have
been used. “To take potential biased out-
comes caused by selective loss to follow up
into account, we used multiple imputation
(five imputed datasets), which, assuming
missing at random for missing values, gives
unbiased results with correct SEs.”
Incomplete outcome data (attrition bias)
Sick Leave
Low risk Lost to follow up: T1: 15.4%; T2: 12.8%
but appropriate imputation methods have
been used. “To take potential biased out-
comes caused by selective loss to follow up
into account, we used multiple imputation
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(five imputed datasets), which, assuming
missing at random for missing values, gives
unbiased results with correct SEs.”
Selective reporting (reporting bias) Low risk The study protocol is available and all of
the study’s pre-specified (primary and sec-
ondary) outcomes that are of interest in the
review have been reported in the pre-spec-
ified way
Other bias Unclear risk None identified
Hollinghurst 2010
Methods RCT. Recruitment: patients were recruited from 55 general practices in Bristol, London,
and Warwickshire between October 2005 and February 2008. Follow up: 8 months.
Lost to follow up: 53% for sickness absence and 29% for clinical outcomes
Participants 297were randomised (T1: 149; T2: 148). Setting: patients betweenwhowhere identified
in primary care as having a new episode of depression
Inclusion: patients between 18 and 75 who where identified in primary care as having
a new episode of depression which was defined as being diagnosed within the 4 weeks
preceding referral. Depression was defined as a score of 14 or more on the BDI12 and
an ICD-10 diagnosis of depression using the CIS-R) Exclusion: patients treated for
depression in the 3 months before the present episode, patients with a history of bipolar
disorder, psychotic disorder, alcohol or substance misuse, and those already receiving
psychotherapy
Female: T1: 69%; T2: 67%
Age: T1: 35.6 (SD 11.9); T2: 34.4 (SD 11.3)
Marital status:
T1: 34% married; T2: 39% married
T1: 50% single; T2: 47% single
T1: 16% separated or divorced or widowed; T2: 15% separated or divorced or widowed
Employment status:
T1: 65% employed; T2: 56% employed
T1: 15% student; T2: 24% student
T1: 20% not in employment; T2: 20% not in employment
Highest educational level:
T1: 65% A level or above; T2: 63% A level or above
T1: 32% other; T2: 33% other
T1: 3% no educational qualifications; T2: 4% no educational qualifications
Interventions T1: Online CBT in addition to usual care: participants receiving online CBT were
offered up to ten sessions of 55 minutes, to be completed within 4 months from the date
of randomisation when possible. Each participant was assigned their own therapist for
the duration of the study. Participants and therapists typed free text into the computer,
with messages sent instantaneously, using only this means of communication
T2: Usual care from GP while on a 8-month waiting list for online CBT: participants
on the waiting list were not to receive psychotherapy during the study follow-up period.
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Those on the waiting list who had still an eligible Beck Depression Inventory (BDI)
score after 8 months were offered the intervention at that time
Outcomes Absenteeism:
1) the number of working days lost because of depression (time off work) over 8 months
Clinical:
1) depression severity, assessed by the BDI
2) recovery, defined as a score of less than 10 on the BDI
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “Randomization was by means of a com-
puter-generated code, implemented by an
individual who was not involved in the re-
cruitment process, and communicated to
the participant within 48 h of the baseline
interview.”
Allocation concealment (selection bias) Low risk “Randomization was by means of a com-
puter-generated code, implemented by an
individual who was not involved in the re-
cruitment process, and communicated to
the participant within 48 h of the baseline
interview.” “The allocation was concealed
in advance from participants, researchers
involved in recruitment, and therapists.”
Blinding of participants and personnel
(performance bias)
Sick Leave
High risk Risk of performance bias is considered high
as patients were aware of their allocation
status and both treatments are not equally
desirable for patients: “Randomization was
by means of a computer-generated code,
implemented by an individual who was not
involved in the recruitment process, and
communicated to the participant within 48
h of the baseline interview.”
Blinding of outcome assessment (detection
bias)
Sick Leave
High risk The number of working days lost because
of depression was recorded in a diary by
the participants themselves. As participants
were aware of their intervention status, risk
of bias high
Blinding of outcome assessment (detection
bias)
High risk The BDI is a self-report inventory. As par-
ticipants were aware of their intervention
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Depressive symptoms status, risk of bias high
Incomplete outcome data (attrition bias)
Depressive symptoms
High risk Loss to follow up is high: T1: 27%; T2:
32% even though appropriate method has
been used to account for thesemissing data:
“Fourth, a sensitivity analysis investigated
the effect of missing data with multiple im-
putation by chained equation methods in
Stata.” “Analyses imputing missing values
suggested that differences in attrition be-
tween the groups did not introduce any no-
ticeable bias.”
Incomplete outcome data (attrition bias)
Sick Leave
High risk Loss to follow up is high: T1: 50%; T2:
55% even though appropriate method has
been used to account for this missing data:
“we imputed missing observations of cost
and QALYs using the multiple imputation
by chained equation procedure in Stata
release 10.” “We acknowledge that more
complete data would have been available if
we had used questionnaires completed face
to face or data from practice records. How-
ever, the results of the imputation suggest
that any information lost is unlikely to have
a major influence on the results or conclu-
sions.”
Selective reporting (reporting bias) Unclear risk No design paper or trial registration could
be identified to assess this risk
Other bias Unclear risk None identified
Kendrick 2005
Methods RCT, randomisation on the level of patients stratified for referring GP; 3 conditions.
Recruitment: general practices referred patients to the study. CMHNs were employed
by local NHS trusts. Follow up: 26 weeks. Lost to follow up: 26%
Participants 247 randomised (T1: 90; T2: 79; T3: 78). Setting: community mental health, UK.
Inclusion: age: 18-65; new episode of anxiety, depression or reaction to life difficul-
ties; minimum duration symptoms: 4 weeks; maximum duration symptoms: 6 months;
GHQ-12 score at least 3
Exclusion: patient already in contact with psychiatric services; Patient already receiving
psychological treatment; Severe mental illness such as schizophrenia, manic-depressive
psychosis; severe substance misuse, dementia or severe depression with active suicidal
ideas; housebound patients; patients without the spoken and written language skills
necessary to participate; seriously ill and terminally ill patients; temporary residents
Mean age: T1: 35.8 (SD 10.92); T2: 34.2 (SD 11.33); T3: 34.9 (SD 11.77)
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Female: T1: 72%; T2: 70%;T3: 69%
Married or cohabiting: T1: 60%; T2: 58%; T3: 48%
Fulltime or part-time employed: T1: 66%; T2: 75%; T3: 69%
Interventions T1: CMHN problem-solving treatment:
1. explanation of treatment and rationale
2. clarification and definition of problems
3. choice of achievable goals
4. generations of alternative solutions
5. selection of preferred solution
6. clarification of necessary steps to implement solution
7. evaluation of progress; Initial 1-hour session + 5 follow-up sessions of 30-45 minutes.
T2: Generic CMHN; nurses were asked to use whatever treatment theywere experienced
in giving; initial 1-hour session + 5 follow-up sessions of 30 to 45 minutes. Range 0 to
8 sessions
T3: GP care: usual care, but asked not to refer patients to a psychological therapist during
the study period unless absolutely necessary
Outcomes Absenteeism:





1) SAS, however, subscale “work outside the home” not separately reported
Notes Personal communication: data for depressed subsample was provided
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “The telephone randomisation service at
the university of York was contracted.”
Allocation concealment (selection bias) Low risk “Remote central randomisation was pro-
vided by telephone”
“Randomisation sequences were in block
sizes of either three or six, to prevent prac-
titioners from guessing to which arm the
next referral would be.”
Blinding of participants and personnel
(performance bias)
Sick Leave
High risk High risk for the comparison with the GP
usual care group (T3) as this treatment can-
not be considered equally desirable as T1
and T1 for patients and patients were not
blinded. “Table 16: n = 50 received their
preferred treatment; n = 114 did not receive
their preferred treatment; n = 83 reported
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no preference”
Blinding of outcome assessment (detection
bias)
Sick Leave
High risk Sick leave was measured by self-report and
patients were not blinded to treatment al-
location
“Number of days off paid work was cap-
tured by a resource-use questionnaire filled
out by patients.”
“Patients were reminded not to reveal their
allocation at the follow-up assessments.”
Blinding of outcome assessment (detection
bias)
Depressive symptoms
High risk Depression symptom score (CIS-R and
HADS-D) were measured by self-report
and patients were not blinded. “The com-
puterised version of the CIS-R, which is
self-complete, was used in this study.” “Pa-
tients were reminded not to reveal their al-
location at the follow-up assessments.”
Incomplete outcome data (attrition bias)
Depressive symptoms
High risk Loss to follow up is considered to be high
(26%). Risk of attrition bias due to fol-
low-up losses is therefore considered to
be high, although sensitivity analyses were
conducted and the authors conclude other-
wise; “sensitivity analyses were conducted
to see whether the result changed depend-
ing on what assumptions were made about
the missing data”. “Table 12 shows that the
main findings are not particularly sensitive
to the different assumptions about missing
data that were investigated.”
It was harder to retain patients in the GP
care (thus higher loss to follow up in that
group): “Although the overall follow-up
rates were good, there was a lower follow-
up rate in the GP arm. It is difficult to
tell whether this biased the findings in a
particular direction. Follow-up rates were
better among those patients who received
the treatment they preferred, so it is likely
that there were more disaffected patients
in the GP care arm. However, it is not
known whether those who dropped out re-
mained more symptomatic than those who
were followed up. Failing to receive their
treatment of preference was not associated
with a worse outcome on the CIS-R among
thosewhowere followedup.The sensitivity
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analyses suggest that CMHN care, whether
generic care or specific PST, is unlikely to
be more effective than GP care, unless one
believes the LOCF analysis and makes the
extreme assumption that all the dropouts
remained as symptomatic as they were at
the time of last assessment.”
Incomplete outcome data (attrition bias)
Sick Leave
High risk Loss to follow up for sick leave data is con-
sidered to be high (26%). Risk of attri-
tion bias due to follow-up losses is there-
fore considered to be high, although sen-
sitivity analyses were conducted and the
authors conclude otherwise; “cost results
from this analysis were validated by substi-
tutingwhere possible data from theGPcase
notes in place of imputed values for miss-
ing data, and repeating the analysis. Over-
all, the results did not change significantly.
”
“36% had at least one resource item miss-
ing over the 6-month follow up. There-
fore, complete resource use data were avail-
able for 159 (64%) of the patients. The re-
sults presented here are based mainly on
the 184 patients for whom complete CIS-
R data were available over the 6-month pe-
riod. To achieve this sample, 25 (14%) of
the patientswhohadCIS-Rdata but not re-
source-use information had to be imputed.
The results were then compared with those
obtained using data from GP notes where
available instead of imputation, and those
obtained using only the 159 patients with
complete resource-use data. After imput-
ing missing values for the 25 patients with
missing resource-use data, the numbers of
patients included in the economic analysis
in each group were as follows: 51 patients
in GP care (28%), 62 patients in generic
CMHN care (34%) and 71 patients in PS
CMHN care (38%).”
Selective reporting (reporting bias) Low risk No indication for selective reporting could
be identified. However, in the design study,
the comparisons of T1 with T2 was not
pre-specified
Other bias Unclear risk None identified
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Methods RCT. Recruitment: a total of 459 eligible outpatients were referred to the Helsinki
Psychotherapy Study from psychiatric services in the Helsinki region from June 1994
to June 2000. Follow up: 5 years. Lost to follow up: 19% (for all participants over five
years), lost to follow up for the subgroup of people with depressive disorder: 51% (over
five years)
Participants 326 were randomised (T: 97; T2: 101; T3: 128). Subgroup of people with depressive
disorder: 161. Setting: outpatient. Inclusion: 20 to 45 years of age and suffered from
a longstanding (> 1 year) disorder causing dysfunction in work ability. They were also
required to meet DSM-IV criteria for anxiety or mood disorders
Exclusion: psychotic disorder or severe personality disorder, adjustment disorder, sub-
stance-related disorder, organic brain disease or other diagnosed severe organic disease,
and mental retardation. Individuals treated with psychotherapy within the previous 2
years and psychiatric health employees were also excluded
Age: T1: 33.6 (SD 7.2); T2: 32.1 (SD 7.0); T3: 31.6 (SD 6.6)
Male: T1: 25.8%; T2: 25.7%; T3: 21.1%
Employed or student: T1: 83.2%; T2: 85.1%; T3: 75.4%
Academic education: T: 28.9%; T2: 19.8%; T3: 75.4%
Interventions T1: Solution-focused therapy: is a brief, focal, transference-based therapeutic approach
which helps patients by exploring and working through specific intrapsychic and inter-
personal conflicts. The therapy included one session every second or third week, with a
limit of 12 sessions, over no more than 8 months
T2: Short-term psychodynamic psychotherapy: is characterized by the exploration of a
focus, which can be identified by both the therapist and the patient. This consists of
material from current and past interpersonal and intrapsychic conflicts and the applica-
tion of confrontation, clarification, and interpretation in a process in which the therapist
is active in creating the alliance and ensuring the time-limited focus. The therapy was
scheduled for 20 weekly treatment sessions over 5 to 6 months
T3: Long-term psychodynamic psychotherapy: is an open-ended, intensive, transfer-
ence-based therapeutic approach which helps patients by exploring and working through
a broad area of intrapsychic and interpersonal conflicts. The therapy is characterized
by a framework in which the central elements are exploration of unconscious conflicts,
developmental deficits, and distortions of intrapsychic structures. Confrontation, clarifi-
cation and interpretation are major elements, as well as the therapist’s actions in ensuring
alliance and working through the therapeutic relationship to attain conflict resolution
and greater self-awareness. Therapy includes both expressive and supportive elements,
the use of which depends on patient needs. The frequency of sessions was 2 to 3 times
a week, and the duration of the therapy was up to 3 years
Outcomes Absenteeism:
1) number of sick-leave days during last 3 months
Clinical:
1) depressive symptoms assessed by the Beck Depression Inventory (BDI)
2) depressive symptoms assessed by the Hamilton Depression Rating Scale (HDRS)
Functioning:
1) the work-subscale (SAS-work) of the social adjustment scale (SAS-SR)
Notes
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Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “Concealed assignment codes were given
sequentially to patients in consecutively
numbered envelopes.”
Allocation concealment (selection bias) Low risk “The patients who fulfilled the selection
criteria at baseline were randomized into
solution-focused therapy, short-term psy-
chodynamic psychotherapy or long-term
psychodynamic psychotherapy or long-
term psychodynamic psychotherapy in a
1:1:1.3 ratio using a central computer-
ized randomization schedule. Concealed
assignment codes were given sequentially
to patients in consecutively numbered en-
velopes.”
Blinding of participants and personnel
(performance bias)
Sick Leave
High risk Due to the nature of the intervention, the
participants and personnel could not be
blinded
Blinding of outcome assessment (detection
bias)
Sick Leave
High risk Sick leave was measured by self-report and
the patients were not blinded for their allo-
cation status. Outcome is likely to be influ-
enced by this lack of blinding. “The num-
ber of sick leave days from work during the
past 3monthswere collected by single-item
questions included in a follow-upquestion-
naire developed in the project.” “Unavoid-
able weaknesses in a study like this are [...]
the lack of blindness of assessments.”
Blinding of outcome assessment (detection
bias)
Depressive symptoms
High risk The BDI is a self-report inventory and
patient were not blinded for their alloca-
tion status. Outcome is likely to be influ-
enced by this lack of blinding. The HDRS
is a clinician-administered scale but clin-
icians were also not blinded: “raters were
not blinded since they were provided with
information on the treatment group at the
five interview sessions during the 3-year fol-
low up.”
Incomplete outcome data (attrition bias)
Depressive symptoms
Low risk Loss to followup is 19%andmissing values
were replaced by multiple imputation; this
did not alter the results. “Analyses based
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onmultiple imputation and taking into ac-
count the need for treatment at the time
of dropout did not, however, notably alter
the results, suggesting that the results pre-
sented are unbiased (data not shown).”
Incomplete outcome data (attrition bias)
Sick Leave
High risk Loss to follow up is considered to be high:
39% at one year and 52% at five years
Selective reporting (reporting bias) Unclear risk No design paper or trial registration could
be identified to assess this risk
Other bias Unclear risk None identified
Krogh 2009
Methods Randomized pragmatic trial. Recruitment: between January 2005 and July 2006. Follow-
up: 12 months. Lost to follow up: 17% at 4 months and 22% at 12 months
Participants 165 were randomised (T1:55; T2:55; T3:55); Setting: outpatient; this trial was carried
out at a single location at Copenhagen University. Inclusion: age 18-55 years, referred
by a medical doctor or psychologist, meeting ICD-10 criteria for unipolar depression,
living in the Greater Copenhagen catchment area, able to read and understand informed
consent. Exclusion: being engaged in regular sports activity for more than 1 hour per
week, ongoing alcohol or substance abuse judged to be at risk of suicide, poor Danish
language skills, having a medical condition that contraindicated physical exercise, or had
been on sickness leave for than 24 consecutive months
Age: T1: 41.9 (SD 8.7); T2: 38.1 (SD 9.0); T3: 36.7 (SD 8.7)
Female: T1: 81.8%; T2: 78.2%; T3: 61.8%
Ethnicity: T1: 90.9% Caucasian; T2: 92.7% Caucasian; T3: 90.9% Caucasian
Occupational status:
T1: 41.8% unemployed; 40% fulltime work; 14.5% part-time work; 3.6% < 20 hrs/wk
T2: 54.5% unemployed; 32.7% fulltime work; 10.9% part-time work; 1.8% < 20 hrs/
wk
T3: 36.4% unemployed; 41.8% fulltime work; 18.2% part-time work; 3.6% > 20 hrs/
wk
Interventions T1: Supervised strength training. Designed to increase muscular strength, initially with
12 repetitions of 50% of repetition maximum 2 or 3 times per exercise. As the patients
progressed, the numbers of repetitions were reduced to 10 and 8, with an increase of
RM to 75%. The training was a circuit-training program with 6 exercise on machines
involving large muscle groups. As a supplement to this, free weights and sandbags were
used for exercising the calf muscles, the arm abductors, the triceps muscles, and the hip
abductors. All patients were scheduled to meet twice per week during a 4-month period
for a total of 32 sessions
T2:Aerobic training.Designed to increase fitness asmeasured bymaximal oxygenuptake.
The program involved 10 different aerobic exercises using largemuscle groups. Machines
were used for cycling, running, stepping, abdominal exercises, and rowing. Additional
exercises were sliding movements on small carpets, trampoline, step bench, jump rope,
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and Ski Fitter. During the first 8 sessions, each exercise was done twice for 2 minutes
with a 2-minute rest at an intensity level of 70% of maximal heart rate. This gradually
increased to a level at which exercise was done for 3 minutes with a 1-minute rest at
an intensity level of 89% during the last 8 sessions. All patients were scheduled to meet
twice per week during a 4-month period for a total of 32 sessions
T3: Relaxation training. Designed to avoid muscular contractions or stimulation of the
cardiovascular system, and the patients did not engage in activities perceived higher than
12 on the Borg Scale. The first 20 to 30 minutes were used for exercises on mattresses
or Bobath Balls or back massage using a Ball Stick Ball. This was followed by light
balance exercises for 10 to 20 minutes and by relaxation exercises with alternating muscle
contraction and relaxation in different muscle groups while lying down for 20 to 30
minutes
Outcomes Absenteeism:
1) self-reported percentage of days absent from work during the last 10 working days at
4 and 12 months
Clinical:
1) severity of depression, assessed by the Hamilton Rating Scale for Depression (HAM-
D17)
2) remission, defined as not fulfilling the ICD-10 criteria for depression and having a
HAM-D17 < 8
3) severity of depression, assessed by the Beck Depression Inventory (BDI)
Employment status:




Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “Randomization was carried out by the
CTU using computerized restricted ran-
domization with a block size of 6. The
block size and thus the allocation sequence
were unknown to the DEMO trial staff.”
“The strengths of our trial were the central-
ized randomization, which provided ade-
quate generation of the allocation sequence
and adequate allocation concealment”
Allocation concealment (selection bias) Low risk “Randomization was centralized and strat-
ified according to medicine status.” “The
strengths of our trial were the centralized
randomization, which provided adequate
generation of the allocation sequence and
adequate allocation concealment”
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Blinding of participants and personnel
(performance bias)
Sick Leave
High risk “The same 2 physiotherapists were used
throughout the trial period. The type and
number of exercise interventions were dis-
tributed evenly between the two, and thus
the physiotherapists were not blinded to
allocation”. “And the patients were in-
structed not to reveal their group assign-
ment.” “The lack of blinding of treatment
allocation for patients and psychotherapists
could lead to collateral interventions, possi-
bly confounding our results.” As the relax-
ation condition was not equally desirable
to patients as the other two groups, the risk
of performance bias is considered high
Blinding of outcome assessment (detection
bias)
Sick Leave
High risk Absenteeism measured by self-report. As
patients were aware of their allocation sta-
tus, risk of bias high
Blinding of outcome assessment (detection
bias)
Depressive symptoms
Low risk For HAM-D17: “The assessor was blinded
to intervention group, and the patients
were instructed not to reveal their group as-
signment. After assessment the assessor was
requested to guess which group the patient
has been assigned to, making it possible to
examine whether the blinding was success-
ful [ .. ] This indicated that the blinding of
the assessors was successful”
Incomplete outcome data (attrition bias)
Depressive symptoms
High risk Loss to follow up at endpoint was high:
22%(36/165) and skewed.Risk of attrition
biaswas therefore considered high although
an appropriate method was used to deal
with missing values in the analyses and the
authors conclude otherwise
“Analysis of age, sex, HAM-D17, or ab-
sence from work during the last 10 work-
ing days at entry did not suggest any signif-
icant differences between missing partici-
pants and participants included in the anal-
ysis at either 4months or 12 months.” “It is
then plausible to consider the missing data
as ’missing at random’, making the mixed
effect model a plausible approach to esti-
mate the effect, based on the total sample
with missing cases included.”
“This approach uses data from all included
patients (intention-to-treat), handles entry
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differences, and is able to handle missing
data (restricted maximum likelihood pro-
cedure) with higher precision and power
compared to more traditional methods
such as the last observation carried forward.
” “There was skewed attrition, and the fol-
low-up assessment was significantly later
than 4 months in the control group.”
Incomplete outcome data (attrition bias)
Sick Leave
High risk Loss to follow up at endpoint was high:
22%(36/165) and skewed.Risk of attrition
biaswas therefore considered high although
an appropriate method was used to deal
with missing values in the analyses and the
authors conclude otherwise
“Analysis of age, sex, HAM-D17, or ab-
sence from work during the last 10 work-
ing days at entry did not suggest any signif-
icant differences between missing partici-
pants and participants included in the anal-
ysis at either 4months or 12 months.” “It is
then plausible to consider the missing data
as ’missing at random’, making the mixed
effect model a plausible approach to esti-
mate the effect, based on the total sample
with missing cases included.”
“This approach uses data from all included
patients (intention-to-treat), handles entry
differences, and is able to handle missing
data (restricted maximum likelihood pro-
cedure) with higher precision and power
compared to more traditional methods
such as the last observation carried forward.
” “There was skewed attrition, and the fol-
low-up assessment was significantly later
than 4 months in the control group.”
Selective reporting (reporting bias) High risk In the study protocol, no report was made
regarding the third treatment group (relax-
ation)
Other bias Unclear risk None identified
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Methods A single-centre, two-armed, parallel-group, observer-blinded randomised clinical supe-
riority trial. Recruitment: between September 2008 and April 2011, participants were
referred to trial site from various clinical settings. Follow up: 3 months. Lost to follow
up: 13%
Participants 115were randomised (T1: 56;T2: 59). Setting: outpatient; the participants were enrolled
at the trial site in Copenhagen (Denmark) from various clinical settings. Inclusion: men
and women between 18 and 60 years of age, referred from a clinical setting by a physician
or a psychologist, a diagnose of major depression (DSM-IV) based on the Danish version
of theMini International Neuropsychiatric Interview, score above 12 on the HAM-D17
and living in the Greater Copenhagen catchments area, able to comprehend and sign
the informed consent statement
Exclusion: current drugs abuse, any antidepressant medication within the last two
months, current psychotherapeutic treatment, contraindications to physical exercise,
more than 1 hour or recreational exercise per week, suicidal behaviour according to the
17-item Hamilton depression rating scale (HAM-D17 item 3 > 2), pregnancy, current/
previous psychotic or manic symptoms, or lack of informed consent
Age: T1: 39.7 (SD11.3); T2: 43.4 (SD 11.2)
Female: T1: 71.4%; T2: 62.7%
Occupational status:
T1: 35.7% unemployed; T2: 45.7%
T1: 35.7% sickness leave; T2: 30.5% sickness leave
T1: 74.3% job attendance, last 10 days; T2: 73.8% job attendance, last 10 days
Interventions T1: Aerobic training group: designed to increase fitness as measured by maximal oxygen
uptake. After initial 10 minutes of general low-intensity warm-up, the participants did
30 minutes of aerobic exercise on a stationary cycle ergometer followed by five minutes
low-intensity cool down period. During the initial four weeks, the aim was to work out
at intensity levels corresponding to at least 65% to their maximal capacity, progressing to
70% and 80% during the second and third month, respectively. The participants carried
a pulse monitor during exercise to guide and document intensity levels
T2: Stretching exercise group: designed as an attention control group with the purpose of
providing the same level of social interaction and contact with health care professionals as
in the aerobic exercise group. This was done in order to assess the potential antidepressant
effect of aerobic exercise in it self, and not the effect of aerobic exercise plus social
interaction. This stretching exercise group performed low intensity exercise, which we
did not expect to contain any antidepressant effect per se. The initial 10 minutes were
low-intensity warm-up on a stationary bike, then a 20 minutes program of stretching,
followed by 15 minutes of various low intensity exercises such as throwing and catching
balls
Both groups were scheduled to meet three times per week for three months for a total
of 36 sessions
Outcomes Absenteeism:
1) the number of days spent on the job within the last ten working days, expressed as a
percentage
Clinical:
1) depression severity, assessed by the HAM-D17
2) core depression items, assessed by HAM-D6
3) remission, defined as not fulfilling the DSM-IV criteria for major depression and a
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HAM-D17 score below 8
4) self-reported depression, assessed by the Beck Depression Inventory (BDI)
Employment status:
1) employment status or sick leave at the time of the interview
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk ”The randomization was centralized and
carried out by the Copenhagen Trial Unit
(CTU) using a computerized randomiza-
tion sequence with alternating block sizes
unknown to the investigators.“
Allocation concealment (selection bias) Low risk ”The randomization was centralized and
carried out by the Copenhagen Trial Unit
(CTU) using a computerized randomiza-
tion sequence with alternating block sizes
unknown to the investigators.“
Blinding of participants and personnel
(performance bias)
Sick Leave
High risk ”Prior to the first training session of the
participant, the trial psychotherapist would
contact the CTU by phone for participant
allocation.“ ”Neither participants nor the
physiotherapist conducting the interven-
tion were blinded to the allocation.“
Blinding of outcome assessment (detection
bias)
Sick Leave
Low risk The outcome assessors were all blinded to
participant allocation
”Prior to the follow up interview, partici-
pants were instructed not to reveal their al-
location to the outcome assessors. The sta-
tistical analysis and preparation of the first
draft was carried out blinded to group as-
signment.“
Blinding of outcome assessment (detection
bias)
Depressive symptoms
Low risk The outcome assessors were all blinded to
participant allocation. The HAM-D17 is a
structured interviewer based questionnaire,
so risk of bias low (this does not apply to
the BDI as this is a self-report instrument)
Incomplete outcome data (attrition bias)
Depressive symptoms
Low risk Lost to follow up: T1: 16.1%; T2: 10.2%
but appropriate method has been used to
account for these missing data: ”All contin-
uous outcome measures were analyzed us-
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ing a repeated measurement linear mixed
effect model with an unstructured variance
matrix [ .. ] The mixed effects function is
able to handle missing continuous data us-
ing a likelihood estimation of missing data.
“
Incomplete outcome data (attrition bias)
Sick Leave
Low risk Lost to follow up: T1: 16.1%; T2: 10.2%
but appropriate method has been used to
account for these missing data: ” “All con-
tinuous outcome measures were analyzed
using a repeatedmeasurement linear mixed
effect model with an unstructured variance
matrix [ .. ] The mixed effects function is
able to handle missing continuous data us-
ing a likelihood estimation of missing data.
”
Selective reporting (reporting bias) Unclear risk No design paper or trial registration could
be identified to assess this risk
Other bias Unclear risk None reported
Lerner 2012
Methods RCT. Recruitment: 6 months. Follow up: 4 months. Lost to follow up: 8.9%
Participants 79 were randomised (T1:52; T2:27); Setting: workplace; this study involved State Gov-
ernment in Maine
Inclusion: ages 18 to 62 years and employed 15 hours per week or more and fulfilled the
criteria for current MDD and/or dysthymia, a WLQ productivity loss of at least 5% in
the past 2 weeks (this score is consistent with an impaired ability to work approximately
20% of the time over 2 weeks). Exclusion: planning to retire within 2 years, receiving
work disability benefits, active alcoholism or drugs-abuse based on the five-item CAGE,
pregnant or 6months postpartum, schizophrenia or bipolar disorder, non-English speak-
ing and/or reading, and/or diagnosed with one or more of 12 medical conditions that
have symptoms that potentially interfere with working (e.g. angina, congestive hart fail-
ure, stroke, diabetes, chronic obstructive lung disease)
Comorbidity: T1: 80.8%; T2: 71.1%
Age: T1: 45.5 (SD 9.8); T2: 45.9 (SD 8.6)
Male: T1: 23.1%; T2: 18.5%
Ethinicity: T1: 100% white; 96.3% white
Marital status: T1: 47.1% married; T2: 48.1% married
Interventions T1: Work and Health Initiative (WHI) intervention. Provided over the phone by EAP
counsellors trained in its methods. The program lasts for 8 weeks with 1-hour visits
occurring every 2 weeks. This multi component work-focused programs consists of: 1)
work coaching andmodification, 2) care coordination, 3) cognitive-behavioral strategies.
In the WHI, the counsellor and employee co-create a care plan for dealing with each
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functional problem and review specific assignments and progress at each session. A
motivational enhancement approach is utilized to promote and solidify change. In both
groups: electronic feedback on depression and advise to seek care
T2: Usual care. Primary care, specialty care, behavioral health programs, and/or standard
EAP services. In both groups: electronic feedback on depression and advise to seek care
Outcomes Absenteeism:
1) the WLQ Work Absence Module measured self-reported time missed from work in
the past 2 weeks because of health or medical care
Clinical:
1) change in depression symptom severity as measured by the PHQ-9
Functioning:
1) Work limitations Questionnaires Short Form (WLQ), a self-report survey tool for
assessing the impact of health problems, including at-work performance. 4 Dimensions
of performance are measured
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “Employees were allocated by electronic
randomization.”
Allocation concealment (selection bias) Low risk Web-based randomisation
Blinding of participants and personnel
(performance bias)
Sick Leave
High risk Participants received information about the
RCT and were thus aware of the treatment
condition to which they were randomised.
Seven counsellors volunteered to conduct
the WHI intervention
Blinding of outcome assessment (detection
bias)
Sick Leave
High risk The WLQ Work absence module is a self-
report measure. As participants were aware
of their allocation status, risk of bias high
Blinding of outcome assessment (detection
bias)
Depressive symptoms
High risk The PHQ-9 relies on patient self-report. As
participants were aware of their allocation
status, risk of bias high
Incomplete outcome data (attrition bias)
Depressive symptoms
Low risk “Five (9.6%) employees in the WHI treat-
ment group and 2 (7.4%) of the usual
groupdidnot complete the follow-upques-
tionnaire and were considered dropouts.
” “Sensitivity analyses including the seven
employees that were lost to follow-up con-
firmed the results.”
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Incomplete outcome data (attrition bias)
Sick Leave
Low risk “Five (9.6%) employees in the WHI treat-
ment group and 2 (7.4%) of the usual
groupdidnot complete the follow-upques-
tionnaire and were considered dropouts.
” “Sensitivity analyses including the seven
employees that were lost to follow-up con-
firmed the results.”
Selective reporting (reporting bias) Unclear risk No design paper or trial registration could
be identified to assess this risk
Other bias Unclear risk None identified
McCrone 2004
Methods RCT, 2 conditions. Recruitment: by screening in the GP waiting rooms and of GP
referrals using the GHQ-12. Score at least 4: seen by GP who administered inclusion
and exclusion criteria. Follow up: 6 months. Lost to follow up at 6 months: T1: 27%;
T2: 24%
Participants 274 were randomised (T1: 146; T2: 128). Setting: Primary care, UK
Inclusion: GP patients aged 18 to 75 years; diagnosis (ICD): depression, mixed anxiety/
depression or anxiety disorder. CIS-R score at least 12
Exclusion: active suicidal ideas, Psychotic disorder, organic mental disorder or alcohol or
drug dependence. Having taken medication for anxiety or depression continuously for
at least 6 months immediately prior to entry; unable to read or write; unable to attend
8 sessions at practice
Mean age: T1: 43.6 (SD 14.3); T2: 43.4 (SD 13.7)
Female: T1: 73% T2: 75%
Married or cohabiting: T1: 54%; T2: 52%
Employed: T1: 66%; T2: 58%
Interventions T1: Computerised CBT: interactive, multimedia. Feedback to patient and GP after each
session. 15 minute introductory video, 8 x 50 minute sessions of CBT, with homework
projects between sessions
T2: TAU: General practitioner care as usual: no constraints. Could include medication,
discussion of problems with GP, practical or social help, referral to counsellor, practice
nurse, mental health professional, or further physical examination
Outcomes Absenteeism:




1) Work and Social Adjustment Scale
Notes
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Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk ”The random allocation schedule was gen-
erated at the Institute of Psychiatry. An in-
dividual unit of randomization was used.“
Allocation concealment (selection bias) Low risk ”Random allocation schedule was gener-
ated at the Institute of Psychiatry, before
the study commenced and away from GP
practices. Cards in sealed and numbered
envelopes were used. Only to be opened by
practice nurse who ran study. Integrity was
checked by the first author on her regular
visits to the practices.“
Blinding of participants and personnel
(performance bias)
Sick Leave
High risk No blinding, risk of performance bias con-
sidered high as the treatment of interest
(T1) cannot be considered equally desir-
able as Treatment as usual (T2) for pa-
tients. ”Patients randomized to ’Beating the
Blues’ (T1) also received pharmacotherapy,
if prescribed by their GP, and/or general
GP support and practical/social help“, of-
fered as part of treatment as usual, with the
exception of any face-to-face counselling
or psychological intervention. We did not
constrain the interventions received by pa-
tients allocated to treatment as usual (T2)
.” Moreover, patients in the Treatment as
Usual (T2) group were found to attend
other health care professionals more often.
“Large differences were observed for the
proportion of patients attending accident
and emergency or outpatient departments,
and having contacts with community psy-
chiatric nurses, counsellors and other ther-
apists. Greater use was made by the TAU
group for all these services.”
Blinding of outcome assessment (detection
bias)
Sick Leave
High risk No blinding of outcome assessors was re-
ported. Sick leave was based on the sick
leave certificates of theGP, whowas also the
treatment provider of treatment as usual.
“We recorded the number of days of ab-
sence from work during the baseline and
follow-up periods on the basis of an issue
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of a certificate by the general practitioner.”
Blinding of outcome assessment (detection
bias)
Depressive symptoms
High risk No blinding of patients was reported and
depressive symptoms were measured by
self-report
“Depressive symptoms were measured
with self-report and participants were not
blinded to treatment allocation.”
Incomplete outcome data (attrition bias)
Depressive symptoms
High risk Loss to follow up was relatively high (>
20%) for the depression outcome
From Figure 2 of the publication on de-
pression outcome (Proudfoot et al 2004):
Loss to follow up: T1: 27%; T2: 24%
Incomplete outcome data (attrition bias)
Sick Leave
Low risk Sick leave data were part of the cost data,
and a high percentage of the cost data were
complete at follow up. “A total of 274 pa-
tients were randomised into two groups
(BtB, n = 146; TAU, n = 128), with cost
data available for both baseline and follow-
up periods for 261 (95%) patients (138
BtB, 123 TAU).”
Selective reporting (reporting bias) Unclear risk No design paper or trial registration could
be identified to assess this risk
Other bias Unclear risk None identified
Miller 1998
Methods RCT. multicentre, 2 conditions. Recruitment: referrals from physicians or mental health
professionals, media advertising, and word of mouth. Follow up: 12 weeks. Lost to follow
up: 2%
Participants 635 were randomised: (T1: 426; T2: 209). Setting: 12 outpatient centres in USA
Inclusion: age 21 to 65 years; Diagnosis of chronic MDD with two or less cumulative
depression-free months and who had not met DSM-II-R criteria for dysthymia within 2
months of the onset of currentMDepisodeORof concurrentMDepisode superimposed
on antecedent DSM-III-R dysthymia; Premenopausal women: adequate contraception
Exclusion: organic mental syndrome, current or lifetime diagnosis of bipolar disorder
or cyclothymia, schizophrenia, other psychotic disorders, obsessive-compulsive disorder,
antisocial, schizotypical or severe borderline personality disorder; Principal DSM-III-
R diagnosis of panic disorder, generalized anxiety disorder or PTSD within the past 6
months; DSM-II-R defined anorexia or bulimia nervosa within the past year; Drug or
alcohol abuse or dependence within the past 6 months; Patients deemed at immediate
suicide risk/ medical contraindications to antidepressants; Significant general medical
disorder;Concomitant therapy with any psychotropic drug (except chloral hydrate or
temazepam); Failure of adequate trial of sertraline or imipramine; Treatment withMOA-
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inhibitors within 3 weeks; Any depot neuroleptic within 6 months’; Fluoxetine within
1 month; Regular daily neuroleptic, anxiolytic, or antidepressant medication within 2
weeks; ECT within 3 months




Interventions T1: sertraline (SSRI). Week 1-3: 50 mg/day, then weekly titration in 50 mg/day incre-
ments (max 200 mg/day). 12 weeks, visits every week for the first 6 weeks and every 2
weeks for last 6 weeks. Before this, 1 week placebo run-in
T2: Imipramine (TCA). Week 1: 50 mg/day, week 2: 100 mg/day, week 3: 150 mg/day.
Then weekly titration 50 mg/day increments with a max of 300 mg/day by week 6. 12
weeks, visits every week for the first 6 weeks and every 2 weeks for last 6 weeks. Before
this, 1 week placebo run-in
Outcomes Absenteeism:
1) hours worked per week (12 weeks)
Clinical:
1) full remission, both CGI-I (=sub scale CGI) score of 1 or2 AND total HAM-D score
of 7 (or less) at last visit
2) satisfactory therapeutic response, at last visit: both CGI-I (=sub scale CGI) score of
1 or 2 AND total HAM-D score of 15 or less AND HAM-D-score reduction of at least





1) employed (yes or no)
Work functioning:
1) SAS work composite
2) LIFE work functioning
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not reported
Allocation concealment (selection bias) Unclear risk Not reported
Blinding of participants and personnel
(performance bias)
Sick Leave
Low risk “A novel statistical method was employed
for unblinding patients who experienced
recurrence or clinically significant worsen-
ing of symptoms.” “In consultation with
FDA personnel, the sponsor’s statistician
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monitored the ability of each investigator
to guess the treatment assignment of their
patients still in the study. When breaking
the blind for any patient, the statistician
(R.J.M.) examined the effect of unblind-
ing on our ability to guess the treatment as-
signment for the remaining patients at that
site. If any of these probabilities exceeded
75%, the site agreed to refer all subsequent
relapsers to a third party for treatment.”
Blinding of outcome assessment (detection
bias)
Sick Leave
Unclear risk Sick leave was assessed by the LIFE inter-
view. Interviewers were blind to treatment
condition. “Finally, it should be noted that
while blind to treatment condition, pa-
tients and interviewers were not blind to
the fact that patients were receiving active
medication nor were they blind to the time
of assessment (baseline, week 4, endpoint)
.”
Blinding of outcome assessment (detection
bias)
Depressive symptoms
Unclear risk Depressive symptoms were measured with
the 24 HAM-D (clinician-rated). Inter-
viewers were blind to treatment condition.
“Finally, it should be noted that while blind
to treatment condition, patients and inter-
viewers were not blind to the fact that pa-
tients were receiving active medication nor
were they blind to the time of assessment
(baseline, week 4, endpoint).”
Incomplete outcome data (attrition bias)
Depressive symptoms
Low risk For depressive symptoms, ITT rates of re-
mission could be calculated for 623 (of the
635) patients, which is 98%. “See Figure 1,
Keller et al, 1998.”
Incomplete outcome data (attrition bias)
Sick Leave
Unclear risk Completeness of sick leave data not re-
ported. “Sample sizes [on psychosocial vari-
ables] vary due to sporadic missing data.”
Selective reporting (reporting bias) Unclear risk No indication for selective reporting could
be identified. The design was published in
a paper by Rush et al, albeit concurrently
with the publications on the outcome
Other bias Unclear risk None identified
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Methods Two-armed cluster randomised trial. Recruitment: Recruitment of workers started in
November 2006 and ended in December 2007. Workers eligible according to the OP
were invited to participate. Follow up: 12 months. Lost to follow up main outcome: 10.
6% for all participants and 11% for depressed subgroup
Participants 160 were randomised (T1: 75; T2: 85). Subgroup of depressed workers: 37 (T1: 18; T2:
19). Setting: Occupational healthcare. This study was conducted in the Netherlands,
where most of the workers on sick leave due to CMD visit an OP. The OP offers RTW
interventions to these workers according to the evidence-based (Dutch) guidelines
Inclusion: workers who were on sick leave due to CMD between 2 and 8 weeks. CMD
were defined as stress-related, adjustment, anxiety or depressive disorders. Stress-related
disorders were classified according to the Dutch guidelines for OP (19). Anxiety, depres-
sive, and adjustment disorders were classified by the Diagnostic and Statistical Manual
of Mental Disorders (DSM-IV)
Exclusion: workers with a primary somatic disorder according to the OP and those who
were not able to speak Dutch
Mean age: T1: 44.9 (SD 9.8); T2: 45.9 (SD 9.8)
Female: T1: 75.7%; T2: 66.7%
Educational level:
Low: T1: 8.7%; T2: 17.9%
Middle: T1: 24.6%; T2: 23.1%
High: 66.7%; T2: 59.0%
Interventions T1: Exposure based return to work intervention (RTW-E): In the RTW-E program,
workers received CAU and were gradually exposed in vivo to more demanding work
situations structured by a hierarchy of tasks evoking increasing levels of anxiety, stress,
or anger. The RTW-E program provided workers with several homework assignments
aimed at preparing, executing, and evaluating an exposure-based RTW plan
T2: Care as usual (CAU): aims to help workers regain control and rebuild social and
occupational contacts and activities, according to the OP practice guidelines for CMD.
The OP can support this process by using recommended methods such as stress inoc-
ulation training, cognitive restructuring, graded activity, and time contingency during
the RTW
Outcomes Absenteeism:
1) the time-to-full RTW, calculated as the number of calendar days from the first day
of sick leave to the first day of full RTW. Full RTW was defined as the total number of
contracted working hours per week lasting ≥28 calendar days without a recurrence of
sick leave
Clinical:




Bias Authors’ judgement Support for judgement
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Random sequence generation (selection
bias)
Low risk ”We performed a restricted randomization
with blocks of four OPs.“ After randomiza-
tion researcher KN informed EN about the
allocation of every OP and saved the ran-
domization file.” Personal communication:
“The randomization followed a schedule
generation by randomization software.”
Allocation concealment (selection bias) High risk “The validity of the results of this studymay
have been limited due to a selection bias be-
cause of the absence of allocation for each
OP. As a result, the potential for the selec-
tive inclusion of workers was rather high.”
“However, we could not prevent some OP
from including zero workers, which could
have introduced selection bias.”
Blinding of participants and personnel
(performance bias)
Sick Leave
High risk Blinding of participants and researchers,
but not of personnel was ensured: “The
workers were blind to the differences in
RTW-E and CAU.” “The researchers were
blind to the allocation and outcome mea-
surement.”
Blinding of outcome assessment (detection
bias)
Sick Leave
Low risk Sick leave was assessed by workers’ diaries.
As workers are blinded to allocation status,
risk of detection bias for sick leave is con-
sidered to be low
Blinding of outcome assessment (detection
bias)
Depressive symptoms
High risk Depression is assessed by the 4DSQ, a self-
report questionnaire. As the participants
were blinded to allocation status, risk of
detection bias for depressive symptoms is
considered to be low
Incomplete outcome data (attrition bias)
Depressive symptoms
High risk Loss to follow-up for depression for the
subgroup of depressed workers: 52%
Incomplete outcome data (attrition bias)
Sick Leave
High risk Loss to follow up of sick leave data for the
subgroup of depressed workers was: 11%.
No appropriate method was used to take
selective attrition into account
Selective reporting (reporting bias) High risk Not all (secondary) outcomes measures an-
nounced in the design paper were reported
in the effect study, of which the data on the
HADS-depression subscale
Other bias Unclear risk None identified
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Methods RCT. multicenter, 2 conditions. Recruitment: from general practitioners’ practices. Fol-
low up: 24 weeks. Lost to follow up: T1: 6%; T2: 14%
Participants 177 were randomised: (T1:93; T2:84). Setting: primary care, outpatients in Scotland,
UK. Inclusion: > 18 years old; Depressive episode according to DSM-IV checklist; 17-
HAM-D score > 18
Exclusion: schizophrenia, Bipolar, suicidal, illicit drug abuse or alcohol dependence;
Treatment with any other psychotropic drug within 1 week before entry, or mirtazap-
ine or paroxetine during the present episode, or treatment within 5 weeks before entry
with fluoxetine, or any other antidepressant within 2 weeks before entry; renal, hepatic,
respiratory, cardiovascular, or cerebrovascular disease; pregnancy or lactating, or no con-
traception
Age: T1: 40 (SD 14.3); T2: 40 (SD 11.7)
Female: T1: 75%; T2: 71%
Fulltime or part-time employed: T1: 48%; T2: 58%
Interventions T1: Mirtazapine (TCA): 30 tto 45 mg/day oral
Week 1 - 4 30 mg/day
Week 5 - 24: optional increase to 45 mg/day (discretion of the investigator)
T2: Paroxetine (SSRI): 20-30 mg/day oral
Week 1 - 4: 20 mg/day
Week 5 - 26 optional increase to 30 mg/day (discretion of the investigator)
Outcomes Absenteeism:
1) total mean days lost due to illness in 24 weeks
Clinical:
1) primary: change from baseline on 17-HAM-D; Secondary: 17-HAM-D responder
rates (= at least 50% change from baseline to endpoint); 17 HAM-D remitter rates (=
% with score of 8 or less on two assessments after the first score of 8 or less)
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk A randomisation list was used that was pre-
pared in advance
“Randomization was performed according
to centrally prepared randomization lists.”
Allocation concealment (selection bias) Low risk “Randomization was performed according
to centrally prepared randomization lists.”
Personal communication: “The person as-
sessing eligibility for inclusion was blind to
allocation concealment.”
Blinding of participants and personnel
(performance bias)
Low risk Double-blind study design. Personal com-
munication: “Medication was dispensed by
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Sick Leave the GP who was blinded to treatment allo-
cation.”
Blinding of outcome assessment (detection
bias)
Sick Leave
Low risk Double-blind study design. Sick leave was
assessed by questionnaires filled out by pa-
tients, who were blinded to treatment allo-
cation
Blinding of outcome assessment (detection
bias)
Depressive symptoms
Low risk Double-blind study design. Personal com-
munication: “Outcomes were assessed by
trained research nurses who were blind to
treatment allocation.”
Incomplete outcome data (attrition bias)
Depressive symptoms
High risk Lost to follow-up: T1: 6%; T2: 14% and
no appropriate imputation methods have
been used
“Six excluded mirtazapine patients, four
were lost to follow-up, one dropped out
early, and one refused participation in the
study. Of the 14 excluded paroxetine pa-
tients, five were lost to follow-up, four were
early drop outs, two did not participate any
further, one discontinued due to the lack
of efficacy, one was hospitalized as a results
of a concomitant disease and one did not
fulfil the selection criteria.” “The high at-
trition rate observed in our study should
be taken in to account when interpreting
efficacy results due to possible influence on
overall efficacy results.”
Incomplete outcome data (attrition bias)
Sick Leave
High risk Lost to follow-up: T1: 6%; T2: 14% and
no appropriate imputation methods have
been used
“Six excluded mirtazapine patients, four
were lost to follow-up, one dropped out
early, and one refused participation in the
study. Of the 14 excluded paroxetine pa-
tients, five were lost to follow-up, four were
early drop outs, two did not participate any
further, one discontinued due to the lack
of efficacy, one was hospitalized as a results
of a concomitant disease and one did not
fulfil the selection criteria.” “The high at-
trition rate observed in our study should
be taken in to account when interpreting
efficacy results due to possible influence on
overall efficacy results.”
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Selective reporting (reporting bias) Unclear risk No design paper or trial registration could
be identified to assess this risk
Other bias Unclear risk None identified
Rost 2004
Methods RCT, randomisation on the level of practice, 12 practices were randomised. Recruit-
ment: Trained administrative staff recruited patients who made routine-length visits to
physicians. They asked eligible (see inclusion) patients to participate in 2 min first stage
depression screener. Patients who screened positive and did not meet exclusion criteria
were immediately invited to complete 5 min second stage screener. If they screened pos-
itive, they were asked to participate in study. Follow up: 24 months. Lost to follow up:
27%
Participants 326 employed persons were randomised: (T1: 158; T2: 168). Setting: Community
primary care practices across the US.
Inclusion: Age > 18, sufficient literacy in English and cognitive function to complete
surveys requiring 6-months recall, acces to telephone; Positive first screen: 2 weeks or
more depressed or loss of interest in past year AND1 week or more of this in last month;
Second screen: 5 or more of 9 criteria for major depression in past 2 weeks on Inventory
to diagnose depression.
Exclusion: pregnant, breastfeeding or <3 months postpartum; Acute life-threatening
physical conditions; Pos screeners who reported that symptoms started after loss of a
loved one; pos screeners who did not intend to receive ongoing care in the clinic in the
next year; Second stage screener: self-report lifetime mania, use of lithium or current
alcohol dependence
Age: T1: 37.9 (SD 10.9); T2: 40.2 (SD 10.3)
Female: T1: 84.2%; T2: 85.7%
Married: T1: 45%; T2: 51%
Employed: 100%
Interventions T1: Enhanced care. Primary care team was trained to provide high quality depression
treatment. After enrolment, patients were evaluated for depression by physician and
asked to return within one week to nurse care manager. Subsequent visit: education
about treatment, addressing treatment barriers, checklist for physician’s review, schedul-
ing of next appointment in one week. This continued for 5-7 weeks. Then patients
were monitored (symptoms and treatment adherence) for one year. Physicians reviewed
patients monthly based on report of nurses to see whether guideline recommendations
were followed. Medication algorithm of guideline: initially SSRI or secondary amine
tricyclic. Switch drug classes when response failure
T2: Usual Care. Regular Primary physicians care
Outcomes Absenteeism:
1) total number of work hours lost due to illness or doctor visits over past 4 weeks
Clinical:
1) depression severity: CES-D (adapted)
Productivity:
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1) subjective rating on 0 to 10 scale of productivity at work
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “The practices were stratified and matched
into six pairs.” “Within each pair, one prac-
tice was randomized to the ’enhanced’ care
condition and the other practice delivered
usual care to study participants.”
Allocation concealment (selection bias) High risk Personal communication: “The allocation
of the practice was known to the adminis-
trative staff who screened patients.”
Blinding of participants and personnel
(performance bias)
Sick Leave
Unclear risk Personal communication: “The allocation
of the practice was known to patients eligi-
ble to participate. However, these patients
did not know that there was another arm of
the study that other practices participated
in.”
Blinding of outcome assessment (detection
bias)
Sick Leave
High risk Sick leave was measured by self-report and
patients were not blinded to treatment al-
location
“We measured absenteeism at baseline, 6,
12, 18, and 24 months by calculating lost
work hours from employee reports of how
many full workdays and part workdays they
missed due to illness or doctor visits, re-
flecting that employee reports demonstrate
high agreement with employer records of
absenteeism.”
Blinding of outcome assessment (detection
bias)
Depressive symptoms
High risk Depression was measured by self-report
(CESD-D) and patients were not blinded
to treatment allocation
Incomplete outcome data (attrition bias)
Depressive symptoms
High risk Loss to follow up at endpoint is consid-
ered to be high (27%). Risk of attrition
bias was therefore deemed high although
analyses accounted sufficiently for missing
data according to authors: “Because anal-
ysis of missing data patterns produced no
evidence of non ignorable missingness, we
present unweighted models, noting that
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weightedmodels produce closely compara-
ble results.”
Incomplete outcome data (attrition bias)
Sick Leave
High risk Loss to follow up at endpoint is considered
to be high (27%). Risk of attrition bias was
therefore deemed high although although
analyses accounted sufficiently for missing
data according to authors: “Because anal-
ysis of missing data patterns produced no
evidence of non ignorable missingness, we
present unweighted models, noting that
weightedmodels produce closely compara-
ble results.”
Selective reporting (reporting bias) Unclear risk No design paper or trial registration could
be identified to assess this risk
Other bias Unclear risk None identified
Schene 2006
Methods RCT, two conditions; Regular referrals (including from occupational physicians), 48
weeks treatment. Follow up: 42 months. Lost to follow up at 12 months: T1: 13%; T2:
3%; at 42 months: T1: 25%; T2: 20%
Participants 62 were randomised (T1:32; T2:30). Setting: outpatient unit of Psychiatric department
of Academic hospital. The Netherlands
Inclusion:18 years;MDD(single episode or recurrent); BDI score >15;Work absenteeism
due to depression of at least 50% of regular hours worked per week with a duration
between 10 weeks and 2 years;Clinically estimated contribution of work to the onset
and/or continuation of depression of > 50% of supposed causal factors
Exclusion: MDD with psychotic features;history of psychosis, manic, hypomanic, or
cyclothymic features; history of active drug or alcohol abuse or dependence; personality
disorder according to DSM-IV
Age: T1: 45.2 (SD 7.5); T2: 46.6 (SD 7.4)
Female: T1: 53%; T2: 50%
Married: T1: 63%; T2: 53%
Mean hours employment: T1: 36.5 (SD 10.4); T2: 36.4 (SD 7.8)
Interventions T1: Treatment as usual (TAU) following evidence-based guidelines (APA Guideline)
;This consisted of clinical management according to APAGuideline and antidepressants,
if indicated and accepted by patients, according to our standardized stepwise drug treat-
ment regimen or algorithm. Visits consisted of symptom assessment, psycho-education,
general support and cognitive behavioral techniques, and if indicated medication pre-
scription, dose titration and review of adverse effects. In case of any clinical significant
deterioration in condition patients could be referred for partial or full-time hospitali-
sation within the Program. Patients were treated by three supervised senior psychiatric
residents. Visits regularly took 30 minutes every 2 to 4 weeks
T2: Treatment as usual + occupational therapy (TAU + OT) TAU plus occupational
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therapy (OT): same outpatient treatment; OT: diagnostic phase (4 weeks): occupational
history, video observation in a role-played work situation, contact with occupational
physician of patient’s employer and written conclusions including a plan for work rein-
tegration
therapeutic phase (24 weeks): this phase had three sub-phases: preparation of work
reintegration, contacting the working place and if possible starting to work. In the
individual sessions these three phases were followed: further analyses of the relationship
betweenwork and depression, exploration of work problems, and support and evaluation
of work resume. Specific individual issues from the group sessions were elaborated. The
first half of these two-hour group sessions were spend on discussing and exchanging
individual progress. In the second half seven themes were successively discussed: being
passive, stress on the work place, personal bounds and limits, powerful and powerless,
perfectionism, conflicts and prevention. Patients were treated by three supervised senior
psychiatric residents. + two occupational therapists
diagnostic phase (4 weeks): 5 visits
therapeutic phase (24 weeks): 24 weekly group sessions (8-10 patients) and 12 individual
sessions (45 minutes)
follow-up phase (20 weeks): 3 individual visits
Outcomes Absenteeism:
1) total number of hours worked during 6-month periods up to 42nd month (primary
outcome)
2) proportion of patients working at least 1 hour per week
3) proportion of patients working at least 16 hours per week
4) time from T1 to partial or full return to work
Clinical:
1) % meeting DSM IV criteria at 6/42 months
2) change in BDI at 6/42 months
1) depression according to DSM-IV at 12 months
2) change in BDI-score (baseline-12 months)
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “Patients who met the inclusion criteria
were randomly assigned to TAU or TAU
+OT in blocks of 20 by use of computer-
generated cards stored as concealed assign-
ment codes in consecutively number sealed
envelopes under the responsibility of an in-
dependent research associate.”
Allocation concealment (selection bias) Low risk “Patients who met the inclusion criteria
were them randomly assigned to TAU or
TAU +OT in blocks of 20 by use of com-
puter-generated cards stored as concealed
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assignment codes in consecutively number
sealed envelopes under the responsibility of
an independent research associate.”
Blinding of participants and personnel
(performance bias)
Sick Leave
High risk Risk of performance bias considered high as
the TAU cannot be considered equally de-
sirable as TAU +OT for patients. Personal
communication: “patients and clinical per-
sonnel were not blinded.”
Blinding of outcome assessment (detection
bias)
Sick Leave
High risk Sick leave was measured by self-report and
patients were not blinded to treatment al-
location
“Work resumption data were assessed by a
study-specific questionnaire at T2, T3, T4
and T5.”
Blinding of outcome assessment (detection
bias)
Depressive symptoms
High risk “Depression was assessed by the BDI, a
self-report measure of severity of depressive
symptoms.” Patients were not blinded to
treatment allocation
Incomplete outcome data (attrition bias)
Depressive symptoms
High risk Loss to follow up was high: T1: 25%; T2:
20%. Risk of attrition bias was therefore
deemed high even though appropriate im-
putation methods have been used: “Com-
plete T4 data were obtained on 28 (88%)
of TAU patients and on 29 (97%) of TAU
+OT patients. For T5 these figures were 24
(75%) for TAU and 24 (80%) for TAU +
OT.” “Both GEE and Proc Mixed give un-
biased effect estimates taking into account
missing data.”
Incomplete outcome data (attrition bias)
Sick Leave
High risk Loss to follow up was high: T1:25%; T2:
20%. Risk of attrition bias was therefore
deemed high even though appropriate im-
putation methods have been used: “Com-
plete T4 data were obtained on 28 (88%)
of TAU patients and on 29 (97%) of TAU
+OT patients. For T5 these figures were
24 (75%) for TAU and 24 (80%) for TAU
+OT.” “BothGEE andProcMixed give un-
biased effect estimates taking into account
missing data.”
Selective reporting (reporting bias) Unclear risk No design paper or trial registration could
be identified to assess this risk
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Other bias Unclear risk None identified
Schoenbaum 2001
Methods RCT with randomisation on the level of clinic. Clinic clusters were matched based
on patient demographics, clinician specialty, and distance to mental health providers.
Recruitment: study staff screened consecutive patient visitors. Follow up: 24 months.
Lost to follow-up: T1: 15%; T2: 13%
Participants 1356 were randomised (T1:913; T2: 443). Setting: 46 Primary care clinics in 6 com-
munity-based managed care organisations in the US
Inclusion: depressed, intend to use clinic for next 12 months; Probable depressive disor-
der:at least 2-weeks depressed mood or loss of interest in last year or persistent over year
+ at least 1 week depression in last 30 days
Exclusion: < 18 years, acute medical emergency, did not speak English or Spanish,
no insurance or public pay arrangement that covered care delivered by mental health
specialists
Age: T1: 44.5 (SD15.5); T2: 42.2 (SD 13.9)
Female: T1: 74%; T2: 69%
Married: T1: 54%; T2: 55%
Interventions T1: Quality improvement program (QI meds or QI therapy). Treatment type or content
Quality improvement (QI) program: practices were provided with training and resources
to initiate and monitor QI programs according to local practice goals and resources.
For both interventions (QI-meds and QI therapy): local practice teams were trained
in a 2-day workshop to provide clinician education and to supervise intervention staff.
Practice nurses were trained as depression specialists, following a written protocol, to
assist in initial patient assessment, education and motivation for treatment. Practice
teams were given patient education pamphlets and videotapes, patient tracking forms,
and clinician manuals and pocket reminder cards and were encouraged to distribute
them. The materials described guideline-concordant care and described antidepressant
medication and psychotherapy as equally effective. In both conditions resources were
made available to obtain specific form of therapy (medication or psychotherapy)
For QI-meds: nurse specialists were trained to support medication adherence through
monthly telephone contacts or visits for 6 or 12 months, randomised at patient level
In QI-therapy: practice therapists were trained to provide individual and group CBT,
following a protocol
T2: Usual care: mailing of practice guidelines to primary care professionals
Outcomes Absenteeism:
1) days worked during 24 months follow-up for whole sample
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Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk ”Within blocks, we used a random number
table to assign clusters to usual care or QI
interventions.“
Allocation concealment (selection bias) High risk Randomisation was on the level of prac-
tice and primary care clinicians were not
blinded for allocation during enrolment of
patients
Blinding of participants and personnel
(performance bias)
Sick Leave
High risk Patients and personnel were not blinded:
”We asked all primary care clinicians to
enrolls prior to their knowledge of inter-
vention status.“ ”Patients learned of their
intervention status after enrolment.“ Per-
sonal communication: ”Subjects in the in-
terviews were not blinded, but may or may
not have known their intervention status
given the nature of interventions.“ Inter-
ventions were not equally desirable for pa-
tients, so risk of performance bias high
Blinding of outcome assessment (detection
bias)
Sick Leave
High risk Sick leave was measured by self-report and
patients were not blinded to treatment al-
location
”We also examined days missed from work
due to illness, which patients reported for
the 4weeks preceding each follow-up study.
“
Blinding of outcome assessment (detection
bias)
Depressive symptoms
High risk Depression was measured by self-report
and patients were not blinded to treatment
allocation
’We assessed depressive symptoms at base-
line and follow-up using a 23-item ver-
sion of the Center of Epidemiologic Stud-
ies Depression (CES-D) Scale, developed
by Daniel Ford. This version drops 6 items
and adds others to approximate DSM-IV
criteria. Items responses were summed.”
Incomplete outcome data (attrition bias)
Depressive symptoms
Low risk Lost to follow up for the depressive symp-
toms is 15% but appropriate imputation
methods have been used. “The data are
weighted for the probability of study enrol-
ment and follow-up response to the char-
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acteristics of the eligible sample. We used
multiple imputations for missing items at
each wave.”
Incomplete outcome data (attrition bias)
Sick Leave
Low risk Lost to follow for the economic survey is
15% but appropriate imputation methods
have been used. “The data are weighted for
the probability of study enrolment and fol-
low-up response to the characteristics of the
eligible sample. We used multiple imputa-
tions for missing items at each wave.”
Selective reporting (reporting bias) Unclear risk No design paper or trial registration could
be identified to assess this risk
Other bias Unclear risk None identified
Simon 1998
Methods RCT (consisting of 2 substudies) with two conditions. Recruitment: participating pri-
mary care physicians were asked to refer any adult outpatient initiating care for depres-
sion and willing to consider treatment with antidepressant medication. The research
assistant screened for eligibility
Follow up: 7 months. Lost to follow up: substudy 1: 15%; substudy 2: 23%
Participants 156 patients with MDD were randomised (T1: 80; T2: 76). Setting: Large primary care
clinic in managed care setting in US
Inclusion: diagnosis definite or probable major depression by primary care physician;
Agreed to antidepressant medication; SCL-score of at least 0.75; Age 18 to 80 yrs
Exclusion: current alcohol abuse (score at least 2CAGEquestionnaire); current psychotic
symptoms or serious suicidal ideation or plan; dementia; pregnancy; terminal illness;
limited; command of English; plan to disenrol from insurance plan within 12 months
Age: substudy1: T1: 43.2 (SD 15.4); T2: 42.3 (SD 12.7); substudy2: T1: 43.1 (SD 9.
3); T2: 44.8 (SD 15.9)
Female: substudy1: T1: 78%; T2: 88%; substudy: 77%; T2: 74%
Married or cohabiting: substudy1: T1: 47%; T2: 55%; substudy2: T1: 48%; T2: 32%
Employed: substudy 1: T1: 71%; T2: 63% substudy 2: T1: 87%; T2: 74%
Interventions T1: Multifaceted intervention. Goal: increase likelihood that treatment would be con-
form primary care depression guidelines
Components:
(1) written and videotaped patient education material (2) increased frequency of follow-
up visits during first 8 weeks (3) advice to physicians regarding changes in pharma-
cotherapy (4) monitoring of medication side-effects, medication adherence, treatment
response and follow-up visits frequency by study staff to treating physician
substudy1, psychiatrist-liaison collaborative intervention:
(a) co-management by consulting psychiatrist and physicians during first 6 weeks of
treatment, (b) 1 week after start treatment all patients attended an extended structured
visit with physician to review symptoms, barriers to adherence, side-effects, and goals for
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behavioural activation. (c) after 2 weeks: consultation with study psychiatrist discussing
treatment response andmedication (adjustment if needed), (d) week 3 physician visit, (e)
week 4 psychiatrist visit (f ) monthly case conferences between psychiatrist and physician
substudy 2, psychologist-liaison collaborative intervention:
Standardised brief psychotherapy program. Face-to-face psychiatric consultation on as-
needed basis. Components psychotherapy: (a) education, skills training, and written
homework (b) interventions to enhance medication adherence (c) behavioural activation
and (d) brief cognitive interventions. Weekly meetings between therapists and study
psychiatrists. Study clinicians communicated with physicians throughout study about
progress and changes in medication
psychotherapy: 4-6 visits over 6 weeks (total time 2,5 to 3,5 hour) Telephone contacts
at 2, 4, 12 and 24 weeks after last face-to-face session
T2: Usual primary care. Could include any service normally available including phar-
macotherapy, referral to mental health service or self-referral to non-GHC services
Outcomes Absenteeism:
1) % unable to work due to illness
2) n of days of missed work or school out of last 90 for employed subsample
Clinical:
1) proportion of patients with MDD who experienced at least 50% reduction in depres-
sive symptoms on IDS
2) SCL for employed subsample
3) IDS for employed subsample
Notes Data are provided for subgroup of MDD only, both substudies combined
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “Patients were randomly assigned using
computer generated random numbers.”
Allocation concealment (selection bias) Low risk Personal communication: “The primary
care physicians or the research assistant did
not know anything about the randomiza-
tion status of the next patient. Randomiza-
tion was performed 1-7 days after the base-
line assessment by the study manager.”
Blinding of participants and personnel
(performance bias)
Sick Leave
High risk Personal communication: “Patient partic-
ipants and their treating clinicians were
not blinded - and it would not have been
possible to do so.” Interventions were not
equally desirable for patients, so risk of per-
formance bias high
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Blinding of outcome assessment (detection
bias)
Sick Leave
High risk Sick leave was measured by self-report and
patients were not blinded to treatment al-
location
“One of the four assessments included
questions adapted from the National
Health Interview Survey regarding days of
missed work or school due to health.”
Blinding of outcome assessment (detection
bias)
Depressive symptoms
Low risk “Folllow-up telephone interviewers were
blinded to treatments assignment.” “Two
of the assessments included a 20-item de-
pression scale extracted from the Hopkins
Symptom Checklist or SCL and a version
of the clinician-rated Inventory of Depres-
sive Symptoms or IDS modified for tele-
phone administration.”
Incomplete outcome data (attrition bias)
Depressive symptoms
High risk Lost to follow-up is considered to be high:
T1: 17%; T2: 21%. Risk of attrition bias
was therefore deemed high although appro-
priate imputation methods have been used:
“Model were estimated using generalized
estimating equations (GEE) to account for
multiple assessments and to allow for miss-
ing data”
Incomplete outcome data (attrition bias)
Sick Leave
High risk Lost to follow-up is considered to be high:
T1: 17%; T2: 21%. Risk of attrition bias
was therefore deemed high although appro-
priate imputation methods have been used:
“Model were estimated using generalized
estimating equations (GEE) to account for
multiple assessments and to allow for miss-
ing data”
Selective reporting (reporting bias) Unclear risk No design paper or trial registration could
be identified to assess this risk
Other bias Unclear risk None identified
Vlasveld 2013
Methods RCT. Recruitment: 22 months. Follow up: 12 months. Lost to follow up: 41.3%
Participants 126 were randomised (T1:65; T2:61); Setting: the study was carried out within a large
occupational health service in the Netherlands
Inclusion: workers on sickness absence between 4 and 12 weeks, whose absence was
diagnosed by occupational physicians (OPs) as due to mental disorder, who screened
84Interventions to improve return to work in depressed people (Review)
Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Vlasveld 2013 (Continued)
positively for depressive disorder (i.e. score ≥ 10 on 9-item 0 to 27 depression subscale
of Patient Health Questionnaire), who have informed consent and who met the DSM-
IV criteria for MDD and gave written informed consent
Exclusion: workers who were suicidal, psychotic or had a primary diagnosis of substance
abuse or dependence, as assessed by the MINI
Age: T1: 43.4 (SD 11.4); T2: 41.9 (SD 11.4)
Male: T1: 45.9%; T2: 46.2%
Marital status: T1: 73.3% married or cohabiting; T2: 60.0% married or cohabiting
Educational level: T1: 35.0% high; T2: 36.1% high; T1 30.0% average; T2: 36.0%
average; T1: 35.0% low; T2: 27.9% low
Dutch nationality: T1: 91.8%; T2: 95.4%
Interventions T1: Collaborative care intervention. Provided by the Occupational Physician Care Man-
ager (OP-CM), contained the following elements: 6 to 12 sessions of Problem Solving
Therapy, manual-guided self-help, a workplace intervention and, depending on patient
preference, prescription of antidepressant medication according to a treatment algo-
rithm. In order to enhance the adherence to the treatment model, ongoing supervision
and psychiatric consultation was provided to the OP-CMs. Also, a web-based tracking
system was developed to support the OP-CM in monitoring treatment outcomes and
in adhering to the stepped care protocol. In case of questions regarding the treatment,
prescription of antidepressants, or (lack of ) progress of the worker, the OP-CM was
prompted by the web-based tracking system to consult the psychiatrist
T2: Usual care. Sick-listed workers start to visit the company’s OP before the 6th week
of sickness absence. The guidance of company’s OP is protocolised according to the OP
guidelines of the Dutch Board for Occupational Medicine. In practice, whether or not
sick-listed workers will receive treatment for MDD may vary considerable. The actual
care that was provided was assessed by questionnaires in both groups
Outcomes Absenteeism:
1) the duration until lasting, full RTW. The duration until lasting, full RTWwas defined
as the duration of sickness absence due to MDD in calendar days, from the day of
randomisation until full RTW for at least 4 weeks without partial or full recurrence
2) the total number of sickness absence days, calculated for the entire follow up
Clinical:
1) severity of depression, assessed by the PHQ-9
2) time to first response on depressive symptoms. Response is defined as a reduction in
depressive symptoms of at least 50%
3) time to first remission, defined as a score of less than 5 on the PHQ-9
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk ”The randomization scheme was prepared
by a computer, with blocks of four, by an
independent statistician.“
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Allocation concealment (selection bias) Low risk ”While assessing eligibility for the study,
both the research assistant and the partici-
pant were blinded for the allocation.“
Blinding of participants and personnel
(performance bias)
Sick Leave
High risk Participants were not blinded and both in-
terventions were not equally desirable for
them, so risk of performance bias was high.
”Then, the participant was informed about
the computer generated allocation status
by the research assistant. Next, the baseline
questionnaire was sent by mail.“
Blinding of outcome assessment (detection
bias)
Sick Leave
Low risk Low risk as sickness absence datawere based
on registration database. ”Sickness absence
data were derived from the register of the
occupational service 1 year after random-
ization.“
Blinding of outcome assessment (detection
bias)
Depressive symptoms
High risk Data about depressive symptoms were col-
lected by a self-report questionnaire andpa-
tients were not blinded to treatment allo-
cation
Incomplete outcome data (attrition bias)
Depressive symptoms
High risk Lost to follow up was high. ”Lost to follow-
up rates at 3,6, 9 and 12 months were re-
spectively 22.2%, 28.6%, 33.3% and 41.
3%.“ Risk of attrition bias was considered
high even though an appropriate method
has been described to account for this miss-
ing data: ’If there is missing data on costs
and/or effects, and the additional uncer-
tainty it introduces, multiple imputation
will be used.”
Incomplete outcome data (attrition bias)
Sick Leave
Low risk No missing sickness absence data
Selective reporting (reporting bias) Low risk The study protocol is available and all of
the study’s pre-specified (primary and sec-
ondary) outcomes that are of interest in the
review have been reported in the pre-spec-
ified way
Other bias Unclear risk None identified
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Methods A double-blind, multinational randomised study. Recruitment: outpatients with MDD
were recruited in psychiatric and general practice settings, from September 2005 to
September 2006. Follow up: 24 weeks. Lost to follow up: 23% (clinical outcome) and
24.4% (sick leave)
Participants 295 were randomised (T1: 144; T2: 151). Setting: outpatients of 35 centra of psychi-
atric and general practice settings. Inclusion: patients with MDD (current episode as-
sessed with the MINI), according to the DSM IV-TR criteria, outpatient of either sex,
aged 18-65 years, with a MADRS total score ≥ 26 and a CGI-S score ≥ 4 at baseline
visit. Patients with a secondary current comorbid anxiety disorder (DSM-IV TR criteria)
could be included in the study, expect for obsessive-compulsive disorder, post-traumatic
stress disorder, or panic disorder. Exclusion: if they met one or more of the DSM IV-
TR criteria for any of the following: bipolar disorder, psychotic disorder or features,
current eating disorders (anorexia nervosa, bulimia), mental retardation, any pervasive
developmental disorder or cognitive disorder, or alcohol or drug abuse-related disorders
within 12 months prior to baseline. In addition, patients at serious suicide risk, based
on the investigator’s clinical judgement, or who had a score of ≥ 5 on item 10 of the
MADRS scale, were also excluded, as were those receiving formal behavioural therapy, or
systematic psychotherapy, or were pregnant or breast feeding, or had a history of lactose
intolerance. Patients with a history of hypersensitivity or non-response to citalopram, or
escitalopram, or duloxetine, or with increased intra-ocular pressure, or at risk of acute
narrow-angle glaucoma, were also excluded. Patients were also excluded if they were
taking the following psychotropic drugs within 2 weeks prior to baseline or during the
study: MAOI or RIMA, SSRI (fluoxetine within 5 weeks), SNRIs, and tricyclic antide-
pressants, tryptophan, psychoactive herbal remedies, any drug used for augmentation
of antidepressant action or any other antidepressant drugs, oral antipsychotic and anti-
manic drugs (including lithium), or ECT (within 6 months), dopamine antagonists,
any anxiolytics (including benzodiazepines), any anticonvulsant drug, serotonergic ag-
onists, narcotic analgesics, cardiac glycosides, type 1c anti-arrhythmics, oral anticoagu-
lants, cimetidine, potent inhibitors of CYP2C19, CYP1A2, or medicinal products with
a narrow therapeutic index predominantly metabolised by CYP2D6
Female:
T1: 73.8%; T2: 71.2%
Age:
T1: 43.3 (SD 11.6); T2: 44.5 (SD 11.0)
Marital status:
T1: 27.0% single; T2: 20.5% single
T1: 50.4% married or living as a couple; T2: 50.7% married or living as a couple
T1: 17.7% divorced or separated; T2: 25.3% divorced or separated
T1: 5.0% widowed; T2: 3.4% widowed
Level of education:
T1: 5.0% no degree or diploma; T2: 4.1% no degree or diploma
T1: 29.1% elementary school; T2: 26.0% elementary school
T1: 43.3% high school; T2: 45.2% high school
T1: 11.3% non-university degree; T2: 15.1% non university degree
T1: 11.3% university; T2: 9.6% university
Employment status:
T1: 58.9% paid employment or self-employed; T2: 60.3% paid employment or self-
employed
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Wade 2008 (Continued)
T1: 15.6% unemployed; T2: 18.5% unemployed
T1: 5.0% student; T2: 4.8% student
T1: 6.4% non-working spouse; T2: 3.4% non-working spouse
T1: 7.8% retired; T2: 10.3% retired
T1: 6.4% other; T2: 2.7% other
Occupational status:
T1: 34.8% no data available; T2: 36.3% no data available
T1: 6.5% manager or administrator; T2: 12.9% manager or administrator
T1: 16.3% professional; T2: 15.1% professional
T1: 10.9% associate professional; T2: 10.8% associate professional
T1: 8.7% clerical worker/secretary; T2: 10.8% clerical worker/secretary
T1: 26.1% skilled labourer or factory worker; T2: 17.2% skilled labourer or factory
worker
T1: 27.2% services/sales (retail); T2: 24.7% services/sales
T1: 4.3% other; T2: 8.6% other
Interventions T1: escitalopram (SSRI), 10 mg/day for the first 2 weeks, and 20 mg/day for the rest of
the period
T2: duloxetine (SNRI), 60 mg/day for the 24 weeks, in accordance with the recommen-
dations in the package insert for duloxetine in the participating countries
Outcomes Absenteeism:
1) percentage of patients taking sick leave
2) mean per patient sick leave duration in days
Clinical:
1) adjusted mean change in the MADRS total score
2) MADRS total score
3) HAMD-17
4) remission, defined as MADRS ≤ 12 or post hoc as HAMD-17 ≤ 7)
5) response, defined as ≥50% decrease from baseline in MADRS or (post hoc) HAMD
total score
Work functioning:
1) impairment, assessed by the Sheehan Disability Scale
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “Patients who met the selection criteria at
the baseline visit were assigned to 24 weeks
of double-blind treatment in a 1:1 ratio
of escitalopram or duloxetine treatment ac-
cording to a computer-generation random-
ization list.” “At each study centre, sequen-
tially enrolled patients were assigned to the
lowest randomization number available in
blocks of 4.”
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Wade 2008 (Continued)
Allocation concealment (selection bias) Low risk “The details of the randomization series
were unknown to any of the investigators
andwere contained in a set of sealed opaque
envelopes.”
Blinding of participants and personnel
(performance bias)
Sick Leave
Low risk “All study personnel and participants were
blinded to treatment assignment for the du-
ration of the entire study.”
Blinding of outcome assessment (detection
bias)
Sick Leave
Low risk Sick leave was assessed by physicians, who
are blinded for allocation status
Blinding of outcome assessment (detection
bias)
Depressive symptoms
Low risk The MADRS and HAMD-17 are assessed
by a doctor, whowere blinded for allocation
status
Incomplete outcome data (attrition bias)
Depressive symptoms
High risk Lost to follow up is considered to be high
(23%). Risk of attrition bias was therefore
deemed high and no appropriate method
has been used to account for this miss-
ing data: “The primary endpoint was the
adjusted mean change in MADRS total
score from baseline to week 24, based
on the intention-to-treat set (ITT), com-
prising all patients who took at least one
valid post-baseline MADRS assessment,
and using last-observation-carried-forward
(LOCF) analysis.”
Incomplete outcome data (attrition bias)
Sick Leave
High risk Lost to follow up is considered to be high
(24.4%) Risk of attrition bias was therefore
deemed high and no appropriate method
has been used to account for this missing
data: “In cases of premature study with-
drawal, patients were assigned zero sick
leave for missing assessments.”
Selective reporting (reporting bias) Unclear risk No design paper or trial registration could
be identified to assess this risk
Other bias Unclear risk None identified
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Wang 2007
Methods RCT. Recruitment: occurred between January 2004 and February 2005 using a 2-phase
procedure. Follow up: 12 months. Lost to follow up: 12.3%
Participants 604 were randomised (T1:304; T2:300); Setting: Participants included 604 depressed
workers 18 years and older and enrolled in United Behavioural Health (UBH), a large
managed behavioral health care company; Inclusion: Respondents with at least moderate
depression (phase 1:K-6≥ 9; Phase 2:QIDS-SR≥ 8); Exclusion: employeeswith lifetime
bipolar disorder, substance disorder, recent mental health specialty care or suicidally
Age: T1: 40.7 (SD 10.5); T2: 42.4 (SD 10.8)
Female: T1: 70.7 %; T2: 77.0%%
College graduates: T1: 38.0%; T2: 43.8% (24.6%)
Interventions T1: The structured telephone intervention: telephone outreach and care management
program. Systematically assessed needs for treatment, facilitated entry into in-person
treatment (both psychotherapy and antidepressant medication), monitored and sup-
ported treatment adherence, and (for those declining in-person treatment) provided a
structured psychotherapy intervention by telephone. Intervention participants declining
in-person treatment and experiencing significant depressive symptoms after 2 months
were offered a structured 8-session cognitive behavioural psychotherapy program
T2: Usual care. Patients were advised to consult a clinician and could receive any nor-
mally available insurance benefit or service (eg, psychotherapy or pharmacotherapy), just
not the additional telephone care management components provided to those in the
intervention group
Outcomes Absenteeism:
1) actual weekly hours worked among the employed, assessed byHealth and Productivity
Questionnaire (HPQ), a validated self-report instrument
Clinical:
1) depression severity, assessed by QIDS-SR
Functioning:
1) on-the-job performance, assessed by HPQ
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk ”Randomization was carried out by the
survey research firm conducting eligibil-
ity assessments with a computerized proce-
dure that classified respondents for eligibil-
ity and used a random number generator to
assign participants to intervention or usual
care.“
Allocation concealment (selection bias) Low risk ”Patient treatment allocation was con-
cealed.“
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Wang 2007 (Continued)
Blinding of participants and personnel
(performance bias)
Sick Leave
High risk Participants were not blinded. ”Partici-
pants were advised not to offer information
information to their interviewers regard-
ing their intervention status.“ Interven-
tions not equally desirable for both groups
which entails a high risk of bias. ”Respon-
dents were told they might be invited to
participate in an innovative treatment pro-
gram.“
Blinding of outcome assessment (detection
bias)
Sick Leave
High risk HPQ is a self-report instrument. As pa-
tients were aware of their allocation status,
risk of bias high
Blinding of outcome assessment (detection
bias)
Depressive symptoms
High risk QID-SR is a self-report instrument. As pa-
tients were aware of their allocation status,
risk of bias high
Incomplete outcome data (attrition bias)
Depressive symptoms
Low risk Lost to follow up: T1: 14.5%; T2: 10%
but appropriate method has been used to
account for missing data: ”Multiple impu-
tation was used to adjust for some par-
ticipants not completing either 6-months
(35 intervention and 22 usual care) or 12
month (44 intervention and 30 usual care)
interviews.“ ”Intervention effects on de-
pression severity were estimated using mul-
tiple imputation linear regression with sim-
ulated standard errors.“
Incomplete outcome data (attrition bias)
Sick Leave
Low risk Lost to follow up: T1: 14.5%; T2: 10%
but appropriate method has been used to
account for missing data: ”Multiple impu-
tation was used to adjust for some par-
ticipants not completing either 6-months
(35 intervention and 22 usual care) or 12
month (44 intervention and 30 usual care)
interviews.“ ”Comparable multiple impu-
tation regression analyses were used to es-
timate intervention effects on work out-
comes.”
Selective reporting (reporting bias) Unclear risk No design paper or trial registration could
be identified to assess this risk
Other bias Unclear risk None identified
BDI = Back Depression Inventory
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CAGE = The name of which is an acronym of its four questions, is a widely used method of screening for alcoholism
CAU = Care as usual
CES-D = Center for Epidemiologic Studies Depression scale
CMD = Common mental disorders
CMHN = Community Mental Health Nursing
CIS-R = Clinical Interview Schedule-Revised
CTU = Copenhagen Trial Unit
DSM-IV = Diagnostic and Statistical Manual of Mental Disorders
4DSQ = Four-Dimensional Symptom Questionnaire
EAP = Employee Assistance Programme
ECT = Electroconvulsive therapy
FDA = Food and Drug Administration
GAS = Global Assessment Scale
GCI = Clinical Global Impression Scale
GEE = Generalized Estimating Equation
GP = General practitioner
GHQ-12 = General Health Questionnaire
HADS(-D)= Hospital Anxiety en Depression Scale
HAMD-D(17) = Hamilton Rating Scale for Depression
HDRS = Hamilton Rating Scale for Depression
HPQ = Health and Work Performance Questionnaire
HRSD = Hamilton Rating Scale for Depression
ICD-10 = International Statistical Classification of Diseases and Related Health Problems
IDS = Inventory of Depressive Symptomatology
LOCF = Last Observation Carrierd Forward
MADRS = Montgomery-Asberg Depression Scale
MAO = Monoamine oxidase
MAOI = Monoamine oxidase inhibitor
MINI = Mini International Neuropsychiatric Interview
MOS-SF 36 = Medical Outcomes Study 36-Item Short Form Health Survey
MDD = Major depressive disorder
OP = Occupational Physician
OT = Occupational therapy
PHQ = Patient Health Questionnaire
PST = Problem Solving Therapy
QI = Quality improvement
QIDS-SR = Quick Inventory of Depressive Symptomatology-Self Report
RCT = Randomized controlled trial
RIMA = Reversible inhibitors of monoamine oxidase A
RTW = Return to work
RTW-E = Exposure based return to work program
SAS = Social Adjustment Scale
SCL = Symptom Checklist Score
SNRI = Selective Serotonin and Noradrenalin Reuptake Inhibitor
SSRI = Delective serotonin reuptake inhibitor
TAU = Treatment as usual
TCA = Tricyclic antidepressant
WLQ = Work Limitations Questionnaire
WHI = Work and Health Initiative
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Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Aelfers 2013 Participants are people with a mild to moderate depression
Ahola 2012 Sickness absence was not measured as outcome measure
Alexopoulos No worker population and sickness absence not measured as outcome measure
Amore 2001 Sickness absence was not measured as outcome measure
Bakker 2007 Patients suffered from mental health problems, less than 50% of these are patients with a depressive disorder
Barbui 2009 Sickness absence was not measured as outcome measure
Bech 2000 It is a meta-analysis instead of a RCT
Becker 1998 Participants were people with severe mental ilness such as schizophrenia
Blonk 2007 Patients suffered from psychological complaints, including adjustment disorders. Patients with a major depres-
sion were excluded from the study
Boyer 1998 Sickness absence was not measured as outcome measure
Brandes 2011 Sickness absence was not measured as outcome measure
Brouwers 2007 It is meta-analysis instead of a RCT
Carlin 2010 Sickness absence was not measured as outcome measure
Castillo-Pérez 2010 Sickness absence was not measured as outcome measure
Dick 1985 This study took place in an inpatient care setting
Dunlop 2011 Sickness absence was not measured as outcome measure
Eklund 2012 No RCT but a matched-control design was used
Erkkilä 2011 Sickness absence was not measured as outcome measure
Finley 2003 Sickness absence was not measured as outcome measure
Folke 2012 This study is done in a sample of unemployed individuals
Forman 2012 Participants were students
Furukawa 2012 Participants with mild depression were included in this study; people with a major depressive disorder were
excluded
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(Continued)
Gournay 1995 Participants suffered from a range of non-psychotic symptoms, data for the depressed subgroup only could not
be provided
Hackett 1987 Inclusion criterion in this study was ’clinical diagnosis of chronic muscle contraction headache’
Hirani 2010 Sickness absence was not measured as outcome measure
Hordern 1964 This study took place in a hospital setting
Knekt 2011 It is quasi-experimental study
Kojima 2010 Sickness absence was not measured as outcome measure
Kroenke 2001 Sickness absence was not measured as outcome measure
Kuhs 1996 Sickness absence was not measured as outcome measure
Lagerveld 2012 Major depressive disorder was excluded in this study
Lam 2012 Sickness absence was not measured as outcome measure
Lexis 2011 The focus in this study is on relatively mild complaints
Martinez 2011 Sickness absence was not measured as outcome measure
Meyer 2009 Sickness absence was not measured as outcome measure
Mino 2006 Prevention study; subjects were not depressed
Morgan 2011 Participants are people with sub-threshold depression
Mundt 2001 Sickness absence was not measured as outcome measure
Oakes 2012 Sickness absence was not measured as outcome measure
Salminen 2008 Sickness absence was not measured as outcome measure
Sandahl 2011 Sickness absence was not measured as outcome measure
Schmitt 2008 It is not a RCT but a review
Schoenbaum 2002 This study turned out to be a publication on the same study as Schoenbaum 2001 (which was also included)
Simon 2000 Sickness absence was not measured as outcome measure
Sir 2005 Sickness absence was not measured as outcome measure
Stant 2009 Sickness absence was not measured as outcome measure
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(Continued)
Wells 2000 This trial is the basis of the economic evaluation of Schoenbaum 2001
Zambori 2002 Design was CCT instead of RCT
Zeeuw 2010 This study focuses on employees with minimal symptoms of depression
Characteristics of ongoing studies [ordered by study ID]
Beurden 2013
Trial name or title Not yet assessed
Methods Cluster RCT
Participants common mental disorders
Interventions guideline-based care by occupational physicians
Outcomes Return-to-work
Starting date 2011
Contact information Department of Social and Behavioral Sciences, Tranzo Scientific Center for Care and Welfare, Tilburg Uni-
versity, PO Box 90153, Tilburg, 5000 LE, the Netherlands
Notes
Geraedts 2013
Trial name or title Happy@Work
Methods RCT
Participants Employees with depressive symptoms
Interventions Web-based guided self-help
Outcomes Health and Work Performance Questionnaire
Starting date Not yet assessed
Contact information a.s.geraedts@vu.nl
Notes
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Heer 2013
Trial name or title TCC: PAINDIP
Methods Randomised placebo-controlled multicentre trial
Participants Major depressive disorder (MDD) and (sub)chronic pain
Interventions Transmural collaborative care with consultation letter (TCCCL) and duloxetine in collaboration with primary
care
Outcomes Not yet assessed
Starting date Not yet assessed
Contact information Not yet assessed
Notes
Hellstrom 2013
Trial name or title The effect of IPS-modified, an early intervention for people with mood and anxiety disorders: study protocol
for a randomised clinical superiority trial. Trials 2013, 14:442. doi:10.1186/1745-6215-14-442
Methods Randomized clinical superiority trial
Participants Participants with mood and anxiety disorders recently employed or enrolled in education
Interventions IPS-modified; an individualised supported employment intervention, aiming at supporting people with re-
cently diagnosed anxiety or affective disorders to obtain and sustain competitive employment through mentor
support
Outcomes Competitive employment or education at 24 months




Trial name or title Not yet assessed
Methods RCT with three conditions: two treatment conditions and one waiting list control group
Participants Subjects with symptoms of depression (≥ 16 on the Center for Epidemiological Studies Depression scale)
from the general population
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Warmerdam 2007 (Continued)
Interventions Two Internet-based treatments for depression, namely cognitive behavioural therapy and problem-solving
therapy
Outcomes Absence at work
Starting date Not yet assessed
Contact information eh.warmerdam@psy.vu.nl
Notes Results at 12 weeks are published: https://ce1ul13jdba-qne8l9ebidp.sec.amc.nl/pmc/articles/PMC2629364/
This did not include the work outcome
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D A T A A N D A N A L Y S E S
Comparison 1. Work-directed plus clinical versus clinical alone (medium term)




participants Statistical method Effect size
1 Days of sickness absence 3 251 Std. Mean Difference (IV, Random, 95% CI) -0.40 [-0.66, -0.14]
1.1 Occupational therapy plus
CAU vs. CAU
2 179 Std. Mean Difference (IV, Random, 95% CI) -0.30 [-0.61, 0.01]
1.2 Multi-component work-
focused program vs. CAU
1 72 Std. Mean Difference (IV, Random, 95% CI) -0.66 [-1.15, -0.16]
2 Depressive symptoms 3 251 Std. Mean Difference (IV, Random, 95% CI) -0.32 [-0.88, 0.25]
2.1 Occupational therapy plus
CAU vs. CAU
2 179 Std. Mean Difference (IV, Random, 95% CI) -0.08 [-0.66, 0.50]
2.2 Multi-component work-
focused program vs. CAU
1 72 Std. Mean Difference (IV, Random, 95% CI) -0.84 [-1.34, -0.33]
3 Work functioning 2 189 Std. Mean Difference (IV, Random, 95% CI) -0.31 [-0.79, 0.16]
3.1 Occupational therapy plus
CAU vs. CAU
1 117 Std. Mean Difference (IV, Random, 95% CI) -0.09 [-0.48, 0.29]
3.2 Multi-component work-
focused program vs. CAU
1 72 Std. Mean Difference (IV, Random, 95% CI) -0.58 [-1.08, -0.09]
Comparison 2. Work-directed plus clinical versus clinical alone (long term)




participants Statistical method Effect size
1 Days of sickness absence 2 179 Std. Mean Difference (IV, Random, 95% CI) -0.19 [-0.49, 0.12]
1.1 Occupational therapy plus
CAU vs. CAU
2 179 Std. Mean Difference (IV, Random, 95% CI) -0.19 [-0.49, 0.12]
2 Depressive symptoms 1 117 Std. Mean Difference (IV, Random, 95% CI) -0.63 [-1.02, -0.24]
2.1 Occupational therapy plus
CAU vs. CAU
1 117 Std. Mean Difference (IV, Random, 95% CI) -0.63 [-1.02, -0.24]
3 Work functioning 1 117 Std. Mean Difference (IV, Random, 95% CI) -0.25 [-0.63, 0.14]
3.1 Occupational therapy plus
CAU vs. CAU
1 117 Std. Mean Difference (IV, Random, 95% CI) -0.25 [-0.63, 0.14]
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Comparison 3. Work-directed plus clinical versus work-directed (medium term)




participants Statistical method Effect size
1 Days of sickness absence 1 126 Std. Mean Difference (IV, Random, 95% CI) -0.14 [-0.49, 0.21]
1.1 Collaborative care vs.
CAU
1 126 Std. Mean Difference (IV, Random, 95% CI) -0.14 [-0.49, 0.21]
2 Depressive symptoms 1 74 Std. Mean Difference (IV, Random, 95% CI) 0.26 [-0.20, 0.72]
2.1 Collaborative care vs.
CAU
1 74 Std. Mean Difference (IV, Random, 95% CI) 0.26 [-0.20, 0.72]
Comparison 4. Any work-directed versus alternative work-directed




participants Statistical method Effect size
1 Days of sickness absence 1 75 Std. Mean Difference (IV, Random, 95% CI) 0.45 [-0.00, 0.91]
1.1 RTW-E vs. CAU 1 75 Std. Mean Difference (IV, Random, 95% CI) 0.45 [-0.00, 0.91]
2 Depressive symptoms 1 40 Std. Mean Difference (IV, Random, 95% CI) -0.18 [-0.84, 0.49]
2.1 RTW-E vs. CAU 1 40 Std. Mean Difference (IV, Random, 95% CI) -0.18 [-0.84, 0.49]
Comparison 5. Any antidepressant medication versus any other antidepressant medication




participants Statistical method Effect size
1 Days of sickness absence 5 Std. Mean Difference (IV, Fixed, 95% CI) Totals not selected
1.1 SSRI vs. SNRI 3 Std. Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
1.2 SSRI vs. TCA 1 Std. Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
1.3 SSRI vs. SSRI 1 Std. Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
2 Depressive symptoms 5 1514 Std. Mean Difference (IV, Random, 95% CI) 0.07 [-0.34, 0.48]
2.1 SSRI vs. SNRI 3 599 Std. Mean Difference (IV, Random, 95% CI) 0.18 [-0.37, 0.73]
2.2 SSRI vs. TCA 1 635 Std. Mean Difference (IV, Random, 95% CI) 0.0 [0.0, 0.0]
2.3 SSRI vs. SSRI 1 280 Std. Mean Difference (IV, Random, 95% CI) -0.23 [-0.47, 0.00]
3 Work functioning 1 635 Mean Difference (IV, Random, 95% CI) -0.05 [-0.16, 0.06]
3.1 SSRI vs. TCA 1 635 Mean Difference (IV, Random, 95% CI) -0.05 [-0.16, 0.06]
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Comparison 6. Any antidepressant medication versus placebo




participants Statistical method Effect size
1 Days of sickness absence 1 61 Std. Mean Difference (IV, Random, 95% CI) 0.48 [-0.05, 1.00]
1.1 TCA or MAO vs. placebo 1 61 Std. Mean Difference (IV, Random, 95% CI) 0.48 [-0.05, 1.00]
2 Work functioning 1 61 Std. Mean Difference (IV, Random, 95% CI) -0.58 [-1.11, -0.05]
2.1 TCA or MAO vs. placebo 1 61 Std. Mean Difference (IV, Random, 95% CI) -0.58 [-1.11, -0.05]
Comparison 7. Any psychological versus other psychological (medium term)




participants Statistical method Effect size








1 Std. Mean Difference (IV, Random, 95% CI) 0.0 [0.0, 0.0]








1 Std. Mean Difference (IV, Random, 95% CI) 0.0 [0.0, 0.0]








1 Std. Mean Difference (IV, Random, 95% CI) 0.0 [0.0, 0.0]
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Comparison 8. Any psychological versus other psychological (long term)




participants Statistical method Effect size








1 42 Std. Mean Difference (IV, Random, 95% CI) -4.61 [-5.84, -3.39]








1 145 Std. Mean Difference (IV, Random, 95% CI) -2.44 [-2.90, -1.97]








1 Std. Mean Difference (IV, Random, 95% CI) 0.0 [0.0, 0.0]
Comparison 9. Any psychological versus no intervention or care as usual




participants Statistical method Effect size
1 Days of sickness absence 4 Std. Mean Difference (IV, Random, 95% CI) Subtotals only
1.1 Online/telephone CBT
vs. CAU
3 326 Std. Mean Difference (IV, Random, 95% CI) -0.23 [-0.45, -0.01]
1.2 CMHN vs. usual GP care 1 59 Std. Mean Difference (IV, Random, 95% CI) 0.22 [-0.36, 0.79]
2 Depressive symptoms 4 Std. Mean Difference (IV, Random, 95% CI) Subtotals only
2.1 Online/telephone CBT
vs. CAU
3 408 Std. Mean Difference (IV, Random, 95% CI) -0.56 [-0.76, -0.36]
2.2 CMHN vs. usual GP care 1 78 Std. Mean Difference (IV, Random, 95% CI) 0.22 [-0.31, 0.75]
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Comparison 10. Psychological combined with antidepressant medication versus antidepressant medication alone




participants Statistical method Effect size
1 Days of sickness absence 1 57 Std. Mean Difference (IV, Random, 95% CI) -0.71 [-1.25, -0.17]
1.1 Psychodynamic therapy
plus TCA vs. TCA
1 57 Std. Mean Difference (IV, Random, 95% CI) -0.71 [-1.25, -0.17]
2 Work functioning or
productivity
1 57 Std. Mean Difference (IV, Random, 95% CI) -0.49 [-1.02, 0.04]
2.1 Psychodynamic therapy
plus TCA vs. TCA
1 57 Std. Mean Difference (IV, Random, 95% CI) -0.49 [-1.02, 0.04]
3 Depressive symptoms 1 74 Std. Mean Difference (IV, Random, 95% CI) -0.11 [-0.57, 0.35]
Comparison 11. Psychological combined with antidepressant medication versus no intervention or usual care
(medium term)




participants Statistical method Effect size
1 Days of sickness absence 3 Std. Mean Difference (IV, Random, 95% CI) Subtotals only
1.1 Enhanced primary care vs.
CAU
2 969 Std. Mean Difference (IV, Random, 95% CI) -0.02 [-0.15, 0.12]
1.2 Telephone outreach and
care management program vs.
CAU
1 604 Std. Mean Difference (IV, Random, 95% CI) -0.21 [-0.37, -0.05]
2 Employment status 1 1356 Risk Ratio (M-H, Random, 95% CI) 1.08 [0.99, 1.18]
2.1 Enhanced primary care vs.
CAU
1 1356 Risk Ratio (M-H, Random, 95% CI) 1.08 [0.99, 1.18]
3 Depressive symptoms 2 693 Std. Mean Difference (IV, Random, 95% CI) -0.22 [-0.37, -0.07]
3.1 Enhanced primary care vs.
CAU
1 89 Std. Mean Difference (IV, Random, 95% CI) -0.14 [-0.56, 0.28]
3.2 Telephone outreach and
care management program vs.
CAU
1 604 Std. Mean Difference (IV, Random, 95% CI) -0.23 [-0.39, -0.07]
4 Depressed yes/no 1 1356 Risk Ratio (M-H, Random, 95% CI) 0.89 [0.81, 0.98]
4.1 Enhanced primary care vs.
CAU
1 1356 Risk Ratio (M-H, Random, 95% CI) 0.89 [0.81, 0.98]
5 Work functioning 1 604 Std. Mean Difference (IV, Random, 95% CI) 0.50 [0.34, 0.66]
5.1 Telephone outreach and
care management program vs.
CAU
1 604 Std. Mean Difference (IV, Random, 95% CI) 0.50 [0.34, 0.66]
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Comparison 12. Exercise intervention versus no intervention or care as usual




participants Statistical method Effect size
1 Days of sickness absence 2 Std. Mean Difference (IV, Random, 95% CI) Subtotals only
1.1 Supervised strength
training vs. relaxation
1 65 Std. Mean Difference (IV, Random, 95% CI) -1.11 [-1.68, -0.54]
1.2 Aerobic exercise vs.
relaxation/stretching
2 180 Std. Mean Difference (IV, Random, 95% CI) -0.06 [-0.36, 0.24]
2 Depressive symptoms 2 Std. Mean Difference (IV, Random, 95% CI) Subtotals only
2.1 Supervised strength
training vs. relaxation
1 65 Std. Mean Difference (IV, Random, 95% CI) 0.15 [-0.39, 0.68]
2.2 Aerobic exercise vs.
relaxation/stretching
2 180 Std. Mean Difference (IV, Random, 95% CI) 0.18 [-0.12, 0.48]
Analysis 1.1. Comparison 1 Work-directed plus clinical versus clinical alone (medium term), Outcome 1
Days of sickness absence.
Review: Interventions to improve return to work in depressed people
Comparison: 1 Work-directed plus clinical versus clinical alone (medium term)
Outcome: 1 Days of sickness absence







N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Occupational therapy plus CAU vs. CAU
Hees 2013 78 1.7625 (1.4875) 39 2.13 (1.6) 45.7 % -0.24 [ -0.62, 0.15 ]
Schene 2006 30 66.19 (40.36) 32 83.28 (41.79) 26.8 % -0.41 [ -0.91, 0.09 ]
Subtotal (95% CI) 108 71 72.5 % -0.30 [ -0.61, 0.01 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.29, df = 1 (P = 0.59); I2 =0.0%
Test for overall effect: Z = 1.92 (P = 0.054)
2 Multi-component work-focused program vs. CAU
Lerner 2012 47 1 (1.2) 25 2.2 (2.6) 27.5 % -0.66 [ -1.15, -0.16 ]
Subtotal (95% CI) 47 25 27.5 % -0.66 [ -1.15, -0.16 ]
Heterogeneity: not applicable
Test for overall effect: Z = 2.59 (P = 0.0096)
Total (95% CI) 155 96 100.0 % -0.40 [ -0.66, -0.14 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 1.72, df = 2 (P = 0.42); I2 =0.0%
Test for overall effect: Z = 2.99 (P = 0.0027)
Test for subgroup differences: Chi2 = 1.43, df = 1 (P = 0.23), I2 =30%
-1 -0.5 0 0.5 1
Favours Work + Clinical Favours Clinical
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Analysis 1.2. Comparison 1 Work-directed plus clinical versus clinical alone (medium term), Outcome 2
Depressive symptoms.
Review: Interventions to improve return to work in depressed people
Comparison: 1 Work-directed plus clinical versus clinical alone (medium term)
Outcome: 2 Depressive symptoms







N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Occupational therapy plus CAU vs. CAU
Hees 2013 78 7.1 (6.7) 39 9.6 (7.8) 35.8 % -0.35 [ -0.74, 0.04 ]
Schene 2006 30 18.2 (11.9) 32 15.5 (10.1) 32.2 % 0.24 [ -0.26, 0.74 ]
Subtotal (95% CI) 108 71 68.0 % -0.08 [ -0.66, 0.50 ]
Heterogeneity: Tau2 = 0.12; Chi2 = 3.38, df = 1 (P = 0.07); I2 =70%
Test for overall effect: Z = 0.26 (P = 0.80)
2 Multi-component work-focused program vs. CAU
Lerner 2012 47 7.7 (5.8) 25 12.8 (6.4) 32.0 % -0.84 [ -1.34, -0.33 ]
Subtotal (95% CI) 47 25 32.0 % -0.84 [ -1.34, -0.33 ]
Heterogeneity: not applicable
Test for overall effect: Z = 3.26 (P = 0.0011)
Total (95% CI) 155 96 100.0 % -0.32 [ -0.88, 0.25 ]
Heterogeneity: Tau2 = 0.19; Chi2 = 8.94, df = 2 (P = 0.01); I2 =78%
Test for overall effect: Z = 1.10 (P = 0.27)
Test for subgroup differences: Chi2 = 3.78, df = 1 (P = 0.05), I2 =74%
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Analysis 1.3. Comparison 1 Work-directed plus clinical versus clinical alone (medium term), Outcome 3
Work functioning.
Review: Interventions to improve return to work in depressed people
Comparison: 1 Work-directed plus clinical versus clinical alone (medium term)
Outcome: 3 Work functioning







N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Occupational therapy plus CAU vs. CAU
Hees 2013 78 33.1 (15) 39 34.7 (19.8) 55.3 % -0.09 [ -0.48, 0.29 ]
Subtotal (95% CI) 78 39 55.3 % -0.09 [ -0.48, 0.29 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.48 (P = 0.63)
2 Multi-component work-focused program vs. CAU
Lerner 2012 47 26.5 (23.5) 25 40.1 (22.1) 44.7 % -0.58 [ -1.08, -0.09 ]
Subtotal (95% CI) 47 25 44.7 % -0.58 [ -1.08, -0.09 ]
Heterogeneity: not applicable
Test for overall effect: Z = 2.31 (P = 0.021)
Total (95% CI) 125 64 100.0 % -0.31 [ -0.79, 0.16 ]
Heterogeneity: Tau2 = 0.07; Chi2 = 2.34, df = 1 (P = 0.13); I2 =57%
Test for overall effect: Z = 1.29 (P = 0.20)
Test for subgroup differences: Chi2 = 2.34, df = 1 (P = 0.13), I2 =57%
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Analysis 2.1. Comparison 2 Work-directed plus clinical versus clinical alone (long term), Outcome 1 Days of
sickness absence.
Review: Interventions to improve return to work in depressed people
Comparison: 2 Work-directed plus clinical versus clinical alone (long term)
Outcome: 1 Days of sickness absence







N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Occupational therapy plus CAU vs. CAU
Hees 2013 78 1.3 (1.5625) 39 1.49 (1.5375) 62.9 % -0.12 [ -0.50, 0.26 ]
Schene 2006 30 49.81 (50.21) 32 65.5 (52.65) 37.1 % -0.30 [ -0.80, 0.20 ]
Total (95% CI) 108 71 100.0 % -0.19 [ -0.49, 0.12 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.32, df = 1 (P = 0.57); I2 =0.0%
Test for overall effect: Z = 1.20 (P = 0.23)
Test for subgroup differences: Not applicable
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Analysis 2.2. Comparison 2 Work-directed plus clinical versus clinical alone (long term), Outcome 2
Depressive symptoms.
Review: Interventions to improve return to work in depressed people
Comparison: 2 Work-directed plus clinical versus clinical alone (long term)
Outcome: 2 Depressive symptoms







N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Occupational therapy plus CAU vs. CAU
Hees 2013 78 4.7 (5.4) 39 8.8 (8.2) 100.0 % -0.63 [ -1.02, -0.24 ]
Total (95% CI) 78 39 100.0 % -0.63 [ -1.02, -0.24 ]
Heterogeneity: not applicable
Test for overall effect: Z = 3.14 (P = 0.0017)
Test for subgroup differences: Not applicable
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Analysis 2.3. Comparison 2 Work-directed plus clinical versus clinical alone (long term), Outcome 3 Work
functioning.
Review: Interventions to improve return to work in depressed people
Comparison: 2 Work-directed plus clinical versus clinical alone (long term)
Outcome: 3 Work functioning







N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Occupational therapy plus CAU vs. CAU
Hees 2013 78 31.2 (17.3) 39 35.7 (19.8) 100.0 % -0.25 [ -0.63, 0.14 ]
Total (95% CI) 78 39 100.0 % -0.25 [ -0.63, 0.14 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.25 (P = 0.21)
Test for subgroup differences: Not applicable
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Analysis 3.1. Comparison 3 Work-directed plus clinical versus work-directed (medium term), Outcome 1
Days of sickness absence.
Review: Interventions to improve return to work in depressed people
Comparison: 3 Work-directed plus clinical versus work-directed (medium term)
Outcome: 1 Days of sickness absence







N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Collaborative care vs. CAU
Vlasveld 2013 65 198 (120) 61 215 (118) 100.0 % -0.14 [ -0.49, 0.21 ]
Total (95% CI) 65 61 100.0 % -0.14 [ -0.49, 0.21 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.80 (P = 0.43)
Test for subgroup differences: Not applicable
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Analysis 3.2. Comparison 3 Work-directed plus clinical versus work-directed (medium term), Outcome 2
Depressive symptoms.
Review: Interventions to improve return to work in depressed people
Comparison: 3 Work-directed plus clinical versus work-directed (medium term)
Outcome: 2 Depressive symptoms







N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Collaborative care vs. CAU
Vlasveld 2013 34 7.7 (5.8) 40 5.9 (7.7) 100.0 % 0.26 [ -0.20, 0.72 ]
Total (95% CI) 34 40 100.0 % 0.26 [ -0.20, 0.72 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.10 (P = 0.27)
Test for subgroup differences: Not applicable
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Analysis 4.1. Comparison 4 Any work-directed versus alternative work-directed, Outcome 1 Days of
sickness absence.
Review: Interventions to improve return to work in depressed people
Comparison: 4 Any work-directed versus alternative work-directed
Outcome: 1 Days of sickness absence










N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 RTW-E vs. CAU
Noordik 2013 39 234.54 (140.38) 36 173.44 (124.66) 100.0 % 0.45 [ 0.00, 0.91 ]
Total (95% CI) 39 36 100.0 % 0.45 [ 0.00, 0.91 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.94 (P = 0.052)
Test for subgroup differences: Not applicable
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Analysis 4.2. Comparison 4 Any work-directed versus alternative work-directed, Outcome 2 Depressive
symptoms.
Review: Interventions to improve return to work in depressed people
Comparison: 4 Any work-directed versus alternative work-directed
Outcome: 2 Depressive symptoms










N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 RTW-E vs. CAU
Noordik 2013 13 0.46 (0.97) 27 0.85 (2.54) 100.0 % -0.18 [ -0.84, 0.49 ]
Total (95% CI) 13 27 100.0 % -0.18 [ -0.84, 0.49 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.52 (P = 0.60)
Test for subgroup differences: Not applicable
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Analysis 5.1. Comparison 5 Any antidepressant medication versus any other antidepressant medication,
Outcome 1 Days of sickness absence.
Review: Interventions to improve return to work in depressed people
Comparison: 5 Any antidepressant medication versus any other antidepressant medication
Outcome: 1 Days of sickness absence










N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 SSRI vs. SNRI
Fernandez 2005 62 12.37 (21.51) 73 12.97 (22.52) -0.03 [ -0.37, 0.31 ]
Romeo 2004 49 28 (32) 45 19 (32) 0.28 [ -0.13, 0.69 ]
Wade 2008 83 23.4 (27.87) 88 41.7 (35.41) -0.57 [ -0.88, -0.26 ]
2 SSRI vs. TCA
Miller 1998 426 0.4 (1.98) 209 0.23 (2.26) 0.08 [ -0.08, 0.25 ]
3 SSRI vs. SSRI
Fantino 2007 138 11.56 (2) 142 12.18 (2) -0.31 [ -0.54, -0.07 ]
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Analysis 5.2. Comparison 5 Any antidepressant medication versus any other antidepressant medication,
Outcome 2 Depressive symptoms.
Review: Interventions to improve return to work in depressed people
Comparison: 5 Any antidepressant medication versus any other antidepressant medication
Outcome: 2 Depressive symptoms










N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 SSRI vs. SNRI
Fernandez 2005 62 5.95 (4.78) 73 5.79 (6.13) 23.7 % 0.03 [ -0.31, 0.37 ]
Romeo 2004 84 16.42 (7.63) 93 10.99 (7.58) 24.5 % 0.71 [ 0.41, 1.02 ]
Wade 2008 141 8.89 (8.9) 146 10.58 (8.9) 25.9 % -0.19 [ -0.42, 0.04 ]
Subtotal (95% CI) 287 312 74.1 % 0.18 [ -0.37, 0.73 ]
Heterogeneity: Tau2 = 0.21; Chi2 = 21.60, df = 2 (P = 0.00002); I2 =91%
Test for overall effect: Z = 0.64 (P = 0.52)
2 SSRI vs. TCA
Miller 1998 426 12.6 (0) 209 12.9 (0) Not estimable
Subtotal (95% CI) 426 209 Not estimable
Heterogeneity: not applicable
Test for overall effect: not applicable
3 SSRI vs. SSRI
Fantino 2007 138 13.9 (6.37) 142 15.4 (6.37) 25.9 % -0.23 [ -0.47, 0.00 ]
Subtotal (95% CI) 138 142 25.9 % -0.23 [ -0.47, 0.00 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.96 (P = 0.050)
Total (95% CI) 851 663 100.0 % 0.07 [ -0.34, 0.48 ]
Heterogeneity: Tau2 = 0.16; Chi2 = 27.38, df = 3 (P<0.00001); I2 =89%
Test for overall effect: Z = 0.34 (P = 0.74)
Test for subgroup differences: Chi2 = 1.85, df = 1 (P = 0.17), I2 =46%
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Analysis 5.3. Comparison 5 Any antidepressant medication versus any other antidepressant medication,
Outcome 3 Work functioning.
Review: Interventions to improve return to work in depressed people
Comparison: 5 Any antidepressant medication versus any other antidepressant medication
Outcome: 3 Work functioning








N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 SSRI vs. TCA
Miller 1998 426 1.84 (0.65) 209 1.89 (0.68) 100.0 % -0.05 [ -0.16, 0.06 ]
Total (95% CI) 426 209 100.0 % -0.05 [ -0.16, 0.06 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.88 (P = 0.38)
Test for subgroup differences: Not applicable
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Analysis 6.1. Comparison 6 Any antidepressant medication versus placebo, Outcome 1 Days of sickness
absence.
Review: Interventions to improve return to work in depressed people
Comparison: 6 Any antidepressant medication versus placebo
Outcome: 1 Days of sickness absence







N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 TCA or MAO vs. placebo
Agosti 1991 38 1.48 (2.49) 23 0.29 (2.44) 100.0 % 0.48 [ -0.05, 1.00 ]
Total (95% CI) 38 23 100.0 % 0.48 [ -0.05, 1.00 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.77 (P = 0.076)
Test for subgroup differences: Not applicable
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Analysis 6.2. Comparison 6 Any antidepressant medication versus placebo, Outcome 2 Work functioning.
Review: Interventions to improve return to work in depressed people
Comparison: 6 Any antidepressant medication versus placebo
Outcome: 2 Work functioning







N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 TCA or MAO vs. placebo
Agosti 1991 38 1.8 (1.4) 23 2.6 (1.3) 100.0 % -0.58 [ -1.11, -0.05 ]
Total (95% CI) 38 23 100.0 % -0.58 [ -1.11, -0.05 ]
Heterogeneity: not applicable
Test for overall effect: Z = 2.15 (P = 0.032)
Test for subgroup differences: Not applicable
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Analysis 7.1. Comparison 7 Any psychological versus other psychological (medium term), Outcome 1 Days
of sickness absence.
Review: Interventions to improve return to work in depressed people
Comparison: 7 Any psychological versus other psychological (medium term)
Outcome: 1 Days of sickness absence







N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Short-term psychodynamic therapy vs. solution-focused therapy
Knekt 2013 34 2.79 (0.85) 13 2.58 (0.77) 0.25 [ -0.39, 0.89 ]
2 Long-term psychodynamic therapy vs. solution-focused therapy
Knekt 2013 38 4.18 (1.5) 13 2.58 (0.77) 1.16 [ 0.49, 1.83 ]
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Analysis 7.2. Comparison 7 Any psychological versus other psychological (medium term), Outcome 2
Depressive symptoms.
Review: Interventions to improve return to work in depressed people
Comparison: 7 Any psychological versus other psychological (medium term)
Outcome: 2 Depressive symptoms







N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Short-term psychodynamic therapy vs. solution-focused therapy
Knekt 2013 91 9.5 (1) 45 10.7 (1) -1.19 [ -1.58, -0.81 ]
2 Long-term psychodynamic therapy vs. solution-focused therapy
Knekt 2013 115 12.6 (0.9) 45 10.7 (1) 2.04 [ 1.62, 2.45 ]
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Analysis 7.3. Comparison 7 Any psychological versus other psychological (medium term), Outcome 3Work
functioning.
Review: Interventions to improve return to work in depressed people
Comparison: 7 Any psychological versus other psychological (medium term)
Outcome: 3 Work functioning







N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Short-term psychodynamic therapy vs solution-focused therapy
Knekt 2013 91 1.91 (0.06) 45 1.95 (0.06) -0.66 [ -1.03, -0.30 ]
2 Long-term psychodynamic therapy vs solution-focused therapy
Knekt 2013 115 2.01 (0.06) 45 1.95 (0.06) 1.00 [ 0.63, 1.36 ]
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Analysis 8.1. Comparison 8 Any psychological versus other psychological (long term), Outcome 1 Days of
sickness absence.
Review: Interventions to improve return to work in depressed people
Comparison: 8 Any psychological versus other psychological (long term)
Outcome: 1 Days of sickness absence







N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Short-term psychodynamic therapy vs. solution-focused therapy
Knekt 2013 23 4.13 (1.55) 13 5.5 (1.33) 100.0 % -0.91 [ -1.62, -0.19 ]
Subtotal (95% CI) 23 13 100.0 % -0.91 [ -1.62, -0.19 ]
Heterogeneity: not applicable
Test for overall effect: Z = 2.49 (P = 0.013)
2 Long-term psychodynamic therapy vs. solution-focused therapy
Knekt 2013 29 1.55 (0.5) 13 5.5 (1.33) 100.0 % -4.61 [ -5.84, -3.39 ]
Subtotal (95% CI) 29 13 100.0 % -4.61 [ -5.84, -3.39 ]
Heterogeneity: not applicable
Test for overall effect: Z = 7.38 (P < 0.00001)
Test for subgroup differences: Chi2 = 26.20, df = 1 (P = 0.00), I2 =96%
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Analysis 8.2. Comparison 8 Any psychological versus other psychological (long term), Outcome 2
Depressive symptoms.
Review: Interventions to improve return to work in depressed people
Comparison: 8 Any psychological versus other psychological (long term)
Outcome: 2 Depressive symptoms







N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Short-term psychodynamic therapy vs. solution-focused therapy
Knekt 2013 79 8.5 (0.9) 39 9.7 (1) 50.4 % -1.28 [ -1.69, -0.86 ]
Subtotal (95% CI) 79 39 50.4 % -1.28 [ -1.69, -0.86 ]
Heterogeneity: not applicable
Test for overall effect: Z = 5.99 (P < 0.00001)
2 Long-term psychodynamic therapy vs. solution-focused therapy
Knekt 2013 106 7.6 (0.8) 39 9.7 (1) 49.6 % -2.44 [ -2.90, -1.97 ]
Subtotal (95% CI) 106 39 49.6 % -2.44 [ -2.90, -1.97 ]
Heterogeneity: not applicable
Test for overall effect: Z = 10.28 (P < 0.00001)
Total (95% CI) 185 78 100.0 % -1.85 [ -2.99, -0.72 ]
Heterogeneity: Tau2 = 0.62; Chi2 = 13.23, df = 1 (P = 0.00028); I2 =92%
Test for overall effect: Z = 3.20 (P = 0.0014)
Test for subgroup differences: Chi2 = 13.23, df = 1 (P = 0.00), I2 =92%
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Analysis 8.3. Comparison 8 Any psychological versus other psychological (long term), Outcome 3 Work
functioning.
Review: Interventions to improve return to work in depressed people
Comparison: 8 Any psychological versus other psychological (long term)
Outcome: 3 Work functioning







N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Short-term psychodynamic therapy vs. solution-focused therapy
Knekt 2013 79 1.8 (0.06) 39 1.82 (0.06) -0.33 [ -0.72, 0.05 ]
2 Long-term psychodynamic therapy vs. solution-focused therapy
Knekt 2013 106 1.81 (0.05) 39 1.82 (0.06) -0.19 [ -0.56, 0.18 ]
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Analysis 9.1. Comparison 9 Any psychological versus no intervention or care as usual, Outcome 1 Days of
sickness absence.
Review: Interventions to improve return to work in depressed people
Comparison: 9 Any psychological versus no intervention or care as usual
Outcome: 1 Days of sickness absence







N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Online/telephone CBT vs. CAU
Bee 2010 5 3.85 (1.76) 7 4.29 (0.56) 3.5 % -0.34 [ -1.50, 0.82 ]
McCrone 2004 88 3.84 (19.01) 86 11.22 (40.45) 53.5 % -0.23 [ -0.53, 0.06 ]
Hollinghurst 2010 74 7.6 (17.9) 66 12.7 (27.2) 42.9 % -0.22 [ -0.56, 0.11 ]
Subtotal (95% CI) 167 159 100.0 % -0.23 [ -0.45, -0.01 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.04, df = 2 (P = 0.98); I2 =0.0%
Test for overall effect: Z = 2.09 (P = 0.037)
2 CMHN vs. usual GP care
Kendrick 2005 20 17.6 (35.07) 8 10.93 (13.35) 49.1 % 0.21 [ -0.61, 1.03 ]
Kendrick 2005 23 17.7 (33.1) 8 10.93 (13.35) 50.9 % 0.22 [ -0.58, 1.03 ]
Subtotal (95% CI) 43 16 100.0 % 0.22 [ -0.36, 0.79 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.00, df = 1 (P = 0.98); I2 =0.0%
Test for overall effect: Z = 0.74 (P = 0.46)
Test for subgroup differences: Chi2 = 2.05, df = 1 (P = 0.15), I2 =51%
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Analysis 9.2. Comparison 9 Any psychological versus no intervention or care as usual, Outcome 2
Depressive symptoms.
Review: Interventions to improve return to work in depressed people
Comparison: 9 Any psychological versus no intervention or care as usual
Outcome: 2 Depressive symptoms







N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Online/telephone CBT vs. CAU
Bee 2010 5 7.5 (4.43) 7 10.8 (3.7) 2.7 % -0.76 [ -1.97, 0.45 ]
Hollinghurst 2010 109 14.7 (11.6) 101 22.2 (15.2) 51.6 % -0.56 [ -0.83, -0.28 ]
McCrone 2004 94 9.3 (8.5) 92 14.9 (11.3) 45.7 % -0.56 [ -0.85, -0.27 ]
Subtotal (95% CI) 208 200 100.0 % -0.56 [ -0.76, -0.36 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.11, df = 2 (P = 0.95); I2 =0.0%
Test for overall effect: Z = 5.56 (P < 0.00001)
2 CMHN vs. usual GP care
Kendrick 2005 23 21.9 (15.7) 12 14.2 (13) 47.4 % 0.51 [ -0.20, 1.22 ]
Kendrick 2005 31 13.8 (11.3) 12 14.2 (13) 52.6 % -0.03 [ -0.70, 0.63 ]
Subtotal (95% CI) 54 24 100.0 % 0.22 [ -0.31, 0.75 ]
Heterogeneity: Tau2 = 0.02; Chi2 = 1.18, df = 1 (P = 0.28); I2 =15%
Test for overall effect: Z = 0.83 (P = 0.41)
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Analysis 10.1. Comparison 10 Psychological combined with antidepressant medication versus
antidepressant medication alone, Outcome 1 Days of sickness absence.
Review: Interventions to improve return to work in depressed people
Comparison: 10 Psychological combined with antidepressant medication versus antidepressant medication alone
Outcome: 1 Days of sickness absence







N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Psychodynamic therapy plus TCA vs. TCA
Burnand 2002 25 34.5 (23) 32 56.2 (34.6) 100.0 % -0.71 [ -1.25, -0.17 ]
Total (95% CI) 25 32 100.0 % -0.71 [ -1.25, -0.17 ]
Heterogeneity: not applicable
Test for overall effect: Z = 2.58 (P = 0.0099)
Test for subgroup differences: Not applicable
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Analysis 10.2. Comparison 10 Psychological combined with antidepressant medication versus
antidepressant medication alone, Outcome 2 Work functioning or productivity.
Review: Interventions to improve return to work in depressed people
Comparison: 10 Psychological combined with antidepressant medication versus antidepressant medication alone
Outcome: 2 Work functioning or productivity







N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Psychodynamic therapy plus TCA vs. TCA
Burnand 2002 25 1.7 (0.8) 32 2.1 (0.8) 100.0 % -0.49 [ -1.02, 0.04 ]
Total (95% CI) 25 32 100.0 % -0.49 [ -1.02, 0.04 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.82 (P = 0.069)
Test for subgroup differences: Not applicable
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Analysis 10.3. Comparison 10 Psychological combined with antidepressant medication versus
antidepressant medication alone, Outcome 3 Depressive symptoms.
Review: Interventions to improve return to work in depressed people
Comparison: 10 Psychological combined with antidepressant medication versus antidepressant medication alone
Outcome: 3 Depressive symptoms







N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Burnand 2002 35 8.9 (7) 39 9.7 (7.3) 100.0 % -0.11 [ -0.57, 0.35 ]
Total (95% CI) 35 39 100.0 % -0.11 [ -0.57, 0.35 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.47 (P = 0.64)
Test for subgroup differences: Not applicable
-1 -0.5 0 0.5 1
Favours Psychodynamic + TCA Favours TCA alone
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Analysis 11.1. Comparison 11 Psychological combined with antidepressant medication versus no
intervention or usual care (medium term), Outcome 1 Days of sickness absence.
Review: Interventions to improve return to work in depressed people
Comparison: 11 Psychological combined with antidepressant medication versus no intervention or usual care (medium term)











N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Enhanced primary care vs. CAU
Schoenbaum 2001 593 1.2 (3.94) 288 1.2 (3.94) 89.9 % 0.0 [ -0.14, 0.14 ]
Simon 1998 48 2.02 (7.82) 40 4.02 (14.46) 10.1 % -0.18 [ -0.60, 0.25 ]
Subtotal (95% CI) 641 328 100.0 % -0.02 [ -0.15, 0.12 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.60, df = 1 (P = 0.44); I2 =0.0%
Test for overall effect: Z = 0.26 (P = 0.80)
2 Telephone outreach and care management program vs. CAU
Wang 2007 304 -0.5375 (1.675) 300 -0.19 (1.7125) 100.0 % -0.21 [ -0.37, -0.05 ]
Subtotal (95% CI) 304 300 100.0 % -0.21 [ -0.37, -0.05 ]
Heterogeneity: not applicable
Test for overall effect: Z = 2.53 (P = 0.011)
Test for subgroup differences: Chi2 = 3.15, df = 1 (P = 0.08), I2 =68%
-0.5 -0.25 0 0.25 0.5
Favours Psych + Antidepressant Favours CAU
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Analysis 11.2. Comparison 11 Psychological combined with antidepressant medication versus no
intervention or usual care (medium term), Outcome 2 Employment status.
Review: Interventions to improve return to work in depressed people
Comparison: 11 Psychological combined with antidepressant medication versus no intervention or usual care (medium term)












1 Enhanced primary care vs. CAU
Schoenbaum 2001 600/913 269/443 100.0 % 1.08 [ 0.99, 1.18 ]
Total (95% CI) 913 443 100.0 % 1.08 [ 0.99, 1.18 ]
Total events: 600 (Psych.+ antidepressant), 269 (CAU)
Heterogeneity: not applicable
Test for overall effect: Z = 1.75 (P = 0.079)
Test for subgroup differences: Not applicable
0.5 0.7 1 1.5 2
Favours Psych + Antidepressant Favours CAU
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Analysis 11.3. Comparison 11 Psychological combined with antidepressant medication versus no
intervention or usual care (medium term), Outcome 3 Depressive symptoms.
Review: Interventions to improve return to work in depressed people
Comparison: 11 Psychological combined with antidepressant medication versus no intervention or usual care (medium term)











N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Enhanced primary care vs. CAU
Simon 1998 49 16.98 (12.8) 40 18.79 (13.2) 12.8 % -0.14 [ -0.56, 0.28 ]
Subtotal (95% CI) 49 40 12.8 % -0.14 [ -0.56, 0.28 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.65 (P = 0.52)
2 Telephone outreach and care management program vs. CAU
Wang 2007 304 8.9 (4.8) 300 10 (4.7) 87.2 % -0.23 [ -0.39, -0.07 ]
Subtotal (95% CI) 304 300 87.2 % -0.23 [ -0.39, -0.07 ]
Heterogeneity: not applicable
Test for overall effect: Z = 2.83 (P = 0.0046)
Total (95% CI) 353 340 100.0 % -0.22 [ -0.37, -0.07 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.17, df = 1 (P = 0.68); I2 =0.0%
Test for overall effect: Z = 2.88 (P = 0.0040)
Test for subgroup differences: Chi2 = 0.17, df = 1 (P = 0.68), I2 =0.0%
-1 -0.5 0 0.5 1
Favours Psych + Antidepressant Favours CAU
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Analysis 11.4. Comparison 11 Psychological combined with antidepressant medication versus no
intervention or usual care (medium term), Outcome 4 Depressed yes/no.
Review: Interventions to improve return to work in depressed people
Comparison: 11 Psychological combined with antidepressant medication versus no intervention or usual care (medium term)












1 Enhanced primary care vs. CAU
Schoenbaum 2001 498/913 272/443 100.0 % 0.89 [ 0.81, 0.98 ]
Total (95% CI) 913 443 100.0 % 0.89 [ 0.81, 0.98 ]
Total events: 498 (Psych.+ antidepressant), 272 (CAU)
Heterogeneity: not applicable
Test for overall effect: Z = 2.45 (P = 0.014)
Test for subgroup differences: Not applicable
0.5 0.7 1 1.5 2
Favours Psych + Antidepressant Favours CAU
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Analysis 11.5. Comparison 11 Psychological combined with antidepressant medication versus no
intervention or usual care (medium term), Outcome 5 Work functioning.
Review: Interventions to improve return to work in depressed people
Comparison: 11 Psychological combined with antidepressant medication versus no intervention or usual care (medium term)











N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Telephone outreach and care management program vs. CAU
Wang 2007 304 0.8 (0.2) 300 0.7 (0.2) 100.0 % 0.50 [ 0.34, 0.66 ]
Total (95% CI) 304 300 100.0 % 0.50 [ 0.34, 0.66 ]
Heterogeneity: not applicable
Test for overall effect: Z = 6.04 (P < 0.00001)
Test for subgroup differences: Not applicable
-1 -0.5 0 0.5 1
Favours Psych + Antidepressant Favours CAU
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Analysis 12.1. Comparison 12 Exercise intervention versus no intervention or care as usual, Outcome 1
Days of sickness absence.
Review: Interventions to improve return to work in depressed people
Comparison: 12 Exercise intervention versus no intervention or care as usual
Outcome: 1 Days of sickness absence







N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Supervised strength training vs. relaxation
Krogh 2009 46 1.4 (4.4) 19 14.5 (20.7) 100.0 % -1.11 [ -1.68, -0.54 ]
Subtotal (95% CI) 46 19 100.0 % -1.11 [ -1.68, -0.54 ]
Heterogeneity: not applicable
Test for overall effect: Z = 3.82 (P = 0.00014)
2 Aerobic exercise vs. relaxation/stretching
Krogh 2009 46 11.2 (19.2) 19 14.5 (20.7) 31.8 % -0.17 [ -0.70, 0.37 ]
Krogh 2012 56 25.22 (2.85) 59 25.24 (2.6) 68.2 % -0.01 [ -0.37, 0.36 ]
Subtotal (95% CI) 102 78 100.0 % -0.06 [ -0.36, 0.24 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.23, df = 1 (P = 0.63); I2 =0.0%
Test for overall effect: Z = 0.38 (P = 0.71)
Test for subgroup differences: Chi2 = 10.21, df = 1 (P = 0.00), I2 =90%
-2 -1 0 1 2
Favours Exercise Favours Relaxation
129Interventions to improve return to work in depressed people (Review)
Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 12.2. Comparison 12 Exercise intervention versus no intervention or care as usual, Outcome 2
Depressive symptoms.
Review: Interventions to improve return to work in depressed people
Comparison: 12 Exercise intervention versus no intervention or care as usual
Outcome: 2 Depressive symptoms







N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Supervised strength training vs. relaxation
Krogh 2009 46 11 (7.1) 19 10 (5.6) 100.0 % 0.15 [ -0.39, 0.68 ]
Subtotal (95% CI) 46 19 100.0 % 0.15 [ -0.39, 0.68 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.54 (P = 0.59)
2 Aerobic exercise vs. relaxation/stretching
Krogh 2009 46 11.9 (6.5) 19 10 (5.6) 31.7 % 0.30 [ -0.24, 0.84 ]
Krogh 2012 56 11.3 (6.6) 59 10.5 (6.4) 68.3 % 0.12 [ -0.24, 0.49 ]
Subtotal (95% CI) 102 78 100.0 % 0.18 [ -0.12, 0.48 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.29, df = 1 (P = 0.59); I2 =0.0%
Test for overall effect: Z = 1.16 (P = 0.25)
Test for subgroup differences: Chi2 = 0.01, df = 1 (P = 0.92), I2 =0.0%
-2 -1 0 1 2
Favours Exercise Favours Relaxation
A D D I T I O N A L T A B L E S
Table 1. Quality of the evidence (GRADE)
Comparison Studies in
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Undetected Knekt I: Low
Knekt II: Low
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A P P E N D I C E S
Appendix 1. Search strategy update 2006 to 2014
MEDLINE (via Ovid)
1. exp Depressive Disorder/
2. exp DEPRESSION/
3. exp Adjustment Disorders/
4. exp Mood Disorders/
5. exp Affective Symptoms/
6. 1 or 2 or 3 or 4 or 5
7. exp Occupational Therapy/
8. exp Occupational Diseases/
9. exp Occupational Medicine/
10. exp Disability Evaluation/
11. exp WORK/






18. work capacity evaluation.mp.
19. vocational guidance.mp.
20. absenteeism.mp.












33. 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18 or 19 or 20 or 21 or 22 or 23 or 24 or 25 or 26 or 27 or 28 or 29
or 30 or 31 or 32
34. randomized controlled trial.pt. OR randomized.mp. OR placebo.mp.
35. 6 and 33 and 34
EMBASE (via Ovid)
1. exp depression/
2. exp mood disorder/
3. exp adjustment disorder/
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31. (disability adj (work or occupation$ or vocation$ or job)).mp. [mp=title, abstract, subject headings, heading word, drug trade
name, original title, device manufacturer, drug manufacturer name]
32. 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18 or 19 or 20 or 21 or 22 or 23 or 24 or 25 or 26 or 27 or
28 or 29 or 30 or 31
33. Random:.tw. OR placebo:.mp. OR double-blind:.tw.
34. 4 and 32 and 33
PsycINFO (via Ovid)
1. exp Affective Disorders/
2. exp Major Depression/
3. “depression (emotion)”.mp.
4. exp Dysthymic Disorder/
5. Neurotic Depressive Reaction.mp.
6. exp Reactive Depression/
7. exp Recurrent Depression/
8. 1 or 2 or 3 or 4 or 5 or 6 or 7
9. exp Disability Evaluation/
10. exp Employability/
11. exp Employee Leave Benefits/
12. exp Job Satisfaction/
13. exp Occupational Guidance/
14. exp Vocational Rehabilitation/
15. exp Disability Management/
16. exp Employee Absenteeism/
17. exp Occupational Status/
18. exp Occupational Stress/
19. exp Occupational Therapy/
20. exp Reemployment/
21. exp Work Related Illnesses/
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28. work capacity evaluation.ti,ab,tc.
29. vocational guidance.ti,ab,tc.
30. Absenteeism.ti,ab,tc.












43. 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18 or 19 or 20 or 21 or 22 or 23 or 24 or 25 or 26 or 27 or 30 or 31 or 32 or
33 or 34 or 35 or 36 or 37 or 38 or 39 or 40 or 41 or 42
44. random*.ti,ab,tc.





50. ((clin* or control* or compare* or evaluat* or prospective*) adj26 (trial* or studi* or study)).ti,ab,tc.
51. exp Placebo/
52. exp Treatment Effectiveness Evaluation/
53. exp Mental Health Program Evaluation/
54. exp Experimental Design/
55. (assign* or crossover or placebo* or ((singl* or doubl* or trebl* or tripl*) adj26 (blind* or dummy or mask*))).ti,ab,tc. or explode
experimental design/ or random*.ti,ab,tc. or explode mental health program evaluation/ or explode treatment effectiveness evaluation/
or explode placebo/ or ((clin* or control* or compare* or evaluat* or prospective*) adj26 (trial* or studi* or study)).ti,ab,tc. or
allocat*.ti,ab,tc.
56. Animal.po.
57. (human or inpatient or outpatient).po.
58. ((human or inpatient or outpatient) and animal).po.
59. (56 not 58)
60. (55 not 59)
61. 8 and 43 and 60
CINAHL (via EBSCOhost)
1. “Depression”
2. (MH “Affective Disorders+”)
3. (MH “Affective Symptoms+”)
4. (MH “Adjustment Disorders+”)
5. (MH “Neurotic Disorders+”)
6. S1 OR S2 OR S3 OR S4 OR S5
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7. (MH “Job Performance”)
8. (MH “Job Re-Entry”)
9. (MH “Employment+”)
10. (MH “Occupational Health+”)
11. (MH “Rehabilitation, Vocational+”)
12. (MH “Sick Leave”)
13. (MH “Work”)
14. (MH “Disability Evaluation+”)
15. (MH “Occupational Therapy+”)
16. TI Return to work OR AB Return to work OR SU Return to work
17. TI Occupational therap* OR AB Occupational therap* OR SU Occupational therap*
18. TI Occupational intervention* OR AB Occupational intervention* OR SU Occupational intervention*
19. TI Supported employment OR AB Supported employment OR SU Supported employment
20. TI employment OR AB Employment OR SU Employment
21. TI vocational rehabilitation OR AB vocational rehabilitation OR SU vocational rehabilitation
22. TI Work capacity evaluation OR AB Work capacity evaluation OR SU Work capacity evaluation
23. TI vocational guidance OR AB vocational guidance OR SU vocational guidance
24. TI absenteeism OR AB absenteeism OR SU absenteeism
25. TI occupational health services OR AB occupational health services OR SU occupational health services
26. TI occupational health OR AB occupational health OR SU occupational health
27. TI unemployed OR AB unemployed OR SU unemployed
28. TI employed OR AB employed OR SU employed
29. TI unemployment OR AB unemployment OR SU unemployment
30. TI Sick leave OR AB sick leave OR SU sick leave
31. TI Sick* absence OR AB sick* absence OR SU sick* absence
32. TI retirement OR AB retirement OR SU retirement
33. TI Disability pension OR AB Disability pension OR SU Disability pension
34. TI Occupation* OR AB Occupation* OR SU Occupation
35. TI Job OR AB Job OR SU Job
36. TI vocational OR AB vocational OR SU vocational
37. S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR
S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 OR S32 OR S33 OR S34 OR S35 OR S36
38. PT clinical trial
39. (MH “Clinical Trials+”)
40. TI (clin* N24 trial*) OR AB (clin* N24 trial*)
41. TI ( ((singl* or doubl8 or tripl* or trebl*) N24 (blind* or mask* or dummy*)) ) OR AB ( ((singl* or doubl8 or tripl* or trebl*) N24
(blind* or mask* or dummy*)) ) OR SU ( ((singl* or doubl8 or tripl* or trebl*) N24 (blind* or mask* or dummy*)) )
42. (MH “Placebos”)
43. TI placebo* OR AB placebo*
44. TI random* OR AB random*
45. (MH “Evaluation Research+”)
46. (MH “Prospective Studies”)
47. TI ( (control* or prospectiv* or volunteer*) ) OR AB ( (control* or prospectiv* or volunteer*) )
48. S38 OR S39 OR S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47
49. S6 AND S37 AND S48




#4 #1 or #2 or #3
#5 Occupational Therapy
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#6 Occupational Diseases
#7 Occupational Medicine
#8 return to work
#9 occupational intervention$
#10 absenteeism





#16 #5 or #6 or #7 or #8 or #9 or #10 or #11 or #12 or #13 or #14 or #15
#17 #4 and #16 in Trials
Appendix 2. Search strategy up until 2006
First, we searched two Cochrane Depression Anxiety Neurosis Group specialised registers (study-based and reference-based) to identify
all potentially eligible studies. We used both work terms as well as terms relating to depression:
CCDANCTR-Studies (searched on 2/8/2006)




Outcomes = Work* or employ* or vocation* or occupat* or “sick days” or “Sick Leave” or “Sick Absence” or “Time Off”
CCDANCTR-References (searched on 2/8/2006)
Keyword = Depress* or Dysthymi* or “Mood Disorder*” or “Affective Disorder” or “Affective Symptoms”
and
Free-text = (“occupational” and (intervention* or therap* or treatment*)) and (work* or employe* or employment* or vocation* or
“sick leave” or disabil* or absentee*)
Second, we searched the following electronic databases up to August 2006: CENTRAL, MEDLINE, EMBASE, CINAHL, PsycINFO,
OSH-ROM (Occupational Safety and Health; all databases except for MEDLINE), NHS-EED (1994 to August 2006), and the
Database of Abstracts of Reviews of Effectiveness (DARE).
In MEDLINE, PsycINFO, EMBASE and CINAHL and OSH-ROM we used three types of terms: depression-related words (see
CCDAN search strategy) combined with work-related words and database-specific methodological filters terms (see CCDAN search
strategy).
WH A T ’ S N E W
Date Event Description
6 June 2014 New citation required and conclusions have changed Full update. This updated review includes 12 new studies with
3440 newparticipants (added to the 11 studies with 2556 par-
ticipants of the former version). We have modified the names
of the interventions in the comparisons: we now includework-
directed and clinical interventions, while in the 2008 version
clinical interventions were under worker-directed interven-
tions. In the update, we refrained from handsearching jour-
nals as this strategy did not yield additional studies in the
2008 version.We have re-assessed all studies that we originally
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(Continued)
included to be able to use the GRADE method. Two new
authors have joined the review team: Babs Faber and Hiske
Hees
H I S T O R Y
Date Event Description
2 November 2008 Amended Converted to new review format.
20 November 2007 New citation required and conclusions have changed Substantive amendment
C O N T R I B U T I O N S O F A U T H O R S
Original review
KN wrote the initial draft of the protocol and will write subsequent drafts of the protocol and review. She and AN designed and
conducted the search strategy. AV, UB, CF, AN, and JV contributed to the draft version of the protocol and contributed to subsequent
versions and revisions of the protocol and review. KN, AV, and UB included eligible studies. UB and CF conducted the quality
assessment of eligible studies. KN and AN extracted the data from the original studies. KN, CF, and JV conducted the data synthesis.
Update 2014
BF adapted the search strategy and conducted the searches. BF, KN, CF, UB, and AV checked resulting studies for eligibility. BF, KN,
AN, AV CF, HH, and UB conducted data extraction. BF, KN, AN, AV, CH, HH, UB, and JV assessed included studies for risk of
bias. BF, KN, and JV ran the analyses. KN wrote the draft of the updated review and all others commented on this draft. JV acted as
an advisor on the whole review process and several specific topics such as meaningful comparisons, GRADE, and meta-analysis.
D E C L A R A T I O N S O F I N T E R E S T
Karen Nieuwenhuijsen was an author of one of the included studies: Noordik 2013.
Babs Faber: none known.
Jos Verbeek: none known.
Angela Neumeyer-Gromen: none known.
Hiske Hees was an author of one of the included studies: Hees 2013.
Arco Verhoeven: none known.
Christina van der Feltz-Cornelis was an author of one of the included studies: Vlasveld 2013. Her employer received an unrestricted
grant from Eli Lilly for an investigator-initiated trial on depression and pain. She also received payment from Benecke for speaking at
a symposium on chronic pain. She has received royalties from various publishers on her books on psychiatry.
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Ute Bültmann: none known.
None of the authors assessed studies they were authors of for eligibility or risk of bias.
S O U R C E S O F S U P P O R T
Internal sources
• Coronel Institute of Occupational Health, Netherlands.
Salary for Karen Nieuwenhuijsen and Babs Faber
• Trimbos Instituut - Netherlands Institute of Mental Health and Addiction, Netherlands.
Salary for Christina van der Feltz-Cornelis
• Federal Institute for Occupational Safety and Health, Germany.
Salary for Angela Neumeyer-Gromen
• Finnish Institute of Occupational Health, Finland.
Salary for Jos Verbeek
• University Medical Center Groningen, Netherlands.
Salary for Ute Bültmann
• Dutch Research Center for Insurance Medicine, Netherlands.
Support and training for authors
External sources
• KIS programme, Ministry of Social Affairs and Employment, Netherlands.
A small grant to Karen Nieuwenhuijsen to help her finish the first version of this review
D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
In order to reflect the latest guidance available in the Cochrane Handbook for Systematic Teviews of Interventions, we used the GRADE
approach. In the former version of the protocol and the published review, we used the Downs and Black checklist to assess quality,
while in this update we used the Cochrane Collaboration’s risk of bias tool. Also, we no longer formally tested heterogeneity but rather
assessed the I² statistic. Furthermore, our search strategy was simplified and we no longer handsearched journals as these were indexed
in MEDLINE and did not yield additional studies. Instead of searching the CCDAN registers, we now directly searched CENTRAL.
I N D E X T E R M S
Medical Subject Headings (MeSH)
∗Absenteeism; ∗Occupational Health; Antidepressive Agents [therapeutic use]; Cognitive Therapy; Depression [∗therapy]; Depressive
Disorder, Major [∗therapy]; Muscle Stretching Exercises; Randomized Controlled Trials as Topic; Return to Work [∗psychology]; Sick
Leave
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MeSH check words
Adult; Humans
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